'en:mesothelial neoplasm'
(id=6829993 ; fe=en:mesothelial neoplasm ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=80460 creation date=2017-06-25 touchdate=2025-12-29 18:08:53.000) ≈ 1111 relations sortantes
- en:mesothelial neoplasm --
r_associated #0: 159 / 1 ->
médecine
n1=en:mesothelial neoplasm | n2=médecine | rel=r_associated | relid=0 | w=159
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:choriocarcinoma
n1=en:mesothelial neoplasm | n2=en:choriocarcinoma | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:fibromatous neoplasm
n1=en:mesothelial neoplasm | n2=en:fibromatous neoplasm | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:malignant tumor of nerve sheath origin
n1=en:mesothelial neoplasm | n2=en:malignant tumor of nerve sheath origin | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:meningioma
n1=en:mesothelial neoplasm | n2=en:meningioma | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:metastatic qualifier
n1=en:mesothelial neoplasm | n2=en:metastatic qualifier | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:neoplastic mesothelial cell
n1=en:mesothelial neoplasm | n2=en:neoplastic mesothelial cell | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 43 / 0.27 ->
en:neuroendocrine neoplasm
n1=en:mesothelial neoplasm | n2=en:neuroendocrine neoplasm | rel=r_associated | relid=0 | w=43
- en:mesothelial neoplasm --
r_associated #0: 42 / 0.264 ->
en:colorectal cancer (in some patients)
n1=en:mesothelial neoplasm | n2=en:colorectal cancer (in some patients) | rel=r_associated | relid=0 | w=42
- en:mesothelial neoplasm --
r_associated #0: 42 / 0.264 ->
en:paraganglioma
n1=en:mesothelial neoplasm | n2=en:paraganglioma | rel=r_associated | relid=0 | w=42
- en:mesothelial neoplasm --
r_associated #0: 42 / 0.264 ->
en:precursor lymphoblastic leukemia/lymphoma (all subtypes)
n1=en:mesothelial neoplasm | n2=en:precursor lymphoblastic leukemia/lymphoma (all subtypes) | rel=r_associated | relid=0 | w=42
- en:mesothelial neoplasm --
r_associated #0: 42 / 0.264 ->
en:reported colon and other abdominal cancer in relatives
n1=en:mesothelial neoplasm | n2=en:reported colon and other abdominal cancer in relatives | rel=r_associated | relid=0 | w=42
- en:mesothelial neoplasm --
r_associated #0: 42 / 0.264 ->
en:skin carcinoma
n1=en:mesothelial neoplasm | n2=en:skin carcinoma | rel=r_associated | relid=0 | w=42
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:cylindromas may show malignant transformation
n1=en:mesothelial neoplasm | n2=en:cylindromas may show malignant transformation | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:desmoid-type fibromatosis
n1=en:mesothelial neoplasm | n2=en:desmoid-type fibromatosis | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:embryonal carcinoma
n1=en:mesothelial neoplasm | n2=en:embryonal carcinoma | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:neuroblastoma (less common)
n1=en:mesothelial neoplasm | n2=en:neuroblastoma (less common) | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:optic nerve glioma
n1=en:mesothelial neoplasm | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:teratoid tumor, atypical
n1=en:mesothelial neoplasm | n2=en:teratoid tumor, atypical | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 41 / 0.258 ->
en:veterinary aspects
n1=en:mesothelial neoplasm | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=41
- en:mesothelial neoplasm --
r_associated #0: 40 / 0.252 ->
en:benign endocrine neoplasm
n1=en:mesothelial neoplasm | n2=en:benign endocrine neoplasm | rel=r_associated | relid=0 | w=40
- en:mesothelial neoplasm --
r_associated #0: 40 / 0.252 ->
en:fibroblastic/myofibroblastic tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:fibroblastic/myofibroblastic tumors (all subtypes) | rel=r_associated | relid=0 | w=40
- en:mesothelial neoplasm --
r_associated #0: 40 / 0.252 ->
en:multiple malignancy
n1=en:mesothelial neoplasm | n2=en:multiple malignancy | rel=r_associated | relid=0 | w=40
- en:mesothelial neoplasm --
r_associated #0: 40 / 0.252 ->
en:plasma cell myeloma
n1=en:mesothelial neoplasm | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=40
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:malignant intestinal neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant intestinal neoplasm | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:malignant kidney neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant kidney neoplasm | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:neoplasms, multiple primary
n1=en:mesothelial neoplasm | n2=en:neoplasms, multiple primary | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially)
n1=en:mesothelial neoplasm | n2=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:paragangliomas, head and neck (79%)
n1=en:mesothelial neoplasm | n2=en:paragangliomas, head and neck (79%) | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 39 / 0.245 ->
en:skeletal neoplasms benign
n1=en:mesothelial neoplasm | n2=en:skeletal neoplasms benign | rel=r_associated | relid=0 | w=39
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:lymphoproliferative disorder (in some patients)
n1=en:mesothelial neoplasm | n2=en:lymphoproliferative disorder (in some patients) | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system
n1=en:mesothelial neoplasm | n2=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:osseous and/or chondromatous neoplasm
n1=en:mesothelial neoplasm | n2=en:osseous and/or chondromatous neoplasm | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:skin squamous cell carcinoma
n1=en:mesothelial neoplasm | n2=en:skin squamous cell carcinoma | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:small intestinal carcinoma
n1=en:mesothelial neoplasm | n2=en:small intestinal carcinoma | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 38 / 0.239 ->
en:soft tissue tumor and/or sarcoma
n1=en:mesothelial neoplasm | n2=en:soft tissue tumor and/or sarcoma | rel=r_associated | relid=0 | w=38
- en:mesothelial neoplasm --
r_associated #0: 37 / 0.233 ->
en:carcinosarcoma of skin
n1=en:mesothelial neoplasm | n2=en:carcinosarcoma of skin | rel=r_associated | relid=0 | w=37
- en:mesothelial neoplasm --
r_associated #0: 37 / 0.233 ->
en:complication aspects
n1=en:mesothelial neoplasm | n2=en:complication aspects | rel=r_associated | relid=0 | w=37
- en:mesothelial neoplasm --
r_associated #0: 37 / 0.233 ->
en:lymphoproliferative disorder
n1=en:mesothelial neoplasm | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=37
- en:mesothelial neoplasm --
r_associated #0: 37 / 0.233 ->
en:malignant tumor, clear cell type
n1=en:mesothelial neoplasm | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=37
- en:mesothelial neoplasm --
r_associated #0: 37 / 0.233 ->
en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm
n1=en:mesothelial neoplasm | n2=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | rel=r_associated | relid=0 | w=37
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:adrenal cortex carcinoma
n1=en:mesothelial neoplasm | n2=en:adrenal cortex carcinoma | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:ampulla of vater adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:ampulla of vater adenocarcinoma | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:basal cell neoplasm
n1=en:mesothelial neoplasm | n2=en:basal cell neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:benign neoplasm
n1=en:mesothelial neoplasm | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:fibrosarcoma
n1=en:mesothelial neoplasm | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:hypothalamic neoplasm
n1=en:mesothelial neoplasm | n2=en:hypothalamic neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:increased risk for hematologic cancer, particularly acute myeloid leukemia
n1=en:mesothelial neoplasm | n2=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:malignant muscle neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant muscle neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:pigmentation
n1=en:mesothelial neoplasm | n2=en:pigmentation | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:plasma cell neoplasm
n1=en:mesothelial neoplasm | n2=en:plasma cell neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 36 / 0.226 ->
en:retinoblastoma
n1=en:mesothelial neoplasm | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=36
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:acute megakaryoblastic leukemia
n1=en:mesothelial neoplasm | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:adenocarcinoma (some)
n1=en:mesothelial neoplasm | n2=en:adenocarcinoma (some) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:adenoid cystic carcinoma
n1=en:mesothelial neoplasm | n2=en:adenoid cystic carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:adenoma and/or adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:adenoma and/or adenocarcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:adipocytic tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:adipocytic tumors (all subtypes) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:benign male reproductive system neoplasm
n1=en:mesothelial neoplasm | n2=en:benign male reproductive system neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:bile duct carcinoma
n1=en:mesothelial neoplasm | n2=en:bile duct carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:biopsy
n1=en:mesothelial neoplasm | n2=en:biopsy | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:blood or lymphatic cancer
n1=en:mesothelial neoplasm | n2=en:blood or lymphatic cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:body system/site cancer
n1=en:mesothelial neoplasm | n2=en:body system/site cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:breast cancer (rare)
n1=en:mesothelial neoplasm | n2=en:breast cancer (rare) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:breast cancer, lobular
n1=en:mesothelial neoplasm | n2=en:breast cancer, lobular | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:breast neoplasm
n1=en:mesothelial neoplasm | n2=en:breast neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:breast neoplasms malignant and unspecified (incl nipple)
n1=en:mesothelial neoplasm | n2=en:breast neoplasms malignant and unspecified (incl nipple) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:carcinoid tumor
n1=en:mesothelial neoplasm | n2=en:carcinoid tumor | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:carotid body tumors (most common)
n1=en:mesothelial neoplasm | n2=en:carotid body tumors (most common) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:cervical carcinoma
n1=en:mesothelial neoplasm | n2=en:cervical carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:chronic lymphocytic leukemia
n1=en:mesothelial neoplasm | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:clear cell renal cell carcinoma
n1=en:mesothelial neoplasm | n2=en:clear cell renal cell carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:craniopharyngioma
n1=en:mesothelial neoplasm | n2=en:craniopharyngioma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:cutaneous leiomyosarcoma (less common)
n1=en:mesothelial neoplasm | n2=en:cutaneous leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:cystic, mucinous and/or serous neoplasm
n1=en:mesothelial neoplasm | n2=en:cystic, mucinous and/or serous neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:development of tumors in adulthood
n1=en:mesothelial neoplasm | n2=en:development of tumors in adulthood | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:dysplasia with neoplasia
n1=en:mesothelial neoplasm | n2=en:dysplasia with neoplasia | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:early-onset hepatocellular carcinoma
n1=en:mesothelial neoplasm | n2=en:early-onset hepatocellular carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:end stage cancer
n1=en:mesothelial neoplasm | n2=en:end stage cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:endocrine neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:endocrine neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:endocrine system cancer
n1=en:mesothelial neoplasm | n2=en:endocrine system cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:endolymphatic sac tumor
n1=en:mesothelial neoplasm | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:environment related neoplasm/cancer
n1=en:mesothelial neoplasm | n2=en:environment related neoplasm/cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:fibrohistiocytic neoplasm
n1=en:mesothelial neoplasm | n2=en:fibrohistiocytic neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:fibrous connective tissue neoplasm
n1=en:mesothelial neoplasm | n2=en:fibrous connective tissue neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:giant cell astrocytoma
n1=en:mesothelial neoplasm | n2=en:giant cell astrocytoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:giant cell neoplasm
n1=en:mesothelial neoplasm | n2=en:giant cell neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:head or neck cancer
n1=en:mesothelial neoplasm | n2=en:head or neck cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:in blood
n1=en:mesothelial neoplasm | n2=en:in blood | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased risk for cancer
n1=en:mesothelial neoplasm | n2=en:increased risk for cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased risk for wilms tumor
n1=en:mesothelial neoplasm | n2=en:increased risk for wilms tumor | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased risk of malignancy (classic feature)
n1=en:mesothelial neoplasm | n2=en:increased risk of malignancy (classic feature) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased risk of myelodysplastic syndrome or leukemia (in some patients)
n1=en:mesothelial neoplasm | n2=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased risk of myelodysplastic syndromes
n1=en:mesothelial neoplasm | n2=en:increased risk of myelodysplastic syndromes | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:increased susceptibility to cancer
n1=en:mesothelial neoplasm | n2=en:increased susceptibility to cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:invasive malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:invasive malignant neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:invertebrate cuticle
n1=en:mesothelial neoplasm | n2=en:invertebrate cuticle | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:kaposi sarcoma (1 patient)
n1=en:mesothelial neoplasm | n2=en:kaposi sarcoma (1 patient) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:laryngeal neoplasm
n1=en:mesothelial neoplasm | n2=en:laryngeal neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant digestive system neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant digestive system neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant neoplasm after immunosuppressive therapy
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm after immunosuppressive therapy | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant neoplasm associated with transplant organ
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm associated with transplant organ | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant neoplasm of abdomen
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of abdomen | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant neoplasm of liver
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of liver | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
n1=en:mesothelial neoplasm | n2=en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant nervous system neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant nervous system neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant skin appendage neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant skin appendage neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant tumor involving an organ by direct extension from fallopian tube
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from fallopian tube | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant tumor involving an organ by direct extension from vagina
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from vagina | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant urinary system neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant urinary system neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:malignant white blood cell disorder
n1=en:mesothelial neoplasm | n2=en:malignant white blood cell disorder | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:meningothelial cell neoplasm
n1=en:mesothelial neoplasm | n2=en:meningothelial cell neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:mesonephric neoplasm
n1=en:mesothelial neoplasm | n2=en:mesonephric neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:minimal residual disease
n1=en:mesothelial neoplasm | n2=en:minimal residual disease | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:miscellaneous soft tissue tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:miscellaneous soft tissue tumors (all subtypes) | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:myxoid subcutaneous tumors
n1=en:mesothelial neoplasm | n2=en:myxoid subcutaneous tumors | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:myxomatous neoplasm
n1=en:mesothelial neoplasm | n2=en:myxomatous neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:neoplasm by special category
n1=en:mesothelial neoplasm | n2=en:neoplasm by special category | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:neoplasm of perivascular myoid type - category
n1=en:mesothelial neoplasm | n2=en:neoplasm of perivascular myoid type - category | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:neoplasm of unspecified nature of respiratory system
n1=en:mesothelial neoplasm | n2=en:neoplasm of unspecified nature of respiratory system | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:neoplastic cell
n1=en:mesothelial neoplasm | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:nervous system tumor morphology
n1=en:mesothelial neoplasm | n2=en:nervous system tumor morphology | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:neuroblastoma
n1=en:mesothelial neoplasm | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:nevus and/or melanoma
n1=en:mesothelial neoplasm | n2=en:nevus and/or melanoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:pancreatic carcinoma
n1=en:mesothelial neoplasm | n2=en:pancreatic carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:paraganglioma, catecholamine-secreting
n1=en:mesothelial neoplasm | n2=en:paraganglioma, catecholamine-secreting | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:parasitology
n1=en:mesothelial neoplasm | n2=en:parasitology | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:primary malignant germ cell neoplasm
n1=en:mesothelial neoplasm | n2=en:primary malignant germ cell neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:propensity to tumor development
n1=en:mesothelial neoplasm | n2=en:propensity to tumor development | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:rarely malignant
n1=en:mesothelial neoplasm | n2=en:rarely malignant | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:renal cell carcinoma
n1=en:mesothelial neoplasm | n2=en:renal cell carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:reproductive neoplasms female malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:reproductive neoplasms female malignant and unspecified | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:retinal cell neoplasm
n1=en:mesothelial neoplasm | n2=en:retinal cell neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:sebaceous epithelioma
n1=en:mesothelial neoplasm | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:sensitivity to genotoxic agents
n1=en:mesothelial neoplasm | n2=en:sensitivity to genotoxic agents | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:serosa
n1=en:mesothelial neoplasm | n2=en:serosa | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:small cell carcinoma of the ovary, hypercalcemic type
n1=en:mesothelial neoplasm | n2=en:small cell carcinoma of the ovary, hypercalcemic type | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:soft tissue neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:somatostatin-producing neuroendocrine tumor
n1=en:mesothelial neoplasm | n2=en:somatostatin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer
n1=en:mesothelial neoplasm | n2=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:testicular sertoli cell tumor, calcified
n1=en:mesothelial neoplasm | n2=en:testicular sertoli cell tumor, calcified | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:therapeutic aspects
n1=en:mesothelial neoplasm | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:thymus epithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:thymus epithelial neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:thyroid follicular cell tumor
n1=en:mesothelial neoplasm | n2=en:thyroid follicular cell tumor | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:trichoblastoma
n1=en:mesothelial neoplasm | n2=en:trichoblastoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma
n1=en:mesothelial neoplasm | n2=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:tumor in vein
n1=en:mesothelial neoplasm | n2=en:tumor in vein | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:tumor lysis syndrome adverse event
n1=en:mesothelial neoplasm | n2=en:tumor lysis syndrome adverse event | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 35 / 0.22 ->
en:undifferentiated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:undifferentiated malignant neoplasm | rel=r_associated | relid=0 | w=35
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:acute lymphoblastic leukemia
n1=en:mesothelial neoplasm | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:acute monocytic leukemia
n1=en:mesothelial neoplasm | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:adrenal glands are most common site
n1=en:mesothelial neoplasm | n2=en:adrenal glands are most common site | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:angiolipoma
n1=en:mesothelial neoplasm | n2=en:angiolipoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:biological polymorphism
n1=en:mesothelial neoplasm | n2=en:biological polymorphism | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:biphasic mesothelioma
n1=en:mesothelial neoplasm | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:bladder neoplasm
n1=en:mesothelial neoplasm | n2=en:bladder neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:bladder urothelial carcinoma
n1=en:mesothelial neoplasm | n2=en:bladder urothelial carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:brain neoplasm
n1=en:mesothelial neoplasm | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:burkitt lymphoma (b-cell lymphoma)
n1=en:mesothelial neoplasm | n2=en:burkitt lymphoma (b-cell lymphoma) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:clear cell acanthoma
n1=en:mesothelial neoplasm | n2=en:clear cell acanthoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:cyst
n1=en:mesothelial neoplasm | n2=en:cyst | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:desmoplastic small cell tumor
n1=en:mesothelial neoplasm | n2=en:desmoplastic small cell tumor | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:electric organ
n1=en:mesothelial neoplasm | n2=en:electric organ | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:esophageal carcinoma
n1=en:mesothelial neoplasm | n2=en:esophageal carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:frequent skin cancer
n1=en:mesothelial neoplasm | n2=en:frequent skin cancer | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:gallbladder carcinoma
n1=en:mesothelial neoplasm | n2=en:gallbladder carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:giant cell lesion of small bones
n1=en:mesothelial neoplasm | n2=en:giant cell lesion of small bones | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:glioma
n1=en:mesothelial neoplasm | n2=en:glioma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:immunodeficiency-related malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:immunodeficiency-related malignant neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:in situ neoplasm (morphology)
n1=en:mesothelial neoplasm | n2=en:in situ neoplasm (morphology) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased hepatocellular carcinoma risk
n1=en:mesothelial neoplasm | n2=en:increased hepatocellular carcinoma risk | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased incidence of hepatocellular carcinoma
n1=en:mesothelial neoplasm | n2=en:increased incidence of hepatocellular carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased risk of chondrosarcoma (mean age of onset 31 years)
n1=en:mesothelial neoplasm | n2=en:increased risk of chondrosarcoma (mean age of onset 31 years) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased risk of hematologic malignancy (1 patient)
n1=en:mesothelial neoplasm | n2=en:increased risk of hematologic malignancy (1 patient) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased risk of meningioma
n1=en:mesothelial neoplasm | n2=en:increased risk of meningioma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:increased risk of tumor formation, especially of the head
n1=en:mesothelial neoplasm | n2=en:increased risk of tumor formation, especially of the head | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:intra-abdominal cancer advanced
n1=en:mesothelial neoplasm | n2=en:intra-abdominal cancer advanced | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:kidney wilms tumor
n1=en:mesothelial neoplasm | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:low incidence of plexiform neurofibromas
n1=en:mesothelial neoplasm | n2=en:low incidence of plexiform neurofibromas | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:lung carcinoma
n1=en:mesothelial neoplasm | n2=en:lung carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:malignant breast neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:malignant head and neck neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant head and neck neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:malignant neoplastic disease in pregnancy
n1=en:mesothelial neoplasm | n2=en:malignant neoplastic disease in pregnancy | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:malignant pancreatic neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:mixed neoplasm
n1=en:mesothelial neoplasm | n2=en:mixed neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:morphology
n1=en:mesothelial neoplasm | n2=en:morphology | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:mucosal neuromas
n1=en:mesothelial neoplasm | n2=en:mucosal neuromas | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:neoplasm by site
n1=en:mesothelial neoplasm | n2=en:neoplasm by site | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:neoplasm, uncertain whether benign or malignant
n1=en:mesothelial neoplasm | n2=en:neoplasm, uncertain whether benign or malignant | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:neoplasms, post-traumatic
n1=en:mesothelial neoplasm | n2=en:neoplasms, post-traumatic | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:neural tissue tumors
n1=en:mesothelial neoplasm | n2=en:neural tissue tumors | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:no progression to cancer
n1=en:mesothelial neoplasm | n2=en:no progression to cancer | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:nonmelanoma skin cancer (in some patients)
n1=en:mesothelial neoplasm | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:paraneoplastic syndrome
n1=en:mesothelial neoplasm | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:parotid oncocytomas
n1=en:mesothelial neoplasm | n2=en:parotid oncocytomas | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:periampullary carcinoma nos
n1=en:mesothelial neoplasm | n2=en:periampullary carcinoma nos | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:pinealoma (trilateral retinoblastoma)
n1=en:mesothelial neoplasm | n2=en:pinealoma (trilateral retinoblastoma) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:possibly increased risk for other cancers
n1=en:mesothelial neoplasm | n2=en:possibly increased risk for other cancers | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:pregnancy complications, neoplastic
n1=en:mesothelial neoplasm | n2=en:pregnancy complications, neoplastic | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:preneoplastic state
n1=en:mesothelial neoplasm | n2=en:preneoplastic state | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:prolactin-producing pituitary gland adenoma
n1=en:mesothelial neoplasm | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:psychology qualifier
n1=en:mesothelial neoplasm | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:solid neoplasm
n1=en:mesothelial neoplasm | n2=en:solid neoplasm | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:squamous cell carcinoma (skin and tongue)
n1=en:mesothelial neoplasm | n2=en:squamous cell carcinoma (skin and tongue) | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:starry sky pattern
n1=en:mesothelial neoplasm | n2=en:starry sky pattern | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:testicular sertoli cell tumor
n1=en:mesothelial neoplasm | n2=en:testicular sertoli cell tumor | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:thyroid gland oncocytic adenoma
n1=en:mesothelial neoplasm | n2=en:thyroid gland oncocytic adenoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:thyroid gland papillary carcinoma
n1=en:mesothelial neoplasm | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 34 / 0.214 ->
en:ultrastructure
n1=en:mesothelial neoplasm | n2=en:ultrastructure | rel=r_associated | relid=0 | w=34
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:acoustic schwannoma
n1=en:mesothelial neoplasm | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:adnexal and/or skin appendage neoplasm
n1=en:mesothelial neoplasm | n2=en:adnexal and/or skin appendage neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:approximately 10% of cases are paraneoplastic
n1=en:mesothelial neoplasm | n2=en:approximately 10% of cases are paraneoplastic | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:basocellular neoplasms develop after second decade
n1=en:mesothelial neoplasm | n2=en:basocellular neoplasms develop after second decade | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:biliary tract neoplasm
n1=en:mesothelial neoplasm | n2=en:biliary tract neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:bone sarcoma
n1=en:mesothelial neoplasm | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:cancer of nose
n1=en:mesothelial neoplasm | n2=en:cancer of nose | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:cardiovascular neoplasm
n1=en:mesothelial neoplasm | n2=en:cardiovascular neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:cartilage-forming neoplasm
n1=en:mesothelial neoplasm | n2=en:cartilage-forming neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:cervical cancer screening
n1=en:mesothelial neoplasm | n2=en:cervical cancer screening | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:chromaffin cell neoplasm
n1=en:mesothelial neoplasm | n2=en:chromaffin cell neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:chronic leukemia
n1=en:mesothelial neoplasm | n2=en:chronic leukemia | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:chronic lymphocytic leukemia, b-cell, susceptibility to
n1=en:mesothelial neoplasm | n2=en:chronic lymphocytic leukemia, b-cell, susceptibility to | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:complex epithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:complex epithelial neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:compound eye
n1=en:mesothelial neoplasm | n2=en:compound eye | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:digestive system carcinoma
n1=en:mesothelial neoplasm | n2=en:digestive system carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:disseminated malignant neoplasm, unspecified
n1=en:mesothelial neoplasm | n2=en:disseminated malignant neoplasm, unspecified | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:egg shell
n1=en:mesothelial neoplasm | n2=en:egg shell | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:environment-related malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:environment-related malignant neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:epidemiologic
n1=en:mesothelial neoplasm | n2=en:epidemiologic | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions
n1=en:mesothelial neoplasm | n2=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:gastric carcinoma
n1=en:mesothelial neoplasm | n2=en:gastric carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:granular cell tumor and/or alveolar soft part sarcoma
n1=en:mesothelial neoplasm | n2=en:granular cell tumor and/or alveolar soft part sarcoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:heart dimension/size
n1=en:mesothelial neoplasm | n2=en:heart dimension/size | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:hepatobiliary neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:hepatobiliary neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:increased risk of malignant lymphoma
n1=en:mesothelial neoplasm | n2=en:increased risk of malignant lymphoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:increased susceptibility to large granular lymphocytic t-cell leukemia
n1=en:mesothelial neoplasm | n2=en:increased susceptibility to large granular lymphocytic t-cell leukemia | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:juvenile ovarian granulosa cell tumor
n1=en:mesothelial neoplasm | n2=en:juvenile ovarian granulosa cell tumor | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:laryngeal carcinoma
n1=en:mesothelial neoplasm | n2=en:laryngeal carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:lund
n1=en:mesothelial neoplasm | n2=en:lund | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:male germ cell tumors (gct), 2 subtypes -
n1=en:mesothelial neoplasm | n2=en:male germ cell tumors (gct), 2 subtypes - | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant endocrine neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant endocrine neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant esophageal neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant esophageal neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant giant cell neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm (morphology)
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm (morphology) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm of anorectum
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of anorectum | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm of digestive organs and peritoneum
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm of lip, oral cavity and pharynx
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm of other specified sites
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of other specified sites | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant neoplasm of skeletal system
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of skeletal system | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant tumor involving an organ by direct extension from ovary
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from ovary | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant tumor involving an organ by direct extension from prostate
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from prostate | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:malignant tumor, small cell type
n1=en:mesothelial neoplasm | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:mast cell neoplasm
n1=en:mesothelial neoplasm | n2=en:mast cell neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:medulloblastoma
n1=en:mesothelial neoplasm | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:mesothelial neoplasms
n1=en:mesothelial neoplasm | n2=en:mesothelial neoplasms | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:miscellaneous and site unspecified neoplasms benign
n1=en:mesothelial neoplasm | n2=en:miscellaneous and site unspecified neoplasms benign | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:miscellaneous and site unspecified neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:miscellaneous and site unspecified neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:miscellaneous bone tumors
n1=en:mesothelial neoplasm | n2=en:miscellaneous bone tumors | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:muscle tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:muscle tumors (all subtypes) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasm by morphology
n1=en:mesothelial neoplasm | n2=en:neoplasm by morphology | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasm of uncertain behavior of other and unspecified sites and tissues
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasm of uncertain behavior of other specified sites
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain behavior of other specified sites | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasm of unspecified nature of bone, soft tissue, and skin
n1=en:mesothelial neoplasm | n2=en:neoplasm of unspecified nature of bone, soft tissue, and skin | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasm/cancer invasiveness
n1=en:mesothelial neoplasm | n2=en:neoplasm/cancer invasiveness | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neoplasms, connective tissue
n1=en:mesothelial neoplasm | n2=en:neoplasms, connective tissue | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neuroepithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:neuroepithelial neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neurofibroma
n1=en:mesothelial neoplasm | n2=en:neurofibroma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:neuronal or mixed neuronal-glial neoplasm
n1=en:mesothelial neoplasm | n2=en:neuronal or mixed neuronal-glial neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:oligodendroglioma
n1=en:mesothelial neoplasm | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:oral cavity carcinoma
n1=en:mesothelial neoplasm | n2=en:oral cavity carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:osteosarcoma and meningioma especially
n1=en:mesothelial neoplasm | n2=en:osteosarcoma and meningioma especially | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:other hematologic disorders
n1=en:mesothelial neoplasm | n2=en:other hematologic disorders | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:ovarian sex cord-stromal tumor
n1=en:mesothelial neoplasm | n2=en:ovarian sex cord-stromal tumor | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:pancreatic squamous cell carcinoma
n1=en:mesothelial neoplasm | n2=en:pancreatic squamous cell carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:papillary thyroid carcinoma (rare)
n1=en:mesothelial neoplasm | n2=en:papillary thyroid carcinoma (rare) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:pituitary gland neoplasm
n1=en:mesothelial neoplasm | n2=en:pituitary gland neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:possible increased risk of germ-cell tumors
n1=en:mesothelial neoplasm | n2=en:possible increased risk of germ-cell tumors | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:primary malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:primary malignant neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:radiation-related neoplasm
n1=en:mesothelial neoplasm | n2=en:radiation-related neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:rehabilitation aspects
n1=en:mesothelial neoplasm | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:renal cell carcinoma (less common)
n1=en:mesothelial neoplasm | n2=en:renal cell carcinoma (less common) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients)
n1=en:mesothelial neoplasm | n2=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:reproductive and genitourinary neoplasms gender unspecified nec
n1=en:mesothelial neoplasm | n2=en:reproductive and genitourinary neoplasms gender unspecified nec | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:sacrococcygeal teratoma
n1=en:mesothelial neoplasm | n2=en:sacrococcygeal teratoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:screening for prostate cancer
n1=en:mesothelial neoplasm | n2=en:screening for prostate cancer | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:sebaceous carcinoma
n1=en:mesothelial neoplasm | n2=en:sebaceous carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:sinonasal undifferentiated carcinoma
n1=en:mesothelial neoplasm | n2=en:sinonasal undifferentiated carcinoma | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:skeletal neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:skeletal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:squamous cell carcinoma (1 patient)
n1=en:mesothelial neoplasm | n2=en:squamous cell carcinoma (1 patient) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:thyroid cancer (follicular cell)
n1=en:mesothelial neoplasm | n2=en:thyroid cancer (follicular cell) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:undifferentiated and biphenotypic leukemia (all subtypes)
n1=en:mesothelial neoplasm | n2=en:undifferentiated and biphenotypic leukemia (all subtypes) | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:vibrissae
n1=en:mesothelial neoplasm | n2=en:vibrissae | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 32 / 0.201 ->
en:well differentiated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:well differentiated malignant neoplasm | rel=r_associated | relid=0 | w=32
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:acinar cell neoplasm
n1=en:mesothelial neoplasm | n2=en:acinar cell neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:advanced malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:advanced malignant neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:astrocytoma
n1=en:mesothelial neoplasm | n2=en:astrocytoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:b-cell non-hodgkin lymphoma
n1=en:mesothelial neoplasm | n2=en:b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:benign epithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:benign epithelial neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:benign female reproductive system neoplasm
n1=en:mesothelial neoplasm | n2=en:benign female reproductive system neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:benign skin neoplasm
n1=en:mesothelial neoplasm | n2=en:benign skin neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:benign soft tissue neoplasm
n1=en:mesothelial neoplasm | n2=en:benign soft tissue neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:cancer alternative therapies
n1=en:mesothelial neoplasm | n2=en:cancer alternative therapies | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:carotid body tumors (most common location)
n1=en:mesothelial neoplasm | n2=en:carotid body tumors (most common location) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:cervical cancer
n1=en:mesothelial neoplasm | n2=en:cervical cancer | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:chemically induced
n1=en:mesothelial neoplasm | n2=en:chemically induced | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:childhood malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:childhood malignant neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:chondrogenic neoplasm
n1=en:mesothelial neoplasm | n2=en:chondrogenic neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:choroid plexus carcinoma
n1=en:mesothelial neoplasm | n2=en:choroid plexus carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:chronic monocytic leukemia
n1=en:mesothelial neoplasm | n2=en:chronic monocytic leukemia | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:chronic myelogenous leukemia, bcr-abl1 positive
n1=en:mesothelial neoplasm | n2=en:chronic myelogenous leukemia, bcr-abl1 positive | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:ductal breast carcinoma
n1=en:mesothelial neoplasm | n2=en:ductal breast carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:duodenal carcinoid
n1=en:mesothelial neoplasm | n2=en:duodenal carcinoid | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:embryonal neoplasm
n1=en:mesothelial neoplasm | n2=en:embryonal neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:endometrial adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:endometrial adenocarcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:endometrial neoplasm
n1=en:mesothelial neoplasm | n2=en:endometrial neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:enzymology
n1=en:mesothelial neoplasm | n2=en:enzymology | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:etiology aspects
n1=en:mesothelial neoplasm | n2=en:etiology aspects | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:eye neoplasm
n1=en:mesothelial neoplasm | n2=en:eye neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:gastrointestinal stromal tumors (less common)
n1=en:mesothelial neoplasm | n2=en:gastrointestinal stromal tumors (less common) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:germ cell and gonadal stromal cell neoplasms (all subtypes)
n1=en:mesothelial neoplasm | n2=en:germ cell and gonadal stromal cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:growth hormone-producing pituitary gland neoplasm
n1=en:mesothelial neoplasm | n2=en:growth hormone-producing pituitary gland neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007)
n1=en:mesothelial neoplasm | n2=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:hereditary malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:hereditary malignant neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:hereditary neoplastic syndrome
n1=en:mesothelial neoplasm | n2=en:hereditary neoplastic syndrome | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:host-tumor interaction
n1=en:mesothelial neoplasm | n2=en:host-tumor interaction | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:hypersensitivity to chemotherapy
n1=en:mesothelial neoplasm | n2=en:hypersensitivity to chemotherapy | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form)
n1=en:mesothelial neoplasm | n2=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:in cerebrospinal fluid
n1=en:mesothelial neoplasm | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:increased malignancy risk, especially lymphoma and skin neoplasm
n1=en:mesothelial neoplasm | n2=en:increased malignancy risk, especially lymphoma and skin neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:increased risk of gastrointestinal cancer
n1=en:mesothelial neoplasm | n2=en:increased risk of gastrointestinal cancer | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections
n1=en:mesothelial neoplasm | n2=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:index tumor
n1=en:mesothelial neoplasm | n2=en:index tumor | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:leukemia
n1=en:mesothelial neoplasm | n2=en:leukemia | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:leukemia (both all and aml)
n1=en:mesothelial neoplasm | n2=en:leukemia (both all and aml) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity)
n1=en:mesothelial neoplasm | n2=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:lymphoma (in some patients)
n1=en:mesothelial neoplasm | n2=en:lymphoma (in some patients) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant bladder neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant bladder neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant gastric neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant gastric neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant genitourinary tract tumor
n1=en:mesothelial neoplasm | n2=en:malignant genitourinary tract tumor | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant neoplasm of connective tissue
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of connective tissue | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant neoplasm of respiratory system
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of respiratory system | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection
n1=en:mesothelial neoplasm | n2=en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant spindle cell neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:malignant tumor of lymphoid hemopoietic and related tissue
n1=en:mesothelial neoplasm | n2=en:malignant tumor of lymphoid hemopoietic and related tissue | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:mammary ductal fibroadenoma
n1=en:mesothelial neoplasm | n2=en:mammary ductal fibroadenoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:metabolic aspects
n1=en:mesothelial neoplasm | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:metachronous malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:metachronous malignant neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:metastatic angiosarcoma
n1=en:mesothelial neoplasm | n2=en:metastatic angiosarcoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:metastatic neoplasm
n1=en:mesothelial neoplasm | n2=en:metastatic neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:mucoepidermoid tumor
n1=en:mesothelial neoplasm | n2=en:mucoepidermoid tumor | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:multiple bilateral renal angiomyolipoma
n1=en:mesothelial neoplasm | n2=en:multiple bilateral renal angiomyolipoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:multiple tumors in 74% of patients
n1=en:mesothelial neoplasm | n2=en:multiple tumors in 74% of patients | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:myocardial rhabdomyoma
n1=en:mesothelial neoplasm | n2=en:myocardial rhabdomyoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:neoplasm of uncertain histogenesis
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain histogenesis | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:neoplasm of unspecified nature of other specified sites
n1=en:mesothelial neoplasm | n2=en:neoplasm of unspecified nature of other specified sites | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:neoplasm/cancer site
n1=en:mesothelial neoplasm | n2=en:neoplasm/cancer site | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:neoplasms, glandular and epithelial
n1=en:mesothelial neoplasm | n2=en:neoplasms, glandular and epithelial | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:nonneoplastic disorders/lesions (all subtypes)
n1=en:mesothelial neoplasm | n2=en:nonneoplastic disorders/lesions (all subtypes) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor)
n1=en:mesothelial neoplasm | n2=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:oncocytic adenoma
n1=en:mesothelial neoplasm | n2=en:oncocytic adenoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:oropharyngeal carcinoma
n1=en:mesothelial neoplasm | n2=en:oropharyngeal carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:oropharyngeal squamous cell carcinoma
n1=en:mesothelial neoplasm | n2=en:oropharyngeal squamous cell carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:osteogenic/miscellaneous bone tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:osteogenic/miscellaneous bone tumors (all subtypes) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:parathyroid gland adenoma
n1=en:mesothelial neoplasm | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:pharmacotherapeutic
n1=en:mesothelial neoplasm | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:pheochromocytoma, adrenal (53%)
n1=en:mesothelial neoplasm | n2=en:pheochromocytoma, adrenal (53%) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:pheochromocytoma, extraadrenal (21%)
n1=en:mesothelial neoplasm | n2=en:pheochromocytoma, extraadrenal (21%) | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:pilocytic astrocytoma
n1=en:mesothelial neoplasm | n2=en:pilocytic astrocytoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:primary adrenocortical nodular hyperplasia
n1=en:mesothelial neoplasm | n2=en:primary adrenocortical nodular hyperplasia | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:prostate carcinoma
n1=en:mesothelial neoplasm | n2=en:prostate carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:renal and urinary tract neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:renal and urinary tract neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:renal cell carcinoma, usually clear cell type
n1=en:mesothelial neoplasm | n2=en:renal cell carcinoma, usually clear cell type | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:reproductive neoplasms male malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:reproductive neoplasms male malignant and unspecified | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:rhabdoid tumor
n1=en:mesothelial neoplasm | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:schwannoma
n1=en:mesothelial neoplasm | n2=en:schwannoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:sex cord-stromal tumor
n1=en:mesothelial neoplasm | n2=en:sex cord-stromal tumor | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:subependymoma
n1=en:mesothelial neoplasm | n2=en:subependymoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:thyroid gland carcinoma
n1=en:mesothelial neoplasm | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:tumors and pregnancy
n1=en:mesothelial neoplasm | n2=en:tumors and pregnancy | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:uterine neoplasm
n1=en:mesothelial neoplasm | n2=en:uterine neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 31 / 0.195 ->
en:uveal melanoma
n1=en:mesothelial neoplasm | n2=en:uveal melanoma | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:adenocarcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:aids-related malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:aids-related malignant neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:air sac
n1=en:mesothelial neoplasm | n2=en:air sac | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:alveolar cell carcinoma (some)
n1=en:mesothelial neoplasm | n2=en:alveolar cell carcinoma (some) | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:basocellular neoplasms
n1=en:mesothelial neoplasm | n2=en:basocellular neoplasms | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:benign teratoma
n1=en:mesothelial neoplasm | n2=en:benign teratoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:bladder carcinoma
n1=en:mesothelial neoplasm | n2=en:bladder carcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:blood vessel neoplasm
n1=en:mesothelial neoplasm | n2=en:blood vessel neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cancer--living with cancer
n1=en:mesothelial neoplasm | n2=en:cancer--living with cancer | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:carcinoma
n1=en:mesothelial neoplasm | n2=en:carcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cellular morphology
n1=en:mesothelial neoplasm | n2=en:cellular morphology | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cellular secretion
n1=en:mesothelial neoplasm | n2=en:cellular secretion | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cervical cancer (rare)
n1=en:mesothelial neoplasm | n2=en:cervical cancer (rare) | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:childhood brain neoplasm
n1=en:mesothelial neoplasm | n2=en:childhood brain neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:clear cell neoplasm
n1=en:mesothelial neoplasm | n2=en:clear cell neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:complex mixed and/or stromal neoplasm
n1=en:mesothelial neoplasm | n2=en:complex mixed and/or stromal neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cutaneous melanoma
n1=en:mesothelial neoplasm | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:cystadenoma
n1=en:mesothelial neoplasm | n2=en:cystadenoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:digestive system neoplasm
n1=en:mesothelial neoplasm | n2=en:digestive system neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:ductal, lobular and/or medullary neoplasm
n1=en:mesothelial neoplasm | n2=en:ductal, lobular and/or medullary neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:duodenal carcinoma
n1=en:mesothelial neoplasm | n2=en:duodenal carcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:follicular lymphoma
n1=en:mesothelial neoplasm | n2=en:follicular lymphoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:genitourinary neoplasms
n1=en:mesothelial neoplasm | n2=en:genitourinary neoplasms | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:hemophagocytic lymphohistiocytosis
n1=en:mesothelial neoplasm | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:hepatocellular carcinoma
n1=en:mesothelial neoplasm | n2=en:hepatocellular carcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:increased risk for monoclonal gammopathy
n1=en:mesothelial neoplasm | n2=en:increased risk for monoclonal gammopathy | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:increased risk of pancreatic cancer
n1=en:mesothelial neoplasm | n2=en:increased risk of pancreatic cancer | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:islet cell tumor
n1=en:mesothelial neoplasm | n2=en:islet cell tumor | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:jaw and kidney tumor (endemic form)
n1=en:mesothelial neoplasm | n2=en:jaw and kidney tumor (endemic form) | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:jugulotympanic paraganglioma
n1=en:mesothelial neoplasm | n2=en:jugulotympanic paraganglioma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:kaposi sarcoma
n1=en:mesothelial neoplasm | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:lipoma
n1=en:mesothelial neoplasm | n2=en:lipoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:lung
n1=en:mesothelial neoplasm | n2=en:lung | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:lymphoma
n1=en:mesothelial neoplasm | n2=en:lymphoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant adrenal gland neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant adrenal gland neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant central nervous system neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant central nervous system neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant mesothelioma
n1=en:mesothelial neoplasm | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant neoplasm musculoskeletal
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm musculoskeletal | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant neoplasm of thoracic vertebral column
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of thoracic vertebral column | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant neoplasm, primary site unknown, so stated
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm, primary site unknown, so stated | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant sex cord-stromal tumor
n1=en:mesothelial neoplasm | n2=en:malignant sex cord-stromal tumor | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant soft tissue neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant soft tissue neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant testicular neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant testicular neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant thoracic neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant thoracic neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant thyroid gland neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant tumor involving an organ by direct extension from uterine cervix
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from uterine cervix | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant tumor involving vasa deferentia by direct extension from prostate
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving vasa deferentia by direct extension from prostate | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:malignant tumor of unknown origin or ill-defined site
n1=en:mesothelial neoplasm | n2=en:malignant tumor of unknown origin or ill-defined site | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:mesothelioma
n1=en:mesothelial neoplasm | n2=en:mesothelioma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:mesothelium
n1=en:mesothelial neoplasm | n2=en:mesothelium | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:multiple tumors
n1=en:mesothelial neoplasm | n2=en:multiple tumors | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:neoplasms, adnexal and skin appendage
n1=en:mesothelial neoplasm | n2=en:neoplasms, adnexal and skin appendage | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:neoplasms, experimental
n1=en:mesothelial neoplasm | n2=en:neoplasms, experimental | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:neoplasms, second primary
n1=en:mesothelial neoplasm | n2=en:neoplasms, second primary | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:neoplastic processes
n1=en:mesothelial neoplasm | n2=en:neoplastic processes | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:nervous system neoplasm
n1=en:mesothelial neoplasm | n2=en:nervous system neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:neurofibromatosis
n1=en:mesothelial neoplasm | n2=en:neurofibromatosis | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:non-hodgkin lymphoma
n1=en:mesothelial neoplasm | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:ovarian carcinoma
n1=en:mesothelial neoplasm | n2=en:ovarian carcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:pancreatic adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:pancreatic adenocarcinoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:pheochromocytomas, extraadrenal (48%)
n1=en:mesothelial neoplasm | n2=en:pheochromocytomas, extraadrenal (48%) | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:phyllodes tumor
n1=en:mesothelial neoplasm | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:pituitary gland adenoma
n1=en:mesothelial neoplasm | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:pleural solitary fibrous tumor
n1=en:mesothelial neoplasm | n2=en:pleural solitary fibrous tumor | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:precancerous condition
n1=en:mesothelial neoplasm | n2=en:precancerous condition | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:protozoal cyst
n1=en:mesothelial neoplasm | n2=en:protozoal cyst | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:radiation therapy
n1=en:mesothelial neoplasm | n2=en:radiation therapy | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:sarcoma
n1=en:mesothelial neoplasm | n2=en:sarcoma | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:secondary malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:secondary malignant neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:skin cancer susceptibility
n1=en:mesothelial neoplasm | n2=en:skin cancer susceptibility | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:small intestine carcinoid
n1=en:mesothelial neoplasm | n2=en:small intestine carcinoid | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:squamous cell neoplasm
n1=en:mesothelial neoplasm | n2=en:squamous cell neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:susceptibility to myelodysplasia
n1=en:mesothelial neoplasm | n2=en:susceptibility to myelodysplasia | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:thyroid gland oncocytic neoplasm
n1=en:mesothelial neoplasm | n2=en:thyroid gland oncocytic neoplasm | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 30 / 0.189 ->
en:tumor cells, benign
n1=en:mesothelial neoplasm | n2=en:tumor cells, benign | rel=r_associated | relid=0 | w=30
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:acute leukemia
n1=en:mesothelial neoplasm | n2=en:acute leukemia | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:anal carcinoma
n1=en:mesothelial neoplasm | n2=en:anal carcinoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:anaplastic malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:anaplastic malignant neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:bilateral malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:bilateral malignant neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:brain morphology
n1=en:mesothelial neoplasm | n2=en:brain morphology | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:breast neoplasms benign (incl nipple)
n1=en:mesothelial neoplasm | n2=en:breast neoplasms benign (incl nipple) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:cancer-related condition
n1=en:mesothelial neoplasm | n2=en:cancer-related condition | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:carcinogenesis
n1=en:mesothelial neoplasm | n2=en:carcinogenesis | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:carcinoma in situ
n1=en:mesothelial neoplasm | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:carotid body paraganglioma
n1=en:mesothelial neoplasm | n2=en:carotid body paraganglioma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:chordoma
n1=en:mesothelial neoplasm | n2=en:chordoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:colon adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:colon adenocarcinoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:colon polyp
n1=en:mesothelial neoplasm | n2=en:colon polyp | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:digestive system neoplasms
n1=en:mesothelial neoplasm | n2=en:digestive system neoplasms | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:embryologic
n1=en:mesothelial neoplasm | n2=en:embryologic | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:epithelioid mesothelioma
n1=en:mesothelial neoplasm | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:ethnologic
n1=en:mesothelial neoplasm | n2=en:ethnologic | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:extra-adrenal paraganglioma
n1=en:mesothelial neoplasm | n2=en:extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:fibroelastoma
n1=en:mesothelial neoplasm | n2=en:fibroelastoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:gastric adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:gastric adenocarcinoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:gastrointestinal neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:gastrointestinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:glomus tympanicum paraganglioma
n1=en:mesothelial neoplasm | n2=en:glomus tympanicum paraganglioma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:granular cell tumors and alveolar soft part sarcomas
n1=en:mesothelial neoplasm | n2=en:granular cell tumors and alveolar soft part sarcomas | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:hemophagocytic lymphohistiocytosis (in some patients)
n1=en:mesothelial neoplasm | n2=en:hemophagocytic lymphohistiocytosis (in some patients) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:hepatic and biliary neoplasms benign
n1=en:mesothelial neoplasm | n2=en:hepatic and biliary neoplasms benign | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:hepatoblastoma
n1=en:mesothelial neoplasm | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:hormone related neoplasm/cancer
n1=en:mesothelial neoplasm | n2=en:hormone related neoplasm/cancer | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:immunology aspects
n1=en:mesothelial neoplasm | n2=en:immunology aspects | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:immunoproliferative disorders
n1=en:mesothelial neoplasm | n2=en:immunoproliferative disorders | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:increased risk for embryonal tumors
n1=en:mesothelial neoplasm | n2=en:increased risk for embryonal tumors | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:increased risk of chondrosarcoma
n1=en:mesothelial neoplasm | n2=en:increased risk of chondrosarcoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:increased risk of malignancy
n1=en:mesothelial neoplasm | n2=en:increased risk of malignancy | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:increased risk of testicular cancer
n1=en:mesothelial neoplasm | n2=en:increased risk of testicular cancer | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:increased susceptibility to b-cell lymphoma
n1=en:mesothelial neoplasm | n2=en:increased susceptibility to b-cell lymphoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:lipomatous neoplasm
n1=en:mesothelial neoplasm | n2=en:lipomatous neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:liver neoplasms
n1=en:mesothelial neoplasm | n2=en:liver neoplasms | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:localized malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:localized malignant neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:lung adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:lung adenocarcinoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:lymphomas nec
n1=en:mesothelial neoplasm | n2=en:lymphomas nec | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:lymphosarcoma
n1=en:mesothelial neoplasm | n2=en:lymphosarcoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignancy in approximately 10%
n1=en:mesothelial neoplasm | n2=en:malignancy in approximately 10% | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant bone neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant cell
n1=en:mesothelial neoplasm | n2=en:malignant cell | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant fibromatous neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant fibromatous neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant fibrous histiocytoma (in about 35% of patients)
n1=en:mesothelial neoplasm | n2=en:malignant fibrous histiocytoma (in about 35% of patients) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant lung neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant lung neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant neoplasm of bone, connective tissue, skin and breast
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant neoplasm of gartner's duct
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of gartner's duct | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant neoplasm of lower limb
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant neoplasm of multiple primary sites
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of multiple primary sites | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant neoplasms of respiratory and intrathoracic organs
n1=en:mesothelial neoplasm | n2=en:malignant neoplasms of respiratory and intrathoracic organs | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant peripheral nerve sheath tumor
n1=en:mesothelial neoplasm | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant skin neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant solid tumor
n1=en:mesothelial neoplasm | n2=en:malignant solid tumor | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant uterine neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant uterine neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:malignant vaginal neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant vaginal neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:mature b-cell neoplasms (all subtypes)
n1=en:mesothelial neoplasm | n2=en:mature b-cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:mesothelial cell
n1=en:mesothelial neoplasm | n2=en:mesothelial cell | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:metastatic malignant neoplasm of unknown primary origin
n1=en:mesothelial neoplasm | n2=en:metastatic malignant neoplasm of unknown primary origin | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:multicystic mesothelioma
n1=en:mesothelial neoplasm | n2=en:multicystic mesothelioma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:neoplasm of uncertain behavior of endocrine glands and nervous system
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain behavior of endocrine glands and nervous system | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:neoplasm of uncertain behavior, site unspecified
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain behavior, site unspecified | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:neoplasm of uncertain malignant potential
n1=en:mesothelial neoplasm | n2=en:neoplasm of uncertain malignant potential | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:neoplasm/cancer type
n1=en:mesothelial neoplasm | n2=en:neoplasm/cancer type | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:neoplasms, hormone-dependent
n1=en:mesothelial neoplasm | n2=en:neoplasms, hormone-dependent | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:nonestrogen-dependent cancer
n1=en:mesothelial neoplasm | n2=en:nonestrogen-dependent cancer | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:optic glioma (19%)
n1=en:mesothelial neoplasm | n2=en:optic glioma (19%) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:papillary renal cell carcinoma
n1=en:mesothelial neoplasm | n2=en:papillary renal cell carcinoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:pheochromocytomas, adrenal (28%)
n1=en:mesothelial neoplasm | n2=en:pheochromocytomas, adrenal (28%) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:plasma cell neoplasms (all subtypes)
n1=en:mesothelial neoplasm | n2=en:plasma cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:primary malignant liver neoplasm
n1=en:mesothelial neoplasm | n2=en:primary malignant liver neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:psammomatous melanotic schwannomas
n1=en:mesothelial neoplasm | n2=en:psammomatous melanotic schwannomas | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:radiotherapeutic
n1=en:mesothelial neoplasm | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:refractory malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:refractory malignant neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:renal cortical adenoma
n1=en:mesothelial neoplasm | n2=en:renal cortical adenoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:seminoma
n1=en:mesothelial neoplasm | n2=en:seminoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:sertoli-leydig cell ovarian tumors may occur
n1=en:mesothelial neoplasm | n2=en:sertoli-leydig cell ovarian tumors may occur | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:squamous cell carcinoma in area of palmoplantar keratoderma (rare)
n1=en:mesothelial neoplasm | n2=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:susceptibility to malignant melanoma
n1=en:mesothelial neoplasm | n2=en:susceptibility to malignant melanoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:thymoma
n1=en:mesothelial neoplasm | n2=en:thymoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:tumors at multiple other sites including cns
n1=en:mesothelial neoplasm | n2=en:tumors at multiple other sites including cns | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:unilateral vestibular schwannoma
n1=en:mesothelial neoplasm | n2=en:unilateral vestibular schwannoma | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:unresectable malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:unresectable malignant neoplasm | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 29 / 0.182 ->
en:vascular and perivascular tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:vascular and perivascular tumors (all subtypes) | rel=r_associated | relid=0 | w=29
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:acute lymphoblastic leukemia (in 1 patient)
n1=en:mesothelial neoplasm | n2=en:acute lymphoblastic leukemia (in 1 patient) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:adenoma
n1=en:mesothelial neoplasm | n2=en:adenoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:aggravated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:aggravated malignant neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:basal cell nevus
n1=en:mesothelial neoplasm | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:benign nervous system neoplasm
n1=en:mesothelial neoplasm | n2=en:benign nervous system neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:benign tumors of the eye, heart, and lungs
n1=en:mesothelial neoplasm | n2=en:benign tumors of the eye, heart, and lungs | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:blood supply aspects
n1=en:mesothelial neoplasm | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:body constitution
n1=en:mesothelial neoplasm | n2=en:body constitution | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:bone-forming neoplasm
n1=en:mesothelial neoplasm | n2=en:bone-forming neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:breast carcinoma
n1=en:mesothelial neoplasm | n2=en:breast carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:bronchogenic carcinoma (some)
n1=en:mesothelial neoplasm | n2=en:bronchogenic carcinoma (some) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:chemical aspects
n1=en:mesothelial neoplasm | n2=en:chemical aspects | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:diagnosis aspect
n1=en:mesothelial neoplasm | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:ductal and lobular neoplasms
n1=en:mesothelial neoplasm | n2=en:ductal and lobular neoplasms | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:ebv-induced b-cell lymphoma
n1=en:mesothelial neoplasm | n2=en:ebv-induced b-cell lymphoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:enteropathy-associated t-cell lymphoma
n1=en:mesothelial neoplasm | n2=en:enteropathy-associated t-cell lymphoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:ganglioneuroblastoma
n1=en:mesothelial neoplasm | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:ganglioneuroma
n1=en:mesothelial neoplasm | n2=en:ganglioneuroma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:genetic aspects
n1=en:mesothelial neoplasm | n2=en:genetic aspects | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:genital cancer
n1=en:mesothelial neoplasm | n2=en:genital cancer | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:germ cell tumor
n1=en:mesothelial neoplasm | n2=en:germ cell tumor | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:giant cell tumor
n1=en:mesothelial neoplasm | n2=en:giant cell tumor | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:head and neck paraganglioma
n1=en:mesothelial neoplasm | n2=en:head and neck paraganglioma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:hematopoietic and lymphoid cell neoplasm
n1=en:mesothelial neoplasm | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:historical aspects qualifier
n1=en:mesothelial neoplasm | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:imaginal discs
n1=en:mesothelial neoplasm | n2=en:imaginal discs | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:in urine
n1=en:mesothelial neoplasm | n2=en:in urine | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:increased risk for lymphoma hodgkin disease
n1=en:mesothelial neoplasm | n2=en:increased risk for lymphoma hodgkin disease | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:increased risk of leukemia
n1=en:mesothelial neoplasm | n2=en:increased risk of leukemia | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:increased risk of medulloblastoma (rare)
n1=en:mesothelial neoplasm | n2=en:increased risk of medulloblastoma (rare) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:increased susceptibility to hematologic malignancies
n1=en:mesothelial neoplasm | n2=en:increased susceptibility to hematologic malignancies | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:lip and oral cavity carcinoma
n1=en:mesothelial neoplasm | n2=en:lip and oral cavity carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:liver carcinoma
n1=en:mesothelial neoplasm | n2=en:liver carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:male breast carcinoma
n1=en:mesothelial neoplasm | n2=en:male breast carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant (primary) neoplasm, unspecified
n1=en:mesothelial neoplasm | n2=en:malignant (primary) neoplasm, unspecified | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant epithelial neoplasms (all subtypes)
n1=en:mesothelial neoplasm | n2=en:malignant epithelial neoplasms (all subtypes) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant eye neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant eye neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant lipomatous neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant lipomatous neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasm associated with aids
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm associated with aids | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasm growth accelerated
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm growth accelerated | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasm of genitourinary organ
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of genitourinary organ | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasm of other and unspecified sites
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of other and unspecified sites | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasms of ill-defined, secondary and unspecified sites
n1=en:mesothelial neoplasm | n2=en:malignant neoplasms of ill-defined, secondary and unspecified sites | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
n1=en:mesothelial neoplasm | n2=en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant tumor involving an organ by direct extension from bladder
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from bladder | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:malignant tumor involving an organ by direct extension from uterus
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from uterus | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:mesenchymal cell neoplasm
n1=en:mesothelial neoplasm | n2=en:mesenchymal cell neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:microbiological
n1=en:mesothelial neoplasm | n2=en:microbiological | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:miscellaneous mesenchymal tumors (all subtypes)
n1=en:mesothelial neoplasm | n2=en:miscellaneous mesenchymal tumors (all subtypes) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:multicystic mesothelioma, benign
n1=en:mesothelial neoplasm | n2=en:multicystic mesothelioma, benign | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:myeloproliferative neoplasm
n1=en:mesothelial neoplasm | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:myxoma
n1=en:mesothelial neoplasm | n2=en:myxoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:neoplasm related morbidities
n1=en:mesothelial neoplasm | n2=en:neoplasm related morbidities | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:neoplasms of uncertain or unknown behaviour
n1=en:mesothelial neoplasm | n2=en:neoplasms of uncertain or unknown behaviour | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:nerve sheath neoplasm
n1=en:mesothelial neoplasm | n2=en:nerve sheath neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:nervous system neoplasms malignant and unspecified nec
n1=en:mesothelial neoplasm | n2=en:nervous system neoplasms malignant and unspecified nec | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:nevi and melanomas
n1=en:mesothelial neoplasm | n2=en:nevi and melanomas | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:no cancer despite harboring complete deletions of the tp53 gene
n1=en:mesothelial neoplasm | n2=en:no cancer despite harboring complete deletions of the tp53 gene | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:osteosarcoma
n1=en:mesothelial neoplasm | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:ovarian cystadenoma
n1=en:mesothelial neoplasm | n2=en:ovarian cystadenoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:papillary neoplasm
n1=en:mesothelial neoplasm | n2=en:papillary neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:paraganglioma and/or glomus tumor
n1=en:mesothelial neoplasm | n2=en:paraganglioma and/or glomus tumor | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:parotid gland adenoma and adenocarcinoma
n1=en:mesothelial neoplasm | n2=en:parotid gland adenoma and adenocarcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:plant morphology
n1=en:mesothelial neoplasm | n2=en:plant morphology | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:plasmacytoma
n1=en:mesothelial neoplasm | n2=en:plasmacytoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:recurrent malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:recurrent malignant neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:respiratory and mediastinal neoplasms malignant and unspecified
n1=en:mesothelial neoplasm | n2=en:respiratory and mediastinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:rhabdoid tumors, malignant (renal or extrarenal)
n1=en:mesothelial neoplasm | n2=en:rhabdoid tumors, malignant (renal or extrarenal) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:roentgenographic
n1=en:mesothelial neoplasm | n2=en:roentgenographic | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:sarcomatoid mesothelioma
n1=en:mesothelial neoplasm | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:secondary neoplasm
n1=en:mesothelial neoplasm | n2=en:secondary neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:signet ring cell carcinoma
n1=en:mesothelial neoplasm | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:squamous cell carcinoma
n1=en:mesothelial neoplasm | n2=en:squamous cell carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:synovial-like neoplasm
n1=en:mesothelial neoplasm | n2=en:synovial-like neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:syringocystadenoma papilliferum
n1=en:mesothelial neoplasm | n2=en:syringocystadenoma papilliferum | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:t-cell non-hodgkin lymphoma
n1=en:mesothelial neoplasm | n2=en:t-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:therapy-related malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:therapy-related malignant neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:throat cancer
n1=en:mesothelial neoplasm | n2=en:throat cancer | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:thyroid gland neoplasm
n1=en:mesothelial neoplasm | n2=en:thyroid gland neoplasm | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:undifferentiated carcinoma
n1=en:mesothelial neoplasm | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:vestibular schwannoma (over 90% of patients)
n1=en:mesothelial neoplasm | n2=en:vestibular schwannoma (over 90% of patients) | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 28 / 0.176 ->
en:yolk sac tumor
n1=en:mesothelial neoplasm | n2=en:yolk sac tumor | rel=r_associated | relid=0 | w=28
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:accelerated neoplasm growth
n1=en:mesothelial neoplasm | n2=en:accelerated neoplasm growth | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:adenomatoid tumor
n1=en:mesothelial neoplasm | n2=en:adenomatoid tumor | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:adrenal gland pheochromocytoma
n1=en:mesothelial neoplasm | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:aplastic anemia
n1=en:mesothelial neoplasm | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:b-cell lymphomas
n1=en:mesothelial neoplasm | n2=en:b-cell lymphomas | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:bence jones proteins increased
n1=en:mesothelial neoplasm | n2=en:bence jones proteins increased | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:benign digestive system neoplasm
n1=en:mesothelial neoplasm | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:benign genitourinary tract neoplasm
n1=en:mesothelial neoplasm | n2=en:benign genitourinary tract neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:bone neoplasm
n1=en:mesothelial neoplasm | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:chemotherapy
n1=en:mesothelial neoplasm | n2=en:chemotherapy | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:childhood leukemia
n1=en:mesothelial neoplasm | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:congenital mesh qualifier
n1=en:mesothelial neoplasm | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:endometrial carcinoma
n1=en:mesothelial neoplasm | n2=en:endometrial carcinoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:glioblastoma
n1=en:mesothelial neoplasm | n2=en:glioblastoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:gonadoblastoma
n1=en:mesothelial neoplasm | n2=en:gonadoblastoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:hamartoma
n1=en:mesothelial neoplasm | n2=en:hamartoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:increased risk in heterozygotes
n1=en:mesothelial neoplasm | n2=en:increased risk in heterozygotes | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:increased risk of breast cancer in women
n1=en:mesothelial neoplasm | n2=en:increased risk of breast cancer in women | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant neoplasm by grade
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm by grade | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant neoplasm, uncertain whether primary or metastatic
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm, uncertain whether primary or metastatic | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant ovarian neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant ovarian neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant peripheral nerve sheath tumors (21%)
n1=en:mesothelial neoplasm | n2=en:malignant peripheral nerve sheath tumors (21%) | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant pharyngeal neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant pharyngeal neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant salivary gland neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant salivary gland neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant thymus neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant thymus neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:malignant vulvar neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant vulvar neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:mature t- and nk-cell neoplasms (all subtypes)
n1=en:mesothelial neoplasm | n2=en:mature t- and nk-cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:melanoma
n1=en:mesothelial neoplasm | n2=en:melanoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:mesothelioma, malignant, after asbestos exposure
n1=en:mesothelial neoplasm | n2=en:mesothelioma, malignant, after asbestos exposure | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:miscellaneous tumors
n1=en:mesothelial neoplasm | n2=en:miscellaneous tumors | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:moderately differentiated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:moderately differentiated malignant neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:multiple giant cell granulomas (bones, joints, soft tissues)
n1=en:mesothelial neoplasm | n2=en:multiple giant cell granulomas (bones, joints, soft tissues) | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:multiple tumors in 28% of patients
n1=en:mesothelial neoplasm | n2=en:multiple tumors in 28% of patients | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:myomatous neoplasm
n1=en:mesothelial neoplasm | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:neoplasm
n1=en:mesothelial neoplasm | n2=en:neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:neoplasm of unspecified nature of other genitourinary organs
n1=en:mesothelial neoplasm | n2=en:neoplasm of unspecified nature of other genitourinary organs | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:neoplasms of histiocytes and accessory lymphoid cells
n1=en:mesothelial neoplasm | n2=en:neoplasms of histiocytes and accessory lymphoid cells | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:neoplasms, cystic, mucinous, and serous
n1=en:mesothelial neoplasm | n2=en:neoplasms, cystic, mucinous, and serous | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:neoplastic polyp
n1=en:mesothelial neoplasm | n2=en:neoplastic polyp | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:nutritional management
n1=en:mesothelial neoplasm | n2=en:nutritional management | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:osseous and chondromatous neoplasms
n1=en:mesothelial neoplasm | n2=en:osseous and chondromatous neoplasms | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418)
n1=en:mesothelial neoplasm | n2=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:parathyroid disease rare
n1=en:mesothelial neoplasm | n2=en:parathyroid disease rare | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:prostate neoplasm
n1=en:mesothelial neoplasm | n2=en:prostate neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:psychological aspect of cancer
n1=en:mesothelial neoplasm | n2=en:psychological aspect of cancer | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:sebaceous adenoma
n1=en:mesothelial neoplasm | n2=en:sebaceous adenoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:sertoli cell tumor
n1=en:mesothelial neoplasm | n2=en:sertoli cell tumor | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:skin appendage tumors may show malignant transformation
n1=en:mesothelial neoplasm | n2=en:skin appendage tumors may show malignant transformation | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:squamous cell carcinoma (skin or mucosa)
n1=en:mesothelial neoplasm | n2=en:squamous cell carcinoma (skin or mucosa) | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:squamous epitheliomas, multiple
n1=en:mesothelial neoplasm | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:surgical aspects
n1=en:mesothelial neoplasm | n2=en:surgical aspects | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:susceptibility to myeloid leukemia
n1=en:mesothelial neoplasm | n2=en:susceptibility to myeloid leukemia | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:synovial neoplasm
n1=en:mesothelial neoplasm | n2=en:synovial neoplasm | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:taxonomic
n1=en:mesothelial neoplasm | n2=en:taxonomic | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:thyroid gland medullary carcinoma
n1=en:mesothelial neoplasm | n2=en:thyroid gland medullary carcinoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:transaminase cell carcinoma
n1=en:mesothelial neoplasm | n2=en:transaminase cell carcinoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:transitional cell papilloma and/or carcinoma
n1=en:mesothelial neoplasm | n2=en:transitional cell papilloma and/or carcinoma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:trophoblastic tumor
n1=en:mesothelial neoplasm | n2=en:trophoblastic tumor | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:vagus nerve paraganglioma
n1=en:mesothelial neoplasm | n2=en:vagus nerve paraganglioma | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
en:viruses
n1=en:mesothelial neoplasm | n2=en:viruses | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
hémangiome
n1=en:mesothelial neoplasm | n2=hémangiome | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
méningiome
n1=en:mesothelial neoplasm | n2=méningiome | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 27 / 0.17 ->
poumon
n1=en:mesothelial neoplasm | n2=poumon | rel=r_associated | relid=0 | w=27
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:abdominal tumors (immunodeficiency-associated form)
n1=en:mesothelial neoplasm | n2=en:abdominal tumors (immunodeficiency-associated form) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:acute monoblastic leukemia
n1=en:mesothelial neoplasm | n2=en:acute monoblastic leukemia | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:acute myeloid leukemia
n1=en:mesothelial neoplasm | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:aids related neoplasm/cancer
n1=en:mesothelial neoplasm | n2=en:aids related neoplasm/cancer | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:aspects of mortality statistics
n1=en:mesothelial neoplasm | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:aspects of radionuclide imaging
n1=en:mesothelial neoplasm | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:associated with other malignancies
n1=en:mesothelial neoplasm | n2=en:associated with other malignancies | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:breast cancer, early-onset (in some patients)
n1=en:mesothelial neoplasm | n2=en:breast cancer, early-onset (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:central nervous system embryonal neoplasm
n1=en:mesothelial neoplasm | n2=en:central nervous system embryonal neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:central nervous system neoplasm
n1=en:mesothelial neoplasm | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:cervical neoplasm
n1=en:mesothelial neoplasm | n2=en:cervical neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:colon carcinoma
n1=en:mesothelial neoplasm | n2=en:colon carcinoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:colorectal cancer, early onset
n1=en:mesothelial neoplasm | n2=en:colorectal cancer, early onset | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:colorectal carcinoma
n1=en:mesothelial neoplasm | n2=en:colorectal carcinoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:complex mixed and stromal neoplasms
n1=en:mesothelial neoplasm | n2=en:complex mixed and stromal neoplasms | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:disseminated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:disseminated malignant neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:dysgerminoma
n1=en:mesothelial neoplasm | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:ependymoma
n1=en:mesothelial neoplasm | n2=en:ependymoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:epithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:epithelial neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:ewing sarcoma
n1=en:mesothelial neoplasm | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:exposure as collected domain
n1=en:mesothelial neoplasm | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:extra-adrenal sympathetic paraganglioma
n1=en:mesothelial neoplasm | n2=en:extra-adrenal sympathetic paraganglioma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:fibroepithelial neoplasm
n1=en:mesothelial neoplasm | n2=en:fibroepithelial neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:follicular neoplasm
n1=en:mesothelial neoplasm | n2=en:follicular neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:gene mutation-related cancer
n1=en:mesothelial neoplasm | n2=en:gene mutation-related cancer | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:gestational trophoblastic tumor
n1=en:mesothelial neoplasm | n2=en:gestational trophoblastic tumor | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:haematopoietic neoplasms (excl leukaemias and lymphomas)
n1=en:mesothelial neoplasm | n2=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:hodgkin lymphoma
n1=en:mesothelial neoplasm | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:increased incidence of rectosigmoid cancer
n1=en:mesothelial neoplasm | n2=en:increased incidence of rectosigmoid cancer | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:increased risk for multiple myeloma
n1=en:mesothelial neoplasm | n2=en:increased risk for multiple myeloma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:low grade fibromyxoid sarcoma
n1=en:mesothelial neoplasm | n2=en:low grade fibromyxoid sarcoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:lymphatic vessel neoplasm
n1=en:mesothelial neoplasm | n2=en:lymphatic vessel neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignancy (34%)
n1=en:mesothelial neoplasm | n2=en:malignancy (34%) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignant neoplasm of other and ill-defined sites: other ill-defined sites
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of other and ill-defined sites: other ill-defined sites | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignant neoplasm of pelvis
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of pelvis | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignant neoplasm of upper limb nos
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of upper limb nos | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignant neoplastic disease in mother complicating childbirth
n1=en:mesothelial neoplasm | n2=en:malignant neoplastic disease in mother complicating childbirth | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:malignant tumor involving an organ by direct extension from endometrium
n1=en:mesothelial neoplasm | n2=en:malignant tumor involving an organ by direct extension from endometrium | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:melanocytic neoplasm
n1=en:mesothelial neoplasm | n2=en:melanocytic neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:multiple schwannomas
n1=en:mesothelial neoplasm | n2=en:multiple schwannomas | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:myelodysplastic syndrome
n1=en:mesothelial neoplasm | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:neoplasms by histologic type
n1=en:mesothelial neoplasm | n2=en:neoplasms by histologic type | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:neoplasms, ductal, lobular, and medullary
n1=en:mesothelial neoplasm | n2=en:neoplasms, ductal, lobular, and medullary | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:neuroepithelial, perineurial, and schwann cell neoplasm
n1=en:mesothelial neoplasm | n2=en:neuroepithelial, perineurial, and schwann cell neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:neuroepitheliomatous neoplasm
n1=en:mesothelial neoplasm | n2=en:neuroepitheliomatous neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:non-hematologic malignancy
n1=en:mesothelial neoplasm | n2=en:non-hematologic malignancy | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:nursing therapy
n1=en:mesothelial neoplasm | n2=en:nursing therapy | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:odontogenic neoplasm
n1=en:mesothelial neoplasm | n2=en:odontogenic neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:oral cavity neoplasm
n1=en:mesothelial neoplasm | n2=en:oral cavity neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:paragangliomas, head and neck (31%)
n1=en:mesothelial neoplasm | n2=en:paragangliomas, head and neck (31%) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:paraneoplastic sps is associated with breast cancer and other malignancies
n1=en:mesothelial neoplasm | n2=en:paraneoplastic sps is associated with breast cancer and other malignancies | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:parathyroid gland carcinoma
n1=en:mesothelial neoplasm | n2=en:parathyroid gland carcinoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:parotid gland monomorphic adenoma
n1=en:mesothelial neoplasm | n2=en:parotid gland monomorphic adenoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:pathological aspects
n1=en:mesothelial neoplasm | n2=en:pathological aspects | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:physiopathological
n1=en:mesothelial neoplasm | n2=en:physiopathological | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:poorly differentiated malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:poorly differentiated malignant neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:possibly increased risk of cancer
n1=en:mesothelial neoplasm | n2=en:possibly increased risk of cancer | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:predisposition to uv-induced malignancies
n1=en:mesothelial neoplasm | n2=en:predisposition to uv-induced malignancies | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:radiation-related malignant neoplasm
n1=en:mesothelial neoplasm | n2=en:radiation-related malignant neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:renal and urinary tract neoplasms benign
n1=en:mesothelial neoplasm | n2=en:renal and urinary tract neoplasms benign | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:respiratory and mediastinal neoplasms benign (excl mesotheliomas)
n1=en:mesothelial neoplasm | n2=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:rhabdomyosarcoma
n1=en:mesothelial neoplasm | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:skin basal cell carcinoma
n1=en:mesothelial neoplasm | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:soft tissue sarcoma
n1=en:mesothelial neoplasm | n2=en:soft tissue sarcoma | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:stage 0 cervical cancer ajcc v6
n1=en:mesothelial neoplasm | n2=en:stage 0 cervical cancer ajcc v6 | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:tumors of the sympathetic nervous system (5 to 10%)
n1=en:mesothelial neoplasm | n2=en:tumors of the sympathetic nervous system (5 to 10%) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:use of ultrasonography
n1=en:mesothelial neoplasm | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
en:uterine leiomyosarcoma (less common)
n1=en:mesothelial neoplasm | n2=en:uterine leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 26 / 0.164 ->
néoplasme
n1=en:mesothelial neoplasm | n2=néoplasme | rel=r_associated | relid=0 | w=26
- en:mesothelial neoplasm --
r_associated #0: 25 / 0.157 ->
néoplasme mésothélial
n1=en:mesothelial neoplasm | n2=néoplasme mésothélial | rel=r_associated | relid=0 | w=25
- en:mesothelial neoplasm --
r_associated #0: 24 / 0.151 ->
carcinome endométrial
n1=en:mesothelial neoplasm | n2=carcinome endométrial | rel=r_associated | relid=0 | w=24
- en:mesothelial neoplasm --
r_associated #0: 24 / 0.151 ->
cellule tumorale
n1=en:mesothelial neoplasm | n2=cellule tumorale | rel=r_associated | relid=0 | w=24
- en:mesothelial neoplasm --
r_associated #0: 24 / 0.151 ->
néoplasme malin
n1=en:mesothelial neoplasm | n2=néoplasme malin | rel=r_associated | relid=0 | w=24
- en:mesothelial neoplasm --
r_associated #0: 22 / 0.138 ->
tumeur du système nerveux
n1=en:mesothelial neoplasm | n2=tumeur du système nerveux | rel=r_associated | relid=0 | w=22
- en:mesothelial neoplasm --
r_associated #0: 21 / 0.132 ->
carcinome de l'endomètre
n1=en:mesothelial neoplasm | n2=carcinome de l'endomètre | rel=r_associated | relid=0 | w=21
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adenocarcinoma
n1=en:mesothelial neoplasm | n2=adenocarcinoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénocarcinome
n1=en:mesothelial neoplasm | n2=adénocarcinome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Adénocarcinome
n1=en:mesothelial neoplasm | n2=Adénocarcinome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénocarcinome du côlon
n1=en:mesothelial neoplasm | n2=adénocarcinome du côlon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénome
n1=en:mesothelial neoplasm | n2=adénome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénome à cellules oncocytaires
n1=en:mesothelial neoplasm | n2=adénome à cellules oncocytaires | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénome malin
n1=en:mesothelial neoplasm | n2=adénome malin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénome oncocytaire
n1=en:mesothelial neoplasm | n2=adénome oncocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
adénosarcome sébacé
n1=en:mesothelial neoplasm | n2=adénosarcome sébacé | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
biopsie
n1=en:mesothelial neoplasm | n2=biopsie | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
blastome
n1=en:mesothelial neoplasm | n2=blastome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer à cellules claires du rein
n1=en:mesothelial neoplasm | n2=cancer à cellules claires du rein | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer colo-rectal
n1=en:mesothelial neoplasm | n2=cancer colo-rectal | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer colorectal
n1=en:mesothelial neoplasm | n2=cancer colorectal | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer cutané
n1=en:mesothelial neoplasm | n2=cancer cutané | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer d'une glande salivaire
n1=en:mesothelial neoplasm | n2=cancer d'une glande salivaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de l'endomètre
n1=en:mesothelial neoplasm | n2=cancer de l'endomètre | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de l'estomac
n1=en:mesothelial neoplasm | n2=cancer de l'estomac | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer de l'estomac
n1=en:mesothelial neoplasm | n2=Cancer de l'estomac | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de l'oeil
n1=en:mesothelial neoplasm | n2=cancer de l'oeil | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de l'oesophage
n1=en:mesothelial neoplasm | n2=cancer de l'oesophage | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de l'utérus
n1=en:mesothelial neoplasm | n2=cancer de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de la glande salivaire
n1=en:mesothelial neoplasm | n2=cancer de la glande salivaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de la gorge
n1=en:mesothelial neoplasm | n2=cancer de la gorge | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de la peau
n1=en:mesothelial neoplasm | n2=cancer de la peau | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer de la peau
n1=en:mesothelial neoplasm | n2=Cancer de la peau | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de la testicule
n1=en:mesothelial neoplasm | n2=cancer de la testicule | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer de la vulve
n1=en:mesothelial neoplasm | n2=cancer de la vulve | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer de la vulve
n1=en:mesothelial neoplasm | n2=Cancer de la vulve | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer des os
n1=en:mesothelial neoplasm | n2=cancer des os | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer des testicules
n1=en:mesothelial neoplasm | n2=cancer des testicules | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du col de l'utérus
n1=en:mesothelial neoplasm | n2=cancer du col de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du col utérin
n1=en:mesothelial neoplasm | n2=cancer du col utérin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer du col utérin
n1=en:mesothelial neoplasm | n2=Cancer du col utérin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du duodénum
n1=en:mesothelial neoplasm | n2=cancer du duodénum | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du pancréas
n1=en:mesothelial neoplasm | n2=cancer du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer du pancréas
n1=en:mesothelial neoplasm | n2=Cancer du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du poumon
n1=en:mesothelial neoplasm | n2=cancer du poumon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du sang
n1=en:mesothelial neoplasm | n2=cancer du sang | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer du testicule
n1=en:mesothelial neoplasm | n2=cancer du testicule | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer duodénal
n1=en:mesothelial neoplasm | n2=cancer duodénal | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer embryonnaire
n1=en:mesothelial neoplasm | n2=cancer embryonnaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer endométrial
n1=en:mesothelial neoplasm | n2=cancer endométrial | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer épithélial
n1=en:mesothelial neoplasm | n2=cancer épithélial | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer gastrique
n1=en:mesothelial neoplasm | n2=cancer gastrique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer glandulaire
n1=en:mesothelial neoplasm | n2=cancer glandulaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer malin de la glande salivaire
n1=en:mesothelial neoplasm | n2=cancer malin de la glande salivaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer oculaire
n1=en:mesothelial neoplasm | n2=cancer oculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer oesophagien
n1=en:mesothelial neoplasm | n2=cancer oesophagien | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer osseux
n1=en:mesothelial neoplasm | n2=Cancer osseux | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer osseux
n1=en:mesothelial neoplasm | n2=cancer osseux | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer pancréatique
n1=en:mesothelial neoplasm | n2=cancer pancréatique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer secondaire
n1=en:mesothelial neoplasm | n2=cancer secondaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer testiculaire
n1=en:mesothelial neoplasm | n2=cancer testiculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer utérin
n1=en:mesothelial neoplasm | n2=cancer utérin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Cancer utérin
n1=en:mesothelial neoplasm | n2=Cancer utérin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancer vulvaire
n1=en:mesothelial neoplasm | n2=cancer vulvaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
cancers
n1=en:mesothelial neoplasm | n2=cancers | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinoma
n1=en:mesothelial neoplasm | n2=carcinoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome
n1=en:mesothelial neoplasm | n2=carcinome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinôme
n1=en:mesothelial neoplasm | n2=carcinôme | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome colo-rectal
n1=en:mesothelial neoplasm | n2=carcinome colo-rectal | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome colorectal
n1=en:mesothelial neoplasm | n2=carcinome colorectal | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome cutané
n1=en:mesothelial neoplasm | n2=carcinome cutané | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome de la peau
n1=en:mesothelial neoplasm | n2=carcinome de la peau | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome du gros intestin
n1=en:mesothelial neoplasm | n2=carcinome du gros intestin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome du pancreas
n1=en:mesothelial neoplasm | n2=carcinome du pancreas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome du pancréas
n1=en:mesothelial neoplasm | n2=carcinome du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome embryonnaire
n1=en:mesothelial neoplasm | n2=carcinome embryonnaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome gastrique
n1=en:mesothelial neoplasm | n2=carcinome gastrique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome glandulaire
n1=en:mesothelial neoplasm | n2=carcinome glandulaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome pancréatique
n1=en:mesothelial neoplasm | n2=carcinome pancréatique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome recto-colique
n1=en:mesothelial neoplasm | n2=carcinome recto-colique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome rectocolique
n1=en:mesothelial neoplasm | n2=carcinome rectocolique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
carcinome utérin
n1=en:mesothelial neoplasm | n2=carcinome utérin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
chordome
n1=en:mesothelial neoplasm | n2=chordome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
dépistage des lésions du col de l'utérus
n1=en:mesothelial neoplasm | n2=dépistage des lésions du col de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
dépistage du cancer du col de l'utérus
n1=en:mesothelial neoplasm | n2=dépistage du cancer du col de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
dysgerminome
n1=en:mesothelial neoplasm | n2=dysgerminome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
embole de tumeur
n1=en:mesothelial neoplasm | n2=embole de tumeur | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
embole tumoral
n1=en:mesothelial neoplasm | n2=embole tumoral | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
embolie tumorale
n1=en:mesothelial neoplasm | n2=embolie tumorale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:« osteogenic » sarcoma
n1=en:mesothelial neoplasm | n2=en:« osteogenic » sarcoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:acute myeloblastic leukaemia
n1=en:mesothelial neoplasm | n2=en:acute myeloblastic leukaemia | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:acute myeloblastic leukemia
n1=en:mesothelial neoplasm | n2=en:acute myeloblastic leukemia | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:adenocarcinoma of colon
n1=en:mesothelial neoplasm | n2=en:adenocarcinoma of colon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:angiomatous meningioma
n1=en:mesothelial neoplasm | n2=en:angiomatous meningioma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:beam radiation therapy
n1=en:mesothelial neoplasm | n2=en:beam radiation therapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:benign growth
n1=en:mesothelial neoplasm | n2=en:benign growth | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:benign tumor
n1=en:mesothelial neoplasm | n2=en:benign tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:benign tumour
n1=en:mesothelial neoplasm | n2=en:benign tumour | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:bone metastases from squamous cell carcinoma
n1=en:mesothelial neoplasm | n2=en:bone metastases from squamous cell carcinoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:cancer of the stomach
n1=en:mesothelial neoplasm | n2=en:cancer of the stomach | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:classic hodgkin lymphoma
n1=en:mesothelial neoplasm | n2=en:classic hodgkin lymphoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:colloid tumor
n1=en:mesothelial neoplasm | n2=en:colloid tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:colonic neoplasms
n1=en:mesothelial neoplasm | n2=en:colonic neoplasms | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:colorectal cancer
n1=en:mesothelial neoplasm | n2=en:colorectal cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:cutaneous radiotherapy
n1=en:mesothelial neoplasm | n2=en:cutaneous radiotherapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:duodenal cancer
n1=en:mesothelial neoplasm | n2=en:duodenal cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:endometrial cancer
n1=en:mesothelial neoplasm | n2=en:endometrial cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:epidemiological
n1=en:mesothelial neoplasm | n2=en:epidemiological | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:epithelial carcinoma
n1=en:mesothelial neoplasm | n2=en:epithelial carcinoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:epulides
n1=en:mesothelial neoplasm | n2=en:epulides | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:epulis
n1=en:mesothelial neoplasm | n2=en:epulis | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:gastric cancer
n1=en:mesothelial neoplasm | n2=en:gastric cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:gelatinous tumor
n1=en:mesothelial neoplasm | n2=en:gelatinous tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:glioneuroma
n1=en:mesothelial neoplasm | n2=en:glioneuroma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:hemangioma
n1=en:mesothelial neoplasm | n2=en:hemangioma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:innocent tumor
n1=en:mesothelial neoplasm | n2=en:innocent tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:leucemia
n1=en:mesothelial neoplasm | n2=en:leucemia | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:leukaemia
n1=en:mesothelial neoplasm | n2=en:leukaemia | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:leukocythemia
n1=en:mesothelial neoplasm | n2=en:leukocythemia | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant colon neoplasm
n1=en:mesothelial neoplasm | n2=en:malignant colon neoplasm | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant neoplasm of salivary gland
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of salivary gland | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant neoplasm of skin
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of skin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant neoplasm of stomach
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of stomach | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant neoplasm of testis
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of testis | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant neoplasm of vulva
n1=en:mesothelial neoplasm | n2=en:malignant neoplasm of vulva | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant tumor of colon
n1=en:mesothelial neoplasm | n2=en:malignant tumor of colon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:malignant tumor of eye
n1=en:mesothelial neoplasm | n2=en:malignant tumor of eye | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:metastatic tumor
n1=en:mesothelial neoplasm | n2=en:metastatic tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:neurilemmoma
n1=en:mesothelial neoplasm | n2=en:neurilemmoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:neurinoma
n1=en:mesothelial neoplasm | n2=en:neurinoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:neuroma
n1=en:mesothelial neoplasm | n2=en:neuroma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:pancreas cancer
n1=en:mesothelial neoplasm | n2=en:pancreas cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:pancreatic cancer
n1=en:mesothelial neoplasm | n2=en:pancreatic cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:pancreatic neoplasm
n1=en:mesothelial neoplasm | n2=en:pancreatic neoplasm | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:papillary renal cell adenoma
n1=en:mesothelial neoplasm | n2=en:papillary renal cell adenoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:radiation treatment
n1=en:mesothelial neoplasm | n2=en:radiation treatment | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:radiotherapy
n1=en:mesothelial neoplasm | n2=en:radiotherapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:roentgenotherapy
n1=en:mesothelial neoplasm | n2=en:roentgenotherapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:roentgentherapy
n1=en:mesothelial neoplasm | n2=en:roentgentherapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:serous
n1=en:mesothelial neoplasm | n2=en:serous | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:serous membrane
n1=en:mesothelial neoplasm | n2=en:serous membrane | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:skin cancer
n1=en:mesothelial neoplasm | n2=en:skin cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:stomach cancer
n1=en:mesothelial neoplasm | n2=en:stomach cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:superficial radiotherapy
n1=en:mesothelial neoplasm | n2=en:superficial radiotherapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:testicular cancer
n1=en:mesothelial neoplasm | n2=en:testicular cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:tumor cell
n1=en:mesothelial neoplasm | n2=en:tumor cell | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:tumor embolism
n1=en:mesothelial neoplasm | n2=en:tumor embolism | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:uterine cancer
n1=en:mesothelial neoplasm | n2=en:uterine cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:von Recklinghausen's disease
n1=en:mesothelial neoplasm | n2=en:von Recklinghausen's disease | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:vulvar cancer
n1=en:mesothelial neoplasm | n2=en:vulvar cancer | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:vulvar tumor
n1=en:mesothelial neoplasm | n2=en:vulvar tumor | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
en:X ray therapy
n1=en:mesothelial neoplasm | n2=en:X ray therapy | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
enzymologie
n1=en:mesothelial neoplasm | n2=enzymologie | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
enzymology
n1=en:mesothelial neoplasm | n2=enzymology | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
épidémiologique
n1=en:mesothelial neoplasm | n2=épidémiologique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
épithélioma sébacé
n1=en:mesothelial neoplasm | n2=épithélioma sébacé | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
épulis
n1=en:mesothelial neoplasm | n2=épulis | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
état prénéoplasique
n1=en:mesothelial neoplasm | n2=état prénéoplasique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
ethnologique
n1=en:mesothelial neoplasm | n2=ethnologique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
fibrosarcome
n1=en:mesothelial neoplasm | n2=fibrosarcome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
ganglioneurome
n1=en:mesothelial neoplasm | n2=ganglioneurome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
gliome périphérique
n1=en:mesothelial neoplasm | n2=gliome périphérique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
la à granulocytes
n1=en:mesothelial neoplasm | n2=la à granulocytes | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
LA à granulocytes
n1=en:mesothelial neoplasm | n2=LA à granulocytes | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lam
n1=en:mesothelial neoplasm | n2=lam | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lanl
n1=en:mesothelial neoplasm | n2=lanl | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lemmome
n1=en:mesothelial neoplasm | n2=lemmome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie
n1=en:mesothelial neoplasm | n2=leucémie | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë granulocytaire
n1=en:mesothelial neoplasm | n2=leucémie aiguë granulocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë lymphoïde
n1=en:mesothelial neoplasm | n2=leucémie aiguë lymphoïde | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aigüe myéloblastique
n1=en:mesothelial neoplasm | n2=leucémie aigüe myéloblastique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë myéloblastique
n1=en:mesothelial neoplasm | n2=leucémie aiguë myéloblastique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë myélocytaire
n1=en:mesothelial neoplasm | n2=leucémie aiguë myélocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë myéloïde
n1=en:mesothelial neoplasm | n2=leucémie aiguë myéloïde | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aigüe myéloïde
n1=en:mesothelial neoplasm | n2=leucémie aigüe myéloïde | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aigüe non lymphoblastique
n1=en:mesothelial neoplasm | n2=leucémie aigüe non lymphoblastique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë non lymphoblastique
n1=en:mesothelial neoplasm | n2=leucémie aiguë non lymphoblastique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie aiguë non lymphocytaire
n1=en:mesothelial neoplasm | n2=leucémie aiguë non lymphocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie blastique granulocytaire
n1=en:mesothelial neoplasm | n2=leucémie blastique granulocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie granuleuse aiguë
n1=en:mesothelial neoplasm | n2=leucémie granuleuse aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie granulocytaire aiguë
n1=en:mesothelial neoplasm | n2=leucémie granulocytaire aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie lymphoïde chronique
n1=en:mesothelial neoplasm | n2=leucémie lymphoïde chronique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myéloblastique aigüe
n1=en:mesothelial neoplasm | n2=leucémie myéloblastique aigüe | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myéloblastique aiguë
n1=en:mesothelial neoplasm | n2=leucémie myéloblastique aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myélocytaire aiguë
n1=en:mesothelial neoplasm | n2=leucémie myélocytaire aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myélogène aigüe
n1=en:mesothelial neoplasm | n2=leucémie myélogène aigüe | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myélogène aiguë
n1=en:mesothelial neoplasm | n2=leucémie myélogène aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myéloïde aiguë
n1=en:mesothelial neoplasm | n2=leucémie myéloïde aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie myéloïde aigüe
n1=en:mesothelial neoplasm | n2=leucémie myéloïde aigüe | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémie non lymphoblastique aiguë
n1=en:mesothelial neoplasm | n2=leucémie non lymphoblastique aiguë | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
leucémies myéloïdes aiguës
n1=en:mesothelial neoplasm | n2=leucémies myéloïdes aiguës | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lipome
n1=en:mesothelial neoplasm | n2=lipome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lung
n1=en:mesothelial neoplasm | n2=lung | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
lymphome folliculaire
n1=en:mesothelial neoplasm | n2=lymphome folliculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
maladie néoplasique maligne
n1=en:mesothelial neoplasm | n2=maladie néoplasique maligne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
maladie résiduelle
n1=en:mesothelial neoplasm | n2=maladie résiduelle | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
maladie résiduelle imperceptible
n1=en:mesothelial neoplasm | n2=maladie résiduelle imperceptible | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
maladies immunoprolifératives
n1=en:mesothelial neoplasm | n2=maladies immunoprolifératives | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
melanoma
n1=en:mesothelial neoplasm | n2=melanoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
mélanome
n1=en:mesothelial neoplasm | n2=mélanome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
méningiome angiomateux
n1=en:mesothelial neoplasm | n2=méningiome angiomateux | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
méningiomes
n1=en:mesothelial neoplasm | n2=méningiomes | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
mésothéliome
n1=en:mesothelial neoplasm | n2=mésothéliome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
métastase tumorale
n1=en:mesothelial neoplasm | n2=métastase tumorale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
métastase
(médecine)
n1=en:mesothelial neoplasm | n2=métastase (médecine) | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
métastase
(médecine, cancer)
n1=en:mesothelial neoplasm | n2=métastase (médecine, cancer) | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
microbiologique
n1=en:mesothelial neoplasm | n2=microbiologique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
myélome plasmocytaire
n1=en:mesothelial neoplasm | n2=myélome plasmocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
myxoma
n1=en:mesothelial neoplasm | n2=myxoma | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
myxome
n1=en:mesothelial neoplasm | n2=myxome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing
n1=en:mesothelial neoplasm | n2=myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neo
n1=en:mesothelial neoplasm | n2=neo | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasie du côlon
n1=en:mesothelial neoplasm | n2=néoplasie du côlon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasie endométriale
n1=en:mesothelial neoplasm | n2=néoplasie endométriale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasie gastro-intestinale
n1=en:mesothelial neoplasm | n2=néoplasie gastro-intestinale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme bénin
n1=en:mesothelial neoplasm | n2=néoplasme bénin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme malin de l'estomac
n1=en:mesothelial neoplasm | n2=néoplasme malin de l'estomac | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme malin gastrique
n1=en:mesothelial neoplasm | n2=néoplasme malin gastrique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme malin non classé
n1=en:mesothelial neoplasm | n2=néoplasme malin non classé | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme métastatique
n1=en:mesothelial neoplasm | n2=néoplasme métastatique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
néoplasme secondaire
n1=en:mesothelial neoplasm | n2=néoplasme secondaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
nésidioblastome
n1=en:mesothelial neoplasm | n2=nésidioblastome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurilemmome
n1=en:mesothelial neoplasm | n2=neurilemmome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurinome
n1=en:mesothelial neoplasm | n2=neurinome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurinome acoustique
n1=en:mesothelial neoplasm | n2=neurinome acoustique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurinome de l'acoustique
n1=en:mesothelial neoplasm | n2=neurinome de l'acoustique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Neurinome de l'acoustique
n1=en:mesothelial neoplasm | n2=Neurinome de l'acoustique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurinome malin
n1=en:mesothelial neoplasm | n2=neurinome malin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurofibromatose
n1=en:mesothelial neoplasm | n2=neurofibromatose | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurofibromatose de Recklinghausen
n1=en:mesothelial neoplasm | n2=neurofibromatose de Recklinghausen | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurofibromatose de recklinghausen
n1=en:mesothelial neoplasm | n2=neurofibromatose de recklinghausen | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurofibromatose de type périphérique
n1=en:mesothelial neoplasm | n2=neurofibromatose de type périphérique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
neurofibromatose de type VI
n1=en:mesothelial neoplasm | n2=neurofibromatose de type VI | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
névrome
n1=en:mesothelial neoplasm | n2=névrome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
névrome cutané
n1=en:mesothelial neoplasm | n2=névrome cutané | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
névrome palissadique encapsulé
n1=en:mesothelial neoplasm | n2=névrome palissadique encapsulé | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
névrome, sai
n1=en:mesothelial neoplasm | n2=névrome, sai | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
oligodendrogliome
n1=en:mesothelial neoplasm | n2=oligodendrogliome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
ostéosarcome
n1=en:mesothelial neoplasm | n2=ostéosarcome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
pancréas (cancer du)
n1=en:mesothelial neoplasm | n2=pancréas (cancer du) | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
parasitologie
n1=en:mesothelial neoplasm | n2=parasitologie | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
partie non précisée tumeur maligne du pancréas
n1=en:mesothelial neoplasm | n2=partie non précisée tumeur maligne du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
poumon vert
n1=en:mesothelial neoplasm | n2=poumon vert | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
radiographique
n1=en:mesothelial neoplasm | n2=radiographique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
radiothérapie
n1=en:mesothelial neoplasm | n2=radiothérapie | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
radiothérapie cutanée
n1=en:mesothelial neoplasm | n2=radiothérapie cutanée | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Recklinghausen (neurofibromatose de)
n1=en:mesothelial neoplasm | n2=Recklinghausen (neurofibromatose de) | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
rétinoblastome
n1=en:mesothelial neoplasm | n2=rétinoblastome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
rhabdomyosarcome
n1=en:mesothelial neoplasm | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
rhabdomyosarcomes
n1=en:mesothelial neoplasm | n2=rhabdomyosarcomes | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
sac alvéolaire
n1=en:mesothelial neoplasm | n2=sac alvéolaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
sarcome
n1=en:mesothelial neoplasm | n2=sarcome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
sarcome fibromyxoïde à faible malignité
n1=en:mesothelial neoplasm | n2=sarcome fibromyxoïde à faible malignité | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannogliome
n1=en:mesothelial neoplasm | n2=schwannogliome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome
n1=en:mesothelial neoplasm | n2=schwannome | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome ancien
n1=en:mesothelial neoplasm | n2=schwannome ancien | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome bénin
n1=en:mesothelial neoplasm | n2=schwannome bénin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome cellulaire
n1=en:mesothelial neoplasm | n2=schwannome cellulaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome dégénéré
n1=en:mesothelial neoplasm | n2=schwannome dégénéré | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome malin
n1=en:mesothelial neoplasm | n2=schwannome malin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome mélanocytaire
n1=en:mesothelial neoplasm | n2=schwannome mélanocytaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome pigmenté
n1=en:mesothelial neoplasm | n2=schwannome pigmenté | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome plexiforme
n1=en:mesothelial neoplasm | n2=schwannome plexiforme | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
schwannome psammomateux
n1=en:mesothelial neoplasm | n2=schwannome psammomateux | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
seconde tumeur maligne
n1=en:mesothelial neoplasm | n2=seconde tumeur maligne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
séreuse
n1=en:mesothelial neoplasm | n2=séreuse | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
séreux
n1=en:mesothelial neoplasm | n2=séreux | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
SIP
n1=en:mesothelial neoplasm | n2=SIP | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
syndromes immuno-prolifératifs
n1=en:mesothelial neoplasm | n2=syndromes immuno-prolifératifs | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
syndromes immunoprolifératifs
n1=en:mesothelial neoplasm | n2=syndromes immunoprolifératifs | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
syringo-cystadénome papillifère
n1=en:mesothelial neoplasm | n2=syringo-cystadénome papillifère | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
syringocystadénome papillaire
n1=en:mesothelial neoplasm | n2=syringocystadénome papillaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
syringocystadénome papillifère
n1=en:mesothelial neoplasm | n2=syringocystadénome papillifère | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur adénomatoïde
n1=en:mesothelial neoplasm | n2=tumeur adénomatoïde | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur bénigne
n1=en:mesothelial neoplasm | n2=tumeur bénigne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
Tumeur bénigne
n1=en:mesothelial neoplasm | n2=Tumeur bénigne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur cancéreuse
n1=en:mesothelial neoplasm | n2=tumeur cancéreuse | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur colique
n1=en:mesothelial neoplasm | n2=tumeur colique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur colo-rectale
n1=en:mesothelial neoplasm | n2=tumeur colo-rectale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur colorectale
n1=en:mesothelial neoplasm | n2=tumeur colorectale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur cutanée maligne
n1=en:mesothelial neoplasm | n2=tumeur cutanée maligne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur d'autres sièges précisés à évolution imprévisible ou inconnue
n1=en:mesothelial neoplasm | n2=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur d'autres sites non précisés à évolution imprévisible
n1=en:mesothelial neoplasm | n2=tumeur d'autres sites non précisés à évolution imprévisible | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur d'autres sites précisés à évolution imprévisible ou inconnue
n1=en:mesothelial neoplasm | n2=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de bénignité ou de malignité non assurée
n1=en:mesothelial neoplasm | n2=tumeur de bénignité ou de malignité non assurée | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de Grawitz
n1=en:mesothelial neoplasm | n2=tumeur de Grawitz | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de l'endomètre
n1=en:mesothelial neoplasm | n2=tumeur de l'endomètre | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de l'oeil
n1=en:mesothelial neoplasm | n2=tumeur de l'oeil | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de l'utérus
n1=en:mesothelial neoplasm | n2=tumeur de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de la glande salivaire
n1=en:mesothelial neoplasm | n2=tumeur de la glande salivaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur de la vulve
n1=en:mesothelial neoplasm | n2=tumeur de la vulve | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur des cellules squameuses
n1=en:mesothelial neoplasm | n2=tumeur des cellules squameuses | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur du pancréas
n1=en:mesothelial neoplasm | n2=tumeur du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur du sac vitellin
n1=en:mesothelial neoplasm | n2=tumeur du sac vitellin | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur du sein
n1=en:mesothelial neoplasm | n2=tumeur du sein | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur du système nerveux central
n1=en:mesothelial neoplasm | n2=tumeur du système nerveux central | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur gastro-intestinale
n1=en:mesothelial neoplasm | n2=tumeur gastro-intestinale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur gastrointestinale
n1=en:mesothelial neoplasm | n2=tumeur gastrointestinale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne colique
n1=en:mesothelial neoplasm | n2=tumeur maligne colique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne d'un testicule
n1=en:mesothelial neoplasm | n2=tumeur maligne d'un testicule | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de gaine nerveuse périphérique
n1=en:mesothelial neoplasm | n2=tumeur maligne de gaine nerveuse périphérique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de l'estomac
n1=en:mesothelial neoplasm | n2=tumeur maligne de l'estomac | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de l'oeil
n1=en:mesothelial neoplasm | n2=tumeur maligne de l'oeil | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de l'oesophage
n1=en:mesothelial neoplasm | n2=tumeur maligne de l'oesophage | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de l'utérus
n1=en:mesothelial neoplasm | n2=tumeur maligne de l'utérus | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de la glande salivaire
n1=en:mesothelial neoplasm | n2=tumeur maligne de la glande salivaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de la peau
n1=en:mesothelial neoplasm | n2=tumeur maligne de la peau | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de la vulve
n1=en:mesothelial neoplasm | n2=tumeur maligne de la vulve | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de siège non précisé
n1=en:mesothelial neoplasm | n2=tumeur maligne de siège non précisé | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne de siège primitif inconnu
n1=en:mesothelial neoplasm | n2=tumeur maligne de siège primitif inconnu | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne des glandes salivaires
n1=en:mesothelial neoplasm | n2=tumeur maligne des glandes salivaires | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne des os
n1=en:mesothelial neoplasm | n2=tumeur maligne des os | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne du côlon
n1=en:mesothelial neoplasm | n2=tumeur maligne du côlon | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne du côlon non précisée
n1=en:mesothelial neoplasm | n2=tumeur maligne du côlon non précisée | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne du muscle
n1=en:mesothelial neoplasm | n2=tumeur maligne du muscle | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne du pancréas
n1=en:mesothelial neoplasm | n2=tumeur maligne du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne du testicule
n1=en:mesothelial neoplasm | n2=tumeur maligne du testicule | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne duodénale
n1=en:mesothelial neoplasm | n2=tumeur maligne duodénale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne gastrique
n1=en:mesothelial neoplasm | n2=tumeur maligne gastrique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne non classée
n1=en:mesothelial neoplasm | n2=tumeur maligne non classée | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne oesophagienne
n1=en:mesothelial neoplasm | n2=tumeur maligne oesophagienne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne osseuse
n1=en:mesothelial neoplasm | n2=tumeur maligne osseuse | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne pancréatique
n1=en:mesothelial neoplasm | n2=tumeur maligne pancréatique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne sans précision de site
n1=en:mesothelial neoplasm | n2=tumeur maligne sans précision de site | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne testiculaire
n1=en:mesothelial neoplasm | n2=tumeur maligne testiculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne utérine
n1=en:mesothelial neoplasm | n2=tumeur maligne utérine | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur maligne vulvaire
n1=en:mesothelial neoplasm | n2=tumeur maligne vulvaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur métastasique
n1=en:mesothelial neoplasm | n2=tumeur métastasique | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur neuroépithéliale
n1=en:mesothelial neoplasm | n2=tumeur neuroépithéliale | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur non classée de bénignité ou de malignité incertaine
n1=en:mesothelial neoplasm | n2=tumeur non classée de bénignité ou de malignité incertaine | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur pancréatique maligne
n1=en:mesothelial neoplasm | n2=tumeur pancréatique maligne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur secondaire
n1=en:mesothelial neoplasm | n2=tumeur secondaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur testiculaire
n1=en:mesothelial neoplasm | n2=tumeur testiculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur testiculaire maligne
n1=en:mesothelial neoplasm | n2=tumeur testiculaire maligne | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur tubulopapillaire du rein
n1=en:mesothelial neoplasm | n2=tumeur tubulopapillaire du rein | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur utérine
n1=en:mesothelial neoplasm | n2=tumeur utérine | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeur vasculaire
n1=en:mesothelial neoplasm | n2=tumeur vasculaire | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeurs du pancréas
n1=en:mesothelial neoplasm | n2=tumeurs du pancréas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeurs du pancreas
n1=en:mesothelial neoplasm | n2=tumeurs du pancreas | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeurs hématopoïétiques
n1=en:mesothelial neoplasm | n2=tumeurs hématopoïétiques | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
tumeurs pancréatiques
n1=en:mesothelial neoplasm | n2=tumeurs pancréatiques | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 20 / 0.126 ->
vibrisses
n1=en:mesothelial neoplasm | n2=vibrisses | rel=r_associated | relid=0 | w=20
- en:mesothelial neoplasm --
r_associated #0: 15 / 0.094 ->
cancer
n1=en:mesothelial neoplasm | n2=cancer | rel=r_associated | relid=0 | w=15
- en:mesothelial neoplasm --
r_associated #0: 15 / 0.094 ->
carcinologie
(oncologie)
n1=en:mesothelial neoplasm | n2=carcinologie (oncologie) | rel=r_associated | relid=0 | w=15
- en:mesothelial neoplasm --
r_associated #0: 15 / 0.094 ->
en:oncology
n1=en:mesothelial neoplasm | n2=en:oncology | rel=r_associated | relid=0 | w=15
- en:mesothelial neoplasm --
r_associated #0: 15 / 0.094 ->
en:specialized branches of medicine
n1=en:mesothelial neoplasm | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
- en:mesothelial neoplasm --
r_associated #0: 15 / 0.094 ->
Spécialités médicales
n1=en:mesothelial neoplasm | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
cancérologie
n1=en:mesothelial neoplasm | n2=cancérologie | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
carcinologie
n1=en:mesothelial neoplasm | n2=carcinologie | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
en:cancer research
n1=en:mesothelial neoplasm | n2=en:cancer research | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
en:cancrology
n1=en:mesothelial neoplasm | n2=en:cancrology | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
en:carcinology
n1=en:mesothelial neoplasm | n2=en:carcinology | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
maladies
n1=en:mesothelial neoplasm | n2=maladies | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
Médecine
n1=en:mesothelial neoplasm | n2=Médecine | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
médecine spécialisée
n1=en:mesothelial neoplasm | n2=médecine spécialisée | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
oncologie
n1=en:mesothelial neoplasm | n2=oncologie | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
spécialités médicales
n1=en:mesothelial neoplasm | n2=spécialités médicales | rel=r_associated | relid=0 | w=5
- en:mesothelial neoplasm --
r_associated #0: 5 / 0.031 ->
tumeurs
n1=en:mesothelial neoplasm | n2=tumeurs | rel=r_associated | relid=0 | w=5
| ≈ 1383 relations entrantes
- en:malignant muscle neoplasm ---
r_associated #0: 591 -->
en:mesothelial neoplasm
n1=en:malignant muscle neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=591
- tumeur maligne du muscle ---
r_associated #0: 590 -->
en:mesothelial neoplasm
n1=tumeur maligne du muscle | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=590
- carcinome de l'endomètre ---
r_associated #0: 473 -->
en:mesothelial neoplasm
n1=carcinome de l'endomètre | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=473
- en:endometrial carcinoma ---
r_associated #0: 469 -->
en:mesothelial neoplasm
n1=en:endometrial carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=469
- lanl ---
r_associated #0: 410 -->
en:mesothelial neoplasm
n1=lanl | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=410
- leucémie myéloïde aiguë ---
r_associated #0: 410 -->
en:mesothelial neoplasm
n1=leucémie myéloïde aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=410
- lam ---
r_associated #0: 401 -->
en:mesothelial neoplasm
n1=lam | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=401
- la à granulocytes ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=la à granulocytes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie aiguë myélocytaire ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie aiguë myélocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie aiguë non lymphoblastique ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie aiguë non lymphoblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie aiguë non lymphocytaire ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie aiguë non lymphocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie aigüe myéloblastique ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie aigüe myéloblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie granuleuse aiguë ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie granuleuse aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie granulocytaire aiguë ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie granulocytaire aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- leucémie non lymphoblastique aiguë ---
r_associated #0: 390 -->
en:mesothelial neoplasm
n1=leucémie non lymphoblastique aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=390
- en:acute myeloid leukemia ---
r_associated #0: 389 -->
en:mesothelial neoplasm
n1=en:acute myeloid leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=389
- leucémie myélogène aiguë ---
r_associated #0: 370 -->
en:mesothelial neoplasm
n1=leucémie myélogène aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=370
- leucémie aigüe non lymphoblastique ---
r_associated #0: 360 -->
en:mesothelial neoplasm
n1=leucémie aigüe non lymphoblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=360
- leucémie myéloblastique aiguë ---
r_associated #0: 360 -->
en:mesothelial neoplasm
n1=leucémie myéloblastique aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=360
- leucémie myélogène aigüe ---
r_associated #0: 360 -->
en:mesothelial neoplasm
n1=leucémie myélogène aigüe | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=360
- tumeur maligne sans précision de site ---
r_associated #0: 360 -->
en:mesothelial neoplasm
n1=tumeur maligne sans précision de site | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=360
- en:malignant neoplasm ---
r_associated #0: 357 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=357
- néoplasme malin ---
r_associated #0: 357 -->
en:mesothelial neoplasm
n1=néoplasme malin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=357
- leucémie blastique granulocytaire ---
r_associated #0: 355 -->
en:mesothelial neoplasm
n1=leucémie blastique granulocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=355
- maladie néoplasique maligne ---
r_associated #0: 355 -->
en:mesothelial neoplasm
n1=maladie néoplasique maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=355
- néoplasme malin non classé ---
r_associated #0: 350 -->
en:mesothelial neoplasm
n1=néoplasme malin non classé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=350
- tumeur maligne de siège primitif inconnu ---
r_associated #0: 350 -->
en:mesothelial neoplasm
n1=tumeur maligne de siège primitif inconnu | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=350
- leucémie myéloïde aigüe ---
r_associated #0: 345 -->
en:mesothelial neoplasm
n1=leucémie myéloïde aigüe | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=345
- tumeur maligne non classée ---
r_associated #0: 340 -->
en:mesothelial neoplasm
n1=tumeur maligne non classée | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=340
- leucémie aiguë granulocytaire ---
r_associated #0: 335 -->
en:mesothelial neoplasm
n1=leucémie aiguë granulocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=335
- leucémie aigüe myéloïde ---
r_associated #0: 335 -->
en:mesothelial neoplasm
n1=leucémie aigüe myéloïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=335
- leucémie myélocytaire aiguë ---
r_associated #0: 335 -->
en:mesothelial neoplasm
n1=leucémie myélocytaire aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=335
- cancer pancréatique ---
r_associated #0: 320 -->
en:mesothelial neoplasm
n1=cancer pancréatique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=320
- leucémies myéloïdes aiguës ---
r_associated #0: 320 -->
en:mesothelial neoplasm
n1=leucémies myéloïdes aiguës | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=320
- carcinome du pancreas ---
r_associated #0: 318 -->
en:mesothelial neoplasm
n1=carcinome du pancreas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=318
- carcinome pancréatique ---
r_associated #0: 316 -->
en:mesothelial neoplasm
n1=carcinome pancréatique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=316
- leucémie aiguë myéloïde ---
r_associated #0: 315 -->
en:mesothelial neoplasm
n1=leucémie aiguë myéloïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=315
- tumeur maligne pancréatique ---
r_associated #0: 315 -->
en:mesothelial neoplasm
n1=tumeur maligne pancréatique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=315
- en:pancreatic carcinoma ---
r_associated #0: 311 -->
en:mesothelial neoplasm
n1=en:pancreatic carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=311
- carcinome du pancréas ---
r_associated #0: 310 -->
en:mesothelial neoplasm
n1=carcinome du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=310
- partie non précisée tumeur maligne du pancréas ---
r_associated #0: 310 -->
en:mesothelial neoplasm
n1=partie non précisée tumeur maligne du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=310
- leucémie aiguë myéloblastique ---
r_associated #0: 305 -->
en:mesothelial neoplasm
n1=leucémie aiguë myéloblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=305
- leucémie myéloblastique aigüe ---
r_associated #0: 305 -->
en:mesothelial neoplasm
n1=leucémie myéloblastique aigüe | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=305
- tumeur pancréatique maligne ---
r_associated #0: 305 -->
en:mesothelial neoplasm
n1=tumeur pancréatique maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=305
- tumeurs du pancreas ---
r_associated #0: 295 -->
en:mesothelial neoplasm
n1=tumeurs du pancreas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=295
- en:schwannoma ---
r_associated #0: 290 -->
en:mesothelial neoplasm
n1=en:schwannoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=290
- schwannogliome ---
r_associated #0: 290 -->
en:mesothelial neoplasm
n1=schwannogliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=290
- schwannome ---
r_associated #0: 286 -->
en:mesothelial neoplasm
n1=schwannome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=286
- neurinome ---
r_associated #0: 285 -->
en:mesothelial neoplasm
n1=neurinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=285
- schwannome bénin ---
r_associated #0: 281 -->
en:mesothelial neoplasm
n1=schwannome bénin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=281
- gliome périphérique ---
r_associated #0: 280 -->
en:mesothelial neoplasm
n1=gliome périphérique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=280
- lemmome ---
r_associated #0: 280 -->
en:mesothelial neoplasm
n1=lemmome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=280
- schwannome cellulaire ---
r_associated #0: 280 -->
en:mesothelial neoplasm
n1=schwannome cellulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=280
- schwannome mélanocytaire ---
r_associated #0: 280 -->
en:mesothelial neoplasm
n1=schwannome mélanocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=280
- tumeur maligne du pancréas ---
r_associated #0: 280 -->
en:mesothelial neoplasm
n1=tumeur maligne du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=280
- tumeurs pancréatiques ---
r_associated #0: 279 -->
en:mesothelial neoplasm
n1=tumeurs pancréatiques | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=279
- tumeur du pancréas ---
r_associated #0: 275 -->
en:mesothelial neoplasm
n1=tumeur du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=275
- cancer du pancréas ---
r_associated #0: 273 -->
en:mesothelial neoplasm
n1=cancer du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=273
- schwannome dégénéré ---
r_associated #0: 270 -->
en:mesothelial neoplasm
n1=schwannome dégénéré | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=270
- schwannome psammomateux ---
r_associated #0: 270 -->
en:mesothelial neoplasm
n1=schwannome psammomateux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=270
- tumeur bénigne ---
r_associated #0: 260 -->
en:mesothelial neoplasm
n1=tumeur bénigne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=260
- tumeurs du pancréas ---
r_associated #0: 260 -->
en:mesothelial neoplasm
n1=tumeurs du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=260
- en:benign neoplasm ---
r_associated #0: 258 -->
en:mesothelial neoplasm
n1=en:benign neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=258
- névrome ---
r_associated #0: 255 -->
en:mesothelial neoplasm
n1=névrome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=255
- névrome palissadique encapsulé ---
r_associated #0: 255 -->
en:mesothelial neoplasm
n1=névrome palissadique encapsulé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=255
- schwannome plexiforme ---
r_associated #0: 255 -->
en:mesothelial neoplasm
n1=schwannome plexiforme | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=255
- en:digestive system neoplasm ---
r_associated #0: 254 -->
en:mesothelial neoplasm
n1=en:digestive system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=254
- schwannome malin ---
r_associated #0: 251 -->
en:mesothelial neoplasm
n1=schwannome malin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=251
- néoplasie gastro-intestinale ---
r_associated #0: 250 -->
en:mesothelial neoplasm
n1=néoplasie gastro-intestinale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=250
- schwannome pigmenté ---
r_associated #0: 250 -->
en:mesothelial neoplasm
n1=schwannome pigmenté | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=250
- tumeur gastro-intestinale ---
r_associated #0: 250 -->
en:mesothelial neoplasm
n1=tumeur gastro-intestinale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=250
- tumeur gastrointestinale ---
r_associated #0: 250 -->
en:mesothelial neoplasm
n1=tumeur gastrointestinale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=250
- tumeur maligne de gaine nerveuse périphérique ---
r_associated #0: 250 -->
en:mesothelial neoplasm
n1=tumeur maligne de gaine nerveuse périphérique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=250
- en:nervous system neoplasm ---
r_associated #0: 249 -->
en:mesothelial neoplasm
n1=en:nervous system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=249
- tumeur du système nerveux ---
r_associated #0: 248 -->
en:mesothelial neoplasm
n1=tumeur du système nerveux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=248
- en:neuroma ---
r_associated #0: 247 -->
en:mesothelial neoplasm
n1=en:neuroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=247
- neurinome malin ---
r_associated #0: 246 -->
en:mesothelial neoplasm
n1=neurinome malin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=246
- neurinome acoustique ---
r_associated #0: 245 -->
en:mesothelial neoplasm
n1=neurinome acoustique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=245
- neurinome de l'acoustique ---
r_associated #0: 245 -->
en:mesothelial neoplasm
n1=neurinome de l'acoustique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=245
- névrome, sai ---
r_associated #0: 245 -->
en:mesothelial neoplasm
n1=névrome, sai | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=245
- schwannome ancien ---
r_associated #0: 245 -->
en:mesothelial neoplasm
n1=schwannome ancien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=245
- neurilemmome ---
r_associated #0: 241 -->
en:mesothelial neoplasm
n1=neurilemmome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=241
- tumeur maligne gastrique ---
r_associated #0: 235 -->
en:mesothelial neoplasm
n1=tumeur maligne gastrique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=235
- en:malignant gastric neoplasm ---
r_associated #0: 234 -->
en:mesothelial neoplasm
n1=en:malignant gastric neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=234
- Cancer osseux ---
r_associated #0: 231 -->
en:mesothelial neoplasm
n1=Cancer osseux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=231
- cancer gastrique ---
r_associated #0: 230 -->
en:mesothelial neoplasm
n1=cancer gastrique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=230
- en:malignant neoplasm of stomach ---
r_associated #0: 230 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of stomach | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=230
- tumeur maligne osseuse ---
r_associated #0: 230 -->
en:mesothelial neoplasm
n1=tumeur maligne osseuse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=230
- cancer osseux ---
r_associated #0: 226 -->
en:mesothelial neoplasm
n1=cancer osseux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=226
- cancer de l'estomac ---
r_associated #0: 225 -->
en:mesothelial neoplasm
n1=cancer de l'estomac | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=225
- carcinome glandulaire ---
r_associated #0: 225 -->
en:mesothelial neoplasm
n1=carcinome glandulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=225
- tumeur maligne de l'estomac ---
r_associated #0: 225 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'estomac | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=225
- tumeur maligne des os ---
r_associated #0: 225 -->
en:mesothelial neoplasm
n1=tumeur maligne des os | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=225
- en:adenocarcinoma ---
r_associated #0: 224 -->
en:mesothelial neoplasm
n1=en:adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=224
- en:malignant bone neoplasm ---
r_associated #0: 222 -->
en:mesothelial neoplasm
n1=en:malignant bone neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=222
- adénocarcinome ---
r_associated #0: 221 -->
en:mesothelial neoplasm
n1=adénocarcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=221
- carcinome gastrique ---
r_associated #0: 215 -->
en:mesothelial neoplasm
n1=carcinome gastrique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=215
- cancer de la testicule ---
r_associated #0: 214 -->
en:mesothelial neoplasm
n1=cancer de la testicule | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=214
- méningiomes ---
r_associated #0: 211 -->
en:mesothelial neoplasm
n1=méningiomes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=211
- cancer testiculaire ---
r_associated #0: 210 -->
en:mesothelial neoplasm
n1=cancer testiculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=210
- tumeur testiculaire maligne ---
r_associated #0: 206 -->
en:mesothelial neoplasm
n1=tumeur testiculaire maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=206
- cancer des os ---
r_associated #0: 205 -->
en:mesothelial neoplasm
n1=cancer des os | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=205
- en:angiomatous meningioma ---
r_associated #0: 205 -->
en:mesothelial neoplasm
n1=en:angiomatous meningioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=205
- en:enzymology ---
r_associated #0: 204 -->
en:mesothelial neoplasm
n1=en:enzymology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=204
- épulis ---
r_associated #0: 203 -->
en:mesothelial neoplasm
n1=épulis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=203
- en:malignant testicular neoplasm ---
r_associated #0: 202 -->
en:mesothelial neoplasm
n1=en:malignant testicular neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=202
- tumeur maligne d'un testicule ---
r_associated #0: 202 -->
en:mesothelial neoplasm
n1=tumeur maligne d'un testicule | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=202
- tumeur maligne testiculaire ---
r_associated #0: 202 -->
en:mesothelial neoplasm
n1=tumeur maligne testiculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=202
- enzymologie ---
r_associated #0: 200 -->
en:mesothelial neoplasm
n1=enzymologie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=200
- hémangiome ---
r_associated #0: 198 -->
en:mesothelial neoplasm
n1=hémangiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=198
- cancer du testicule ---
r_associated #0: 195 -->
en:mesothelial neoplasm
n1=cancer du testicule | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=195
- en:blood vessel neoplasm ---
r_associated #0: 194 -->
en:mesothelial neoplasm
n1=en:blood vessel neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=194
- en:meningioma ---
r_associated #0: 193 -->
en:mesothelial neoplasm
n1=en:meningioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=193
- tumeur maligne des glandes salivaires ---
r_associated #0: 193 -->
en:mesothelial neoplasm
n1=tumeur maligne des glandes salivaires | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=193
- cancer malin de la glande salivaire ---
r_associated #0: 190 -->
en:mesothelial neoplasm
n1=cancer malin de la glande salivaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=190
- en:neuroepithelial neoplasm ---
r_associated #0: 190 -->
en:mesothelial neoplasm
n1=en:neuroepithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=190
- tumeur maligne du testicule ---
r_associated #0: 190 -->
en:mesothelial neoplasm
n1=tumeur maligne du testicule | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=190
- tumeur de la glande salivaire ---
r_associated #0: 189 -->
en:mesothelial neoplasm
n1=tumeur de la glande salivaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=189
- méningiome ---
r_associated #0: 188 -->
en:mesothelial neoplasm
n1=méningiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=188
- tumeur neuroépithéliale ---
r_associated #0: 186 -->
en:mesothelial neoplasm
n1=tumeur neuroépithéliale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=186
- cancer d'une glande salivaire ---
r_associated #0: 185 -->
en:mesothelial neoplasm
n1=cancer d'une glande salivaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=185
- en:malignant neoplasm of salivary gland ---
r_associated #0: 185 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of salivary gland | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=185
- méningiome angiomateux ---
r_associated #0: 184 -->
en:mesothelial neoplasm
n1=méningiome angiomateux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=184
- en:hemangioma ---
r_associated #0: 183 -->
en:mesothelial neoplasm
n1=en:hemangioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=183
- cancer endométrial ---
r_associated #0: 180 -->
en:mesothelial neoplasm
n1=cancer endométrial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=180
- en:malignant salivary gland neoplasm ---
r_associated #0: 180 -->
en:mesothelial neoplasm
n1=en:malignant salivary gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=180
- tumeur maligne de la glande salivaire ---
r_associated #0: 180 -->
en:mesothelial neoplasm
n1=tumeur maligne de la glande salivaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=180
- en:malignant pancreatic neoplasm ---
r_associated #0: 179 -->
en:mesothelial neoplasm
n1=en:malignant pancreatic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=179
- carcinome endométrial ---
r_associated #0: 178 -->
en:mesothelial neoplasm
n1=carcinome endométrial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=178
- en:pancreatic neoplasm ---
r_associated #0: 177 -->
en:mesothelial neoplasm
n1=en:pancreatic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=177
- cancer vulvaire ---
r_associated #0: 176 -->
en:mesothelial neoplasm
n1=cancer vulvaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=176
- rhabdomyosarcome ---
r_associated #0: 175 -->
en:mesothelial neoplasm
n1=rhabdomyosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=175
- en:neoplasm, uncertain whether benign or malignant ---
r_associated #0: 172 -->
en:mesothelial neoplasm
n1=en:neoplasm, uncertain whether benign or malignant | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=172
- en:rhabdomyosarcoma ---
r_associated #0: 172 -->
en:mesothelial neoplasm
n1=en:rhabdomyosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=172
- adénome malin ---
r_associated #0: 170 -->
en:mesothelial neoplasm
n1=adénome malin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=170
- cancer de la vulve ---
r_associated #0: 170 -->
en:mesothelial neoplasm
n1=cancer de la vulve | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=170
- en:malignant neoplasm of testis ---
r_associated #0: 170 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of testis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=170
- tumeur non classée de bénignité ou de malignité incertaine ---
r_associated #0: 170 -->
en:mesothelial neoplasm
n1=tumeur non classée de bénignité ou de malignité incertaine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=170
- adénome à cellules oncocytaires ---
r_associated #0: 169 -->
en:mesothelial neoplasm
n1=adénome à cellules oncocytaires | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=169
- en:malignant vulvar neoplasm ---
r_associated #0: 169 -->
en:mesothelial neoplasm
n1=en:malignant vulvar neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=169
- Adénocarcinome ---
r_associated #0: 165 -->
en:mesothelial neoplasm
n1=Adénocarcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=165
- cancer de l'endomètre ---
r_associated #0: 165 -->
en:mesothelial neoplasm
n1=cancer de l'endomètre | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=165
- tumeur de la vulve ---
r_associated #0: 165 -->
en:mesothelial neoplasm
n1=tumeur de la vulve | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=165
- tumeur maligne vulvaire ---
r_associated #0: 165 -->
en:mesothelial neoplasm
n1=tumeur maligne vulvaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=165
- cancer de la gorge ---
r_associated #0: 161 -->
en:mesothelial neoplasm
n1=cancer de la gorge | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=161
- en:oncocytic adenoma ---
r_associated #0: 161 -->
en:mesothelial neoplasm
n1=en:oncocytic adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=161
- Cancer de l'estomac ---
r_associated #0: 160 -->
en:mesothelial neoplasm
n1=Cancer de l'estomac | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=160
- adénome oncocytaire ---
r_associated #0: 160 -->
en:mesothelial neoplasm
n1=adénome oncocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=160
- enzymology ---
r_associated #0: 160 -->
en:mesothelial neoplasm
n1=enzymology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=160
- cellule tumorale ---
r_associated #0: 158 -->
en:mesothelial neoplasm
n1=cellule tumorale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=158
- en:throat cancer ---
r_associated #0: 158 -->
en:mesothelial neoplasm
n1=en:throat cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=158
- en:neoplastic cell ---
r_associated #0: 156 -->
en:mesothelial neoplasm
n1=en:neoplastic cell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=156
- carcinome cutané ---
r_associated #0: 155 -->
en:mesothelial neoplasm
n1=carcinome cutané | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=155
- en:malignant neoplasm of vulva ---
r_associated #0: 155 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of vulva | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=155
- tumeur maligne de la vulve ---
r_associated #0: 155 -->
en:mesothelial neoplasm
n1=tumeur maligne de la vulve | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=155
- carcinome de la peau ---
r_associated #0: 151 -->
en:mesothelial neoplasm
n1=carcinome de la peau | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=151
- en:benign growth ---
r_associated #0: 150 -->
en:mesothelial neoplasm
n1=en:benign growth | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=150
- en:benign tumour ---
r_associated #0: 150 -->
en:mesothelial neoplasm
n1=en:benign tumour | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=150
- en:cancer of the stomach ---
r_associated #0: 150 -->
en:mesothelial neoplasm
n1=en:cancer of the stomach | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=150
- en:stomach cancer ---
r_associated #0: 150 -->
en:mesothelial neoplasm
n1=en:stomach cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=150
- neo ---
r_associated #0: 150 -->
en:mesothelial neoplasm
n1=neo | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=150
- en:skin carcinoma ---
r_associated #0: 146 -->
en:mesothelial neoplasm
n1=en:skin carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=146
- cancers ---
r_associated #0: 145 -->
en:mesothelial neoplasm
n1=cancers | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=145
- tumeur vasculaire ---
r_associated #0: 145 -->
en:mesothelial neoplasm
n1=tumeur vasculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=145
- en:adenocarcinoma of colon ---
r_associated #0: 142 -->
en:mesothelial neoplasm
n1=en:adenocarcinoma of colon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=142
- en:colon adenocarcinoma ---
r_associated #0: 141 -->
en:mesothelial neoplasm
n1=en:colon adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=141
- adénocarcinome du côlon ---
r_associated #0: 140 -->
en:mesothelial neoplasm
n1=adénocarcinome du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=140
- en:benign tumor ---
r_associated #0: 140 -->
en:mesothelial neoplasm
n1=en:benign tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=140
- cancer de l'oeil ---
r_associated #0: 136 -->
en:mesothelial neoplasm
n1=cancer de l'oeil | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=136
- rétinoblastome ---
r_associated #0: 136 -->
en:mesothelial neoplasm
n1=rétinoblastome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=136
- tumeur de l'oeil ---
r_associated #0: 136 -->
en:mesothelial neoplasm
n1=tumeur de l'oeil | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=136
- vibrisses ---
r_associated #0: 136 -->
en:mesothelial neoplasm
n1=vibrisses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=136
- en:eye neoplasm ---
r_associated #0: 135 -->
en:mesothelial neoplasm
n1=en:eye neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=135
- en:malignant eye neoplasm ---
r_associated #0: 135 -->
en:mesothelial neoplasm
n1=en:malignant eye neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=135
- en:retinoblastoma ---
r_associated #0: 135 -->
en:mesothelial neoplasm
n1=en:retinoblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=135
- en:vibrissae ---
r_associated #0: 135 -->
en:mesothelial neoplasm
n1=en:vibrissae | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=135
- tumeur maligne de l'oeil ---
r_associated #0: 135 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'oeil | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=135
- Cancer du col utérin ---
r_associated #0: 134 -->
en:mesothelial neoplasm
n1=Cancer du col utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=134
- médecine ---
r_associated #0: 130 -->
en:mesothelial neoplasm
n1=médecine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=130
- cancer du col de l'utérus ---
r_associated #0: 126 -->
en:mesothelial neoplasm
n1=cancer du col de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=126
- cancer du col utérin ---
r_associated #0: 126 -->
en:mesothelial neoplasm
n1=cancer du col utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=126
- cancer oculaire ---
r_associated #0: 125 -->
en:mesothelial neoplasm
n1=cancer oculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=125
- en:malignant tumor of eye ---
r_associated #0: 125 -->
en:mesothelial neoplasm
n1=en:malignant tumor of eye | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=125
- néoplasme bénin ---
r_associated #0: 125 -->
en:mesothelial neoplasm
n1=néoplasme bénin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=125
- rhabdomyosarcomes ---
r_associated #0: 125 -->
en:mesothelial neoplasm
n1=rhabdomyosarcomes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=125
- syndromes immuno-prolifératifs ---
r_associated #0: 125 -->
en:mesothelial neoplasm
n1=syndromes immuno-prolifératifs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=125
- en:cervical cancer ---
r_associated #0: 122 -->
en:mesothelial neoplasm
n1=en:cervical cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=122
- adenocarcinoma ---
r_associated #0: 120 -->
en:mesothelial neoplasm
n1=adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=120
- en:immunoproliferative disorders ---
r_associated #0: 119 -->
en:mesothelial neoplasm
n1=en:immunoproliferative disorders | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=119
- maladies immunoprolifératives ---
r_associated #0: 115 -->
en:mesothelial neoplasm
n1=maladies immunoprolifératives | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=115
- syndromes immunoprolifératifs ---
r_associated #0: 115 -->
en:mesothelial neoplasm
n1=syndromes immunoprolifératifs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=115
- tumeur maligne de la peau ---
r_associated #0: 115 -->
en:mesothelial neoplasm
n1=tumeur maligne de la peau | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=115
- en:malignant skin neoplasm ---
r_associated #0: 114 -->
en:mesothelial neoplasm
n1=en:malignant skin neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=114
- cancer cutané ---
r_associated #0: 110 -->
en:mesothelial neoplasm
n1=cancer cutané | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=110
- en:malignant neoplasm of skin ---
r_associated #0: 110 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of skin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=110
- en:malignant esophageal neoplasm ---
r_associated #0: 109 -->
en:mesothelial neoplasm
n1=en:malignant esophageal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=109
- Cancer utérin ---
r_associated #0: 107 -->
en:mesothelial neoplasm
n1=Cancer utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=107
- cancer utérin ---
r_associated #0: 107 -->
en:mesothelial neoplasm
n1=cancer utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=107
- cancer de la peau ---
r_associated #0: 105 -->
en:mesothelial neoplasm
n1=cancer de la peau | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=105
- tumeur d'autres sites précisés à évolution imprévisible ou inconnue ---
r_associated #0: 105 -->
en:mesothelial neoplasm
n1=tumeur d'autres sites précisés à évolution imprévisible ou inconnue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=105
- tumeur de bénignité ou de malignité non assurée ---
r_associated #0: 105 -->
en:mesothelial neoplasm
n1=tumeur de bénignité ou de malignité non assurée | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=105
- tumeur maligne oesophagienne ---
r_associated #0: 105 -->
en:mesothelial neoplasm
n1=tumeur maligne oesophagienne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=105
- en:squamous cell neoplasm ---
r_associated #0: 101 -->
en:mesothelial neoplasm
n1=en:squamous cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=101
- tumeur d'autres sièges précisés à évolution imprévisible ou inconnue ---
r_associated #0: 100 -->
en:mesothelial neoplasm
n1=tumeur d'autres sièges précisés à évolution imprévisible ou inconnue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=100
- tumeur des cellules squameuses ---
r_associated #0: 100 -->
en:mesothelial neoplasm
n1=tumeur des cellules squameuses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=100
- tumeur maligne utérine ---
r_associated #0: 100 -->
en:mesothelial neoplasm
n1=tumeur maligne utérine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=100
- en:uterine cancer ---
r_associated #0: 99 -->
en:mesothelial neoplasm
n1=en:uterine cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=99
- radiothérapie ---
r_associated #0: 97 -->
en:mesothelial neoplasm
n1=radiothérapie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=97
- cancer de l'oesophage ---
r_associated #0: 96 -->
en:mesothelial neoplasm
n1=cancer de l'oesophage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=96
- en:neoplasm of uncertain behavior of other specified sites ---
r_associated #0: 96 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain behavior of other specified sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=96
- cancer de l'œsophage ---
r_associated #0: 95 -->
en:mesothelial neoplasm
n1=cancer de l'œsophage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=95
- en:malignant uterine neoplasm ---
r_associated #0: 95 -->
en:mesothelial neoplasm
n1=en:malignant uterine neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=95
- poumon vert ---
r_associated #0: 95 -->
en:mesothelial neoplasm
n1=poumon vert | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=95
- tumeur cutanée maligne ---
r_associated #0: 95 -->
en:mesothelial neoplasm
n1=tumeur cutanée maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=95
- nésidioblastome ---
r_associated #0: 94 -->
en:mesothelial neoplasm
n1=nésidioblastome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=94
- tumeur maligne de siège non précisé ---
r_associated #0: 94 -->
en:mesothelial neoplasm
n1=tumeur maligne de siège non précisé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=94
- en:radiation therapy ---
r_associated #0: 93 -->
en:mesothelial neoplasm
n1=en:radiation therapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=93
- en:lung ---
r_associated #0: 92 -->
en:mesothelial neoplasm
n1=en:lung | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=92
- tumeur maligne de l'oesophage ---
r_associated #0: 91 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'oesophage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=91
- LA à granulocytes ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=LA à granulocytes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- cancer de l'œsophage ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=cancer de l'œsophage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- en:acute myeloblastic leukaemia ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=en:acute myeloblastic leukaemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- en:endometrial cancer ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=en:endometrial cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- en:pancreatic cancer ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=en:pancreatic cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- lung ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=lung | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- néoplasie endométriale ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=néoplasie endométriale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- tumeur d'autres sites non précisés à évolution imprévisible ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=tumeur d'autres sites non précisés à évolution imprévisible | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- tumeur utérine ---
r_associated #0: 90 -->
en:mesothelial neoplasm
n1=tumeur utérine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=90
- lipome ---
r_associated #0: 85 -->
en:mesothelial neoplasm
n1=lipome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=85
- tumeur du système nerveux central ---
r_associated #0: 85 -->
en:mesothelial neoplasm
n1=tumeur du système nerveux central | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=85
- en:lipoma ---
r_associated #0: 84 -->
en:mesothelial neoplasm
n1=en:lipoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=84
- en:uterine neoplasm ---
r_associated #0: 84 -->
en:mesothelial neoplasm
n1=en:uterine neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=84
- en:central nervous system neoplasm ---
r_associated #0: 82 -->
en:mesothelial neoplasm
n1=en:central nervous system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=82
- en:endometrial neoplasm ---
r_associated #0: 81 -->
en:mesothelial neoplasm
n1=en:endometrial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=81
- syringocystadénome papillaire ---
r_associated #0: 81 -->
en:mesothelial neoplasm
n1=syringocystadénome papillaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=81
- cancer glandulaire ---
r_associated #0: 80 -->
en:mesothelial neoplasm
n1=cancer glandulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=80
- myxoma ---
r_associated #0: 80 -->
en:mesothelial neoplasm
n1=myxoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=80
- sac alvéolaire ---
r_associated #0: 80 -->
en:mesothelial neoplasm
n1=sac alvéolaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=80
- tumeur de l'endomètre ---
r_associated #0: 80 -->
en:mesothelial neoplasm
n1=tumeur de l'endomètre | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=80
- en:tumor cell ---
r_associated #0: 79 -->
en:mesothelial neoplasm
n1=en:tumor cell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=79
- tumeur du sein ---
r_associated #0: 78 -->
en:mesothelial neoplasm
n1=tumeur du sein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=78
- en:air sac ---
r_associated #0: 77 -->
en:mesothelial neoplasm
n1=en:air sac | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=77
- cancer de l'utérus ---
r_associated #0: 76 -->
en:mesothelial neoplasm
n1=cancer de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=76
- en:myxoma ---
r_associated #0: 76 -->
en:mesothelial neoplasm
n1=en:myxoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=76
- syringocystadénome papillifère ---
r_associated #0: 76 -->
en:mesothelial neoplasm
n1=syringocystadénome papillifère | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=76
- Cancer de la vulve ---
r_associated #0: 75 -->
en:mesothelial neoplasm
n1=Cancer de la vulve | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=75
- Tumeur bénigne ---
r_associated #0: 75 -->
en:mesothelial neoplasm
n1=Tumeur bénigne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=75
- tumeur de l'utérus ---
r_associated #0: 75 -->
en:mesothelial neoplasm
n1=tumeur de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=75
- en:syringocystadenoma papilliferum ---
r_associated #0: 73 -->
en:mesothelial neoplasm
n1=en:syringocystadenoma papilliferum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=73
- Cancer de la peau ---
r_associated #0: 70 -->
en:mesothelial neoplasm
n1=Cancer de la peau | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=70
- carcinome utérin ---
r_associated #0: 70 -->
en:mesothelial neoplasm
n1=carcinome utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=70
- en:leukaemia ---
r_associated #0: 70 -->
en:mesothelial neoplasm
n1=en:leukaemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=70
- tumeur colique ---
r_associated #0: 70 -->
en:mesothelial neoplasm
n1=tumeur colique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=70
- en:leukemia ---
r_associated #0: 68 -->
en:mesothelial neoplasm
n1=en:leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=68
- leucémie ---
r_associated #0: 68 -->
en:mesothelial neoplasm
n1=leucémie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=68
- tumeur maligne colique ---
r_associated #0: 68 -->
en:mesothelial neoplasm
n1=tumeur maligne colique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=68
- cancer colo-rectal ---
r_associated #0: 66 -->
en:mesothelial neoplasm
n1=cancer colo-rectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=66
- en:acute myeloblastic leukemia ---
r_associated #0: 66 -->
en:mesothelial neoplasm
n1=en:acute myeloblastic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=66
- carcinome colo-rectal ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=carcinome colo-rectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- carcinome colorectal ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=carcinome colorectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- carcinome recto-colique ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=carcinome recto-colique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- carcinome rectocolique ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=carcinome rectocolique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- en:malignant tumor of colon ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=en:malignant tumor of colon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- en:testicular cancer ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=en:testicular cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- non précisée, tumeur maligne du côlon ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=non précisée, tumeur maligne du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- tumeur colo-rectale ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=tumeur colo-rectale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- tumeur colorectale ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=tumeur colorectale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- tumeur maligne de l'utérus ---
r_associated #0: 65 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=65
- en:leucemia ---
r_associated #0: 64 -->
en:mesothelial neoplasm
n1=en:leucemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=64
- en:leukocythemia ---
r_associated #0: 64 -->
en:mesothelial neoplasm
n1=en:leukocythemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=64
- en:serosa ---
r_associated #0: 63 -->
en:mesothelial neoplasm
n1=en:serosa | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=63
- séreuse ---
r_associated #0: 62 -->
en:mesothelial neoplasm
n1=séreuse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=62
- cancer colorectal ---
r_associated #0: 61 -->
en:mesothelial neoplasm
n1=cancer colorectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=61
- en:colon neoplasm ---
r_associated #0: 61 -->
en:mesothelial neoplasm
n1=en:colon neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=61
- Neurinome de l'acoustique ---
r_associated #0: 60 -->
en:mesothelial neoplasm
n1=Neurinome de l'acoustique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=60
- cancer du sang ---
r_associated #0: 60 -->
en:mesothelial neoplasm
n1=cancer du sang | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=60
- carcinoma ---
r_associated #0: 59 -->
en:mesothelial neoplasm
n1=carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=59
- en:colonic neoplasms ---
r_associated #0: 59 -->
en:mesothelial neoplasm
n1=en:colonic neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=59
- cancer du duodénum ---
r_associated #0: 58 -->
en:mesothelial neoplasm
n1=cancer du duodénum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=58
- en:radiotherapy ---
r_associated #0: 58 -->
en:mesothelial neoplasm
n1=en:radiotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=58
- melanoma ---
r_associated #0: 58 -->
en:mesothelial neoplasm
n1=melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=58
- néoplasme malin gastrique ---
r_associated #0: 58 -->
en:mesothelial neoplasm
n1=néoplasme malin gastrique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=58
- en:malignant colon neoplasm ---
r_associated #0: 56 -->
en:mesothelial neoplasm
n1=en:malignant colon neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=56
- cancer oesophagien ---
r_associated #0: 55 -->
en:mesothelial neoplasm
n1=cancer oesophagien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=55
- carcinome duodénal ---
r_associated #0: 55 -->
en:mesothelial neoplasm
n1=carcinome duodénal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=55
- néoplasie du côlon ---
r_associated #0: 55 -->
en:mesothelial neoplasm
n1=néoplasie du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=55
- tumeur testiculaire ---
r_associated #0: 55 -->
en:mesothelial neoplasm
n1=tumeur testiculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=55
- cancer colique ---
r_associated #0: 54 -->
en:mesothelial neoplasm
n1=cancer colique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=54
- cancer duodénal ---
r_associated #0: 54 -->
en:mesothelial neoplasm
n1=cancer duodénal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=54
- en:skin cancer ---
r_associated #0: 54 -->
en:mesothelial neoplasm
n1=en:skin cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=54
- tumeur maligne du duodénum ---
r_associated #0: 54 -->
en:mesothelial neoplasm
n1=tumeur maligne du duodénum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=54
- en:duodenal cancer ---
r_associated #0: 52 -->
en:mesothelial neoplasm
n1=en:duodenal cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=52
- tumeur maligne duodénale ---
r_associated #0: 52 -->
en:mesothelial neoplasm
n1=tumeur maligne duodénale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=52
- en:carcinoma ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=en:carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- en:melanoma ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=en:melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- en:neurinoma ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=en:neurinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- en:vulvar tumor ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=en:vulvar tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- épithélioma sébacé ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=épithélioma sébacé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- état prénéoplasique ---
r_associated #0: 50 -->
en:mesothelial neoplasm
n1=état prénéoplasique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=50
- en:gastric cancer ---
r_associated #0: 49 -->
en:mesothelial neoplasm
n1=en:gastric cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=49
- tumeur du côlon ---
r_associated #0: 49 -->
en:mesothelial neoplasm
n1=tumeur du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=49
- en:precancerous condition ---
r_associated #0: 48 -->
en:mesothelial neoplasm
n1=en:precancerous condition | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=48
- en:roentgentherapy ---
r_associated #0: 48 -->
en:mesothelial neoplasm
n1=en:roentgentherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=48
- en:sebaceous carcinoma ---
r_associated #0: 48 -->
en:mesothelial neoplasm
n1=en:sebaceous carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=48
- carcinome du gros intestin ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=carcinome du gros intestin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- en:colorectal carcinoma ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=en:colorectal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- microbiologique ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=microbiologique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- néoplasme malin de l'estomac ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=néoplasme malin de l'estomac | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- radiothérapie cutanée ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=radiothérapie cutanée | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- syringo-cystadénome papillifère ---
r_associated #0: 47 -->
en:mesothelial neoplasm
n1=syringo-cystadénome papillifère | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=47
- en:beam radiation therapy ---
r_associated #0: 46 -->
en:mesothelial neoplasm
n1=en:beam radiation therapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=46
- en:roentgenotherapy ---
r_associated #0: 46 -->
en:mesothelial neoplasm
n1=en:roentgenotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=46
- adénome ---
r_associated #0: 45 -->
en:mesothelial neoplasm
n1=adénome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=45
- carcinôme ---
r_associated #0: 45 -->
en:mesothelial neoplasm
n1=carcinôme | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=45
- tumeur cancéreuse ---
r_associated #0: 45 -->
en:mesothelial neoplasm
n1=tumeur cancéreuse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=45
- cancer épithélial ---
r_associated #0: 44 -->
en:mesothelial neoplasm
n1=cancer épithélial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=44
- en:radiation treatment ---
r_associated #0: 44 -->
en:mesothelial neoplasm
n1=en:radiation treatment | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=44
- tumeur maligne du côlon non précisée ---
r_associated #0: 44 -->
en:mesothelial neoplasm
n1=tumeur maligne du côlon non précisée | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=44
- carcinome ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=carcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:acinar cell neoplasm ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=en:acinar cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:head and neck paraganglioma ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=en:head and neck paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:lymphoproliferative disorder ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=en:lymphoproliferative disorder | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:microbiological ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=en:microbiological | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:secondary malignant neoplasm ---
r_associated #0: 43 -->
en:mesothelial neoplasm
n1=en:secondary malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=43
- en:adenoma ---
r_associated #0: 42 -->
en:mesothelial neoplasm
n1=en:adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=42
- en:increased risk of meningioma ---
r_associated #0: 42 -->
en:mesothelial neoplasm
n1=en:increased risk of meningioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=42
- en:innocent tumor ---
r_associated #0: 42 -->
en:mesothelial neoplasm
n1=en:innocent tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=42
- en:malignant genitourinary tract tumor ---
r_associated #0: 42 -->
en:mesothelial neoplasm
n1=en:malignant genitourinary tract tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=42
- tumeur maligne du côlon ---
r_associated #0: 42 -->
en:mesothelial neoplasm
n1=tumeur maligne du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=42
- en:adenomatoid tumor ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:adenomatoid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:clear cell neoplasm ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:clear cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:head or neck cancer ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:head or neck cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:malignant mesothelioma ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:malignant mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:malignant neoplasm growth accelerated ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm growth accelerated | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:metastatic angiosarcoma ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:metastatic angiosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:screening for prostate cancer ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:screening for prostate cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- en:tumors and pregnancy ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=en:tumors and pregnancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- myxome ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=myxome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- ostéosarcome ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=ostéosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- sarcome fibromyxoïde à faible malignité ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=sarcome fibromyxoïde à faible malignité | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- tumeur du sac vitellin ---
r_associated #0: 41 -->
en:mesothelial neoplasm
n1=tumeur du sac vitellin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=41
- cancer de la glande salivaire ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=cancer de la glande salivaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- cancer secondaire ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=cancer secondaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- en:enteropathy-associated t-cell lymphoma ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=en:enteropathy-associated t-cell lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- en:low grade fibromyxoid sarcoma ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=en:low grade fibromyxoid sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- en:malignant central nervous system neoplasm ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=en:malignant central nervous system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- en:neurilemmoma ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=en:neurilemmoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- en:yolk sac tumor ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=en:yolk sac tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- mélanome ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=mélanome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- neurofibromatose de recklinghausen ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=neurofibromatose de recklinghausen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- séreux ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=séreux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- tumeur de Grawitz ---
r_associated #0: 40 -->
en:mesothelial neoplasm
n1=tumeur de Grawitz | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=40
- Cancer du pancréas ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=Cancer du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:chordoma ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:chordoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:clear cell renal cell carcinoma ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:clear cell renal cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:glioneuroma ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:glioneuroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:increased risk for cancer ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:increased risk for cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:low incidence of plexiform neurofibromas ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:low incidence of plexiform neurofibromas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:myeloproliferative neoplasm ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:myeloproliferative neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:neoplasms, ductal, lobular, and medullary ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:neoplasms, ductal, lobular, and medullary | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:pinealoma (trilateral retinoblastoma) ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:pinealoma (trilateral retinoblastoma) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:pleural solitary fibrous tumor ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=en:pleural solitary fibrous tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=myxomes cardiaques et cutanés, lentiginose faciale et syndrome de Cushing | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- neurofibromatose de Recklinghausen ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=neurofibromatose de Recklinghausen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- poumon ---
r_associated #0: 39 -->
en:mesothelial neoplasm
n1=poumon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=39
- en:end stage cancer ---
r_associated #0: 38 -->
en:mesothelial neoplasm
n1=en:end stage cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=38
- en:epulides ---
r_associated #0: 38 -->
en:mesothelial neoplasm
n1=en:epulides | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=38
- en:serous membrane ---
r_associated #0: 38 -->
en:mesothelial neoplasm
n1=en:serous membrane | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=38
- tumeur adénomatoïde ---
r_associated #0: 38 -->
en:mesothelial neoplasm
n1=tumeur adénomatoïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=38
- en:X ray therapy ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:X ray therapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- en:blood or lymphatic cancer ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:blood or lymphatic cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- en:nervous system tumor morphology ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:nervous system tumor morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- en:oligodendroglioma ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:oligodendroglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- en:osteosarcoma ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:osteosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- en:pancreas cancer ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=en:pancreas cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- mésothéliome ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=mésothéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- neurofibromatose de type périphérique ---
r_associated #0: 37 -->
en:mesothelial neoplasm
n1=neurofibromatose de type périphérique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=37
- Recklinghausen (neurofibromatose de) ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=Recklinghausen (neurofibromatose de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:hematopoietic and lymphoid cell neoplasm ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:hematopoietic and lymphoid cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:hypothalamic neoplasm ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:hypothalamic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:increased risk of gastrointestinal cancer ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:increased risk of gastrointestinal cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:malignancy in approximately 10% ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:malignancy in approximately 10% | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:mesothelioma ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:metastatic malignant neoplasm of unknown primary origin ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:metastatic malignant neoplasm of unknown primary origin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:multiple bilateral renal angiomyolipoma ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:multiple bilateral renal angiomyolipoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:neurofibromatosis ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:neurofibromatosis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:serous ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:serous | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:susceptibility to malignant melanoma ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:susceptibility to malignant melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- en:von Recklinghausen's disease ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=en:von Recklinghausen's disease | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- seconde tumeur maligne ---
r_associated #0: 36 -->
en:mesothelial neoplasm
n1=seconde tumeur maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=36
- cancer du côlon ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=cancer du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- dépistage des lésions du col de l'utérus ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=dépistage des lésions du col de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- embole de tumeur ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=embole de tumeur | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- embole tumoral ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=embole tumoral | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- embolie tumorale ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=embolie tumorale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:adrenal cortex carcinoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:adrenal cortex carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:alveolar cell carcinoma (some) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:alveolar cell carcinoma (some) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:benign digestive system neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:benign digestive system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:bile duct carcinoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:bile duct carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:bronchogenic carcinoma (some) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:bronchogenic carcinoma (some) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:burkitt lymphoma (b-cell lymphoma) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:burkitt lymphoma (b-cell lymphoma) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:cancer--living with cancer ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:cancer--living with cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:carotid body paraganglioma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:carotid body paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:childhood leukemia ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:childhood leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:colorectal cancer (in some patients) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:colorectal cancer (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:cyst ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:cyst | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:electric organ ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:electric organ | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:endocrine neoplasms malignant and unspecified ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:endocrine neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:epithelioid mesothelioma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:epithelioid mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:gangliocytoneuroma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:gangliocytoneuroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:gastric adenocarcinoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:gastric adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:giant cell tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:giant cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:hodgkin lymphoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:host-tumor interaction ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:host-tumor interaction | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:increased risk of breast cancer in women ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:increased risk of breast cancer in women | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:increased risk of leukemia ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:increased risk of leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:invasive malignant neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:invasive malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:lipomatous neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:lipomatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant adrenal gland neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant adrenal gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant epithelial neoplasms (all subtypes) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant epithelial neoplasms (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant head and neck neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant head and neck neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant neoplasm of upper limb nos ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of upper limb nos | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant pharyngeal neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant pharyngeal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant sex cord-stromal tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant sex cord-stromal tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant tumor involving an organ by direct extension from fallopian tube ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from fallopian tube | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant tumor of nerve sheath origin ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant tumor of nerve sheath origin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:malignant tumor of unknown origin or ill-defined site ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:malignant tumor of unknown origin or ill-defined site | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:metastatic tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:metastatic tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:minimal residual disease ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:minimal residual disease | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:miscellaneous and site unspecified neoplasms malignant and unspecified ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:miscellaneous and site unspecified neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:muscle tumors (all subtypes) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:muscle tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:neoplasm of uncertain behavior of other and unspecified sites and tissues ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:neoplasms, multiple primary ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:neoplasms, multiple primary | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:nerve sheath neoplasm ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:nerve sheath neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:no cancer despite harboring complete deletions of the tp53 gene ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:no cancer despite harboring complete deletions of the tp53 gene | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:nonestrogen-dependent cancer ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:nonestrogen-dependent cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:optic glioma (19%) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:optic glioma (19%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:ovarian sex cord-stromal tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:ovarian sex cord-stromal tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:parasitology ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:parasitology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:periampullary carcinoma nos ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:periampullary carcinoma nos | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:plasma cell myeloma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:plasma cell myeloma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:prostate carcinoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:prostate carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:roentgenographic ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:roentgenographic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:sarcoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:sex cord-stromal tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:sex cord-stromal tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:somatostatin-producing neuroendocrine tumor ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:somatostatin-producing neuroendocrine tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:squamous cell carcinoma (1 patient) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:squamous cell carcinoma (1 patient) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:thyroid cancer (follicular cell) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:thyroid cancer (follicular cell) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:undifferentiated carcinoma ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=en:undifferentiated carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- myélome plasmocytaire ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=myélome plasmocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- métastase tumorale ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=métastase tumorale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- métastase
(médecine, cancer) ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=métastase (médecine, cancer) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- néoplasme métastatique ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=néoplasme métastatique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- néoplasme secondaire ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=néoplasme secondaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- parasitologie ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=parasitologie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- sarcome ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=sarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- tumeur métastasique ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=tumeur métastasique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- tumeur secondaire ---
r_associated #0: 35 -->
en:mesothelial neoplasm
n1=tumeur secondaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=35
- en:acute megakaryoblastic leukemia ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:acute megakaryoblastic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:basal cell neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:basal cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:basocellular neoplasms develop after second decade ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:basocellular neoplasms develop after second decade | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:biphasic mesothelioma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:biphasic mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:bone metastases from squamous cell carcinoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:bone metastases from squamous cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:bone-forming neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:bone-forming neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:brain neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:brain neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:breast cancer, early-onset (in some patients) ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:breast cancer, early-onset (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:cylindromas may show malignant transformation ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:cylindromas may show malignant transformation | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:digestive system neoplasms ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:digestive system neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:disseminated malignant neoplasm, unspecified ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:disseminated malignant neoplasm, unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:duodenal carcinoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:duodenal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:egg shell ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:egg shell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:esophageal carcinoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:esophageal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:ethnologic ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:ethnologic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:extra-adrenal sympathetic paraganglioma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:extra-adrenal sympathetic paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:fibrohistiocytic neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:fibrohistiocytic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:frequent skin cancer ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:frequent skin cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:granular cell tumor and/or alveolar soft part sarcoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:granular cell tumor and/or alveolar soft part sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:increased risk in heterozygotes ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:increased risk in heterozygotes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:increased risk of malignancy ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:increased risk of malignancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:increased risk of myelodysplastic syndromes ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:increased risk of myelodysplastic syndromes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:kidney wilms tumor ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:kidney wilms tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:localized malignant neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:localized malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:male germ cell tumors (gct), 2 subtypes - ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:male germ cell tumors (gct), 2 subtypes - | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant (primary) neoplasm, unspecified ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant (primary) neoplasm, unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant breast neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant breast neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant fibromatous neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant fibromatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant neoplasm of bone, connective tissue, skin and breast ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of bone, connective tissue, skin and breast | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant neoplastic disease in mother complicating childbirth ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant neoplastic disease in mother complicating childbirth | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant thyroid gland neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant thyroid gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:malignant tumor involving an organ by direct extension from uterus ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from uterus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:multiple malignancy ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:multiple malignancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:multiple tumors in 28% of patients ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:multiple tumors in 28% of patients | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:myocardial rhabdomyoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:myocardial rhabdomyoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:neuronal or mixed neuronal-glial neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:neuronal or mixed neuronal-glial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:odontogenic neoplasm ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:odontogenic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:pancreatic squamous cell carcinoma ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:pancreatic squamous cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:pharmacotherapeutic ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:pharmacotherapeutic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:respiratory and mediastinal neoplasms malignant and unspecified ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:respiratory and mediastinal neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:skeletal neoplasms malignant and unspecified ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:skeletal neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:small cell carcinoma of the ovary, hypercalcemic type ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:small cell carcinoma of the ovary, hypercalcemic type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:soft tissue neoplasms malignant and unspecified ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=en:soft tissue neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- névrome cutané ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=névrome cutané | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- épidémiologique ---
r_associated #0: 34 -->
en:mesothelial neoplasm
n1=épidémiologique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=34
- en:bone sarcoma ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=en:bone sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- en:cervical cancer screening ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=en:cervical cancer screening | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- en:secondary neoplasm ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=en:secondary neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- lymphome folliculaire ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=lymphome folliculaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- maladie résiduelle ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=maladie résiduelle | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- neurofibromatose de type VI ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=neurofibromatose de type VI | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- oligodendrogliome ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=oligodendrogliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- tumeur tubulopapillaire du rein ---
r_associated #0: 33 -->
en:mesothelial neoplasm
n1=tumeur tubulopapillaire du rein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=33
- chorio-carcinome ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=chorio-carcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- dysgerminome ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=dysgerminome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:abdominal tumors (immunodeficiency-associated form) ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:abdominal tumors (immunodeficiency-associated form) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:acute monoblastic leukemia ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:acute monoblastic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:ampulla of vater adenocarcinoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:ampulla of vater adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:aspects of radionuclide imaging ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:aspects of radionuclide imaging | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:basocellular neoplasms ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:basocellular neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:benign female reproductive system neoplasm ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:benign female reproductive system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:cervical carcinoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:cervical carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:classic hodgkin lymphoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:classic hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:colon carcinoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:colon carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:cutaneous leiomyosarcoma (less common) ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:cutaneous leiomyosarcoma (less common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:cystic, mucinous and/or serous neoplasm ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:cystic, mucinous and/or serous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:dysgerminoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:dysgerminoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:etiology aspects ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:etiology aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:fibrosarcoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:fibrosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:growth hormone-producing pituitary gland neoplasm ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:growth hormone-producing pituitary gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:hereditary neoplastic syndrome ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:hereditary neoplastic syndrome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:increased incidence of rectosigmoid cancer ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:increased incidence of rectosigmoid cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:increased risk for hematologic cancer, particularly acute myeloid leukemia ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:increased risk of chondrosarcoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:increased risk of chondrosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:malignant neoplasm musculoskeletal ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm musculoskeletal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:malignant white blood cell disorder ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:malignant white blood cell disorder | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:miscellaneous mesenchymal tumors (all subtypes) ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:miscellaneous mesenchymal tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:multiple tumors ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:multiple tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neoplasm of perivascular myoid type - category ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neoplasm of perivascular myoid type - category | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neoplasm of unspecified nature of bone, soft tissue, and skin ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neoplasm of unspecified nature of bone, soft tissue, and skin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neoplasm/cancer invasiveness ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neoplasm/cancer invasiveness | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neoplasms by histologic type ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neoplasms by histologic type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neoplastic polyp ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neoplastic polyp | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:neural tissue tumors ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:neural tissue tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:other hematologic disorders ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:other hematologic disorders | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:papillary renal cell adenoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:papillary renal cell adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:parathyroid gland adenoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:parathyroid gland adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:precursor lymphoblastic leukemia/lymphoma (all subtypes) ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:precursor lymphoblastic leukemia/lymphoma (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:propensity to tumor development ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:propensity to tumor development | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:psychology qualifier ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:psychology qualifier | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:sacrococcygeal teratoma ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:sacrococcygeal teratoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:susceptibility to myelodysplasia ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:susceptibility to myelodysplasia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:teratoid tumor, atypical ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:teratoid tumor, atypical | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:thyroid gland neoplasm ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:thyroid gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:tumor lysis syndrome adverse event ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=en:tumor lysis syndrome adverse event | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- fibrosarcome ---
r_associated #0: 32 -->
en:mesothelial neoplasm
n1=fibrosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=32
- en:adnexal and/or skin appendage neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:adnexal and/or skin appendage neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:adrenal gland pheochromocytoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:adrenal gland pheochromocytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:aids related neoplasm/cancer ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:aids related neoplasm/cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:benign male reproductive system neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:benign male reproductive system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:benign soft tissue neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:benign soft tissue neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:bilateral malignant neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:bilateral malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:breast carcinoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:breast carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:carcinogenesis ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:carcinogenesis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:cutaneous radiotherapy ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:cutaneous radiotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:epidemiologic ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:epidemiologic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:follicular lymphoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:follicular lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:gallbladder carcinoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:gallbladder carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:gastrointestinal stromal tumors (less common) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:gastrointestinal stromal tumors (less common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:gene mutation-related cancer ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:gene mutation-related cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:haematopoietic neoplasms (excl leukaemias and lymphomas) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:in situ neoplasm (morphology) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:in situ neoplasm (morphology) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:increased incidence of hepatocellular carcinoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:increased incidence of hepatocellular carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:increased risk of chondrosarcoma (mean age of onset 31 years) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:increased risk of chondrosarcoma (mean age of onset 31 years) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:increased susceptibility to hematologic malignancies ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:increased susceptibility to hematologic malignancies | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:jaw and kidney tumor (endemic form) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:jaw and kidney tumor (endemic form) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:jugulotympanic paraganglioma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:jugulotympanic paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:lung carcinoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:lung carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:malignant lung neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:malignant lung neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:malignant tumor involving an organ by direct extension from prostate ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from prostate | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:melanocytic neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:melanocytic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:mesonephric neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:mesonephric neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:mesothelial neoplasms ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:mesothelial neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:myxoid subcutaneous tumors ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:myxoid subcutaneous tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:neoplasm of unspecified nature of respiratory system ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:neoplasm of unspecified nature of respiratory system | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:neuroepitheliomatous neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:neuroepitheliomatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:ovarian carcinoma ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:ovarian carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:papillary neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:papillary neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:pheochromocytoma, extraadrenal (21%) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:pheochromocytoma, extraadrenal (21%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:rarely malignant ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:rarely malignant | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:refractory malignant neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:refractory malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:reported colon and other abdominal cancer in relatives ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:reported colon and other abdominal cancer in relatives | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:rhabdoid tumors, malignant (renal or extrarenal) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:rhabdoid tumors, malignant (renal or extrarenal) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:skeletal neoplasms benign ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:skeletal neoplasms benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:small intestine carcinoid ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:small intestine carcinoid | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:superficial radiotherapy ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:superficial radiotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:tumors of the sympathetic nervous system (5 to 10%) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:tumors of the sympathetic nervous system (5 to 10%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- en:well differentiated malignant neoplasm ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=en:well differentiated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- ganglioneurome ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=ganglioneurome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- neurofibromatose ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=neurofibromatose | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- pancréas (cancer du) ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=pancréas (cancer du) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- tumeurs hématopoïétiques ---
r_associated #0: 31 -->
en:mesothelial neoplasm
n1=tumeurs hématopoïétiques | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=31
- SIP ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=SIP | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- adénosarcome sébacé ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=adénosarcome sébacé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- blastome ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=blastome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:acute lymphoblastic leukemia (in 1 patient) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:acute lymphoblastic leukemia (in 1 patient) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:acute monocytic leukemia ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:acute monocytic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:anaplastic malignant neoplasm ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:anaplastic malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:basal cell nevus ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:basal cell nevus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:benign tumors of the eye, heart, and lungs ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:benign tumors of the eye, heart, and lungs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:bladder urothelial carcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:bladder urothelial carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:breast neoplasms benign (incl nipple) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:breast neoplasms benign (incl nipple) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:carotid body tumors (most common location) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:carotid body tumors (most common location) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:digestive system carcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:digestive system carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:endocrine system cancer ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:endocrine system cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:epidemiological ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:epidemiological | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:fibroelastoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:fibroelastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:increased risk of hematologic malignancy (1 patient) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:increased risk of hematologic malignancy (1 patient) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:increased risk of pancreatic cancer ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:increased risk of pancreatic cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:juvenile ovarian granulosa cell tumor ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:juvenile ovarian granulosa cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:kaposi sarcoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:kaposi sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:liver neoplasms ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:liver neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:lung adenocarcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:lung adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:malignant neoplasm associated with transplant organ ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm associated with transplant organ | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:malignant neoplasm of anorectum ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of anorectum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:malignant urinary system neoplasm ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:malignant urinary system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:neoplasm by morphology ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:neoplasm by morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:neoplasm of uncertain behavior of endocrine glands and nervous system ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain behavior of endocrine glands and nervous system | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:neoplasms, cystic, mucinous, and serous ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:neoplasms, cystic, mucinous, and serous | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:neoplasms, glandular and epithelial ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:neoplasms, glandular and epithelial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:neuroepithelial, perineurial, and schwann cell neoplasm ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:neuroepithelial, perineurial, and schwann cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:oropharyngeal squamous cell carcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:oropharyngeal squamous cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:ovarian cystadenoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:ovarian cystadenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:paraganglioma and/or glomus tumor ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:paraganglioma and/or glomus tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:parotid gland monomorphic adenoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:parotid gland monomorphic adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:pheochromocytoma, adrenal (53%) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:pheochromocytoma, adrenal (53%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:phyllodes tumor ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:phyllodes tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:poorly differentiated malignant neoplasm ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:poorly differentiated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:preneoplastic state ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:preneoplastic state | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:renal and urinary tract neoplasms malignant and unspecified ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:renal and urinary tract neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:stage 0 cervical cancer ajcc v6 ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:stage 0 cervical cancer ajcc v6 | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:subependymoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:subependymoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:transaminase cell carcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:transaminase cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:tumor embolism ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:tumor embolism | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:undifferentiated and biphenotypic leukemia (all subtypes) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:undifferentiated and biphenotypic leukemia (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:undifferentiated malignant neoplasm ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:undifferentiated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- en:uterine leiomyosarcoma (less common) ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=en:uterine leiomyosarcoma (less common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- ethnologique ---
r_associated #0: 30 -->
en:mesothelial neoplasm
n1=ethnologique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=30
- cancer à cellules claires du rein ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=cancer à cellules claires du rein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- carcinome embryonnaire ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=carcinome embryonnaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:cancer alternative therapies ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:cancer alternative therapies | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:cancer-related condition ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:cancer-related condition | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:chemically induced ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:chemically induced | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:childhood brain neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:childhood brain neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:choriocarcinoma ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:choriocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:colorectal cancer, early onset ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:colorectal cancer, early onset | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:complication aspects ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:complication aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:epithelial carcinoma ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:epithelial carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:gastrointestinal neoplasms malignant and unspecified ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:gastrointestinal neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:immunodeficiency-related malignant neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:immunodeficiency-related malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:increased risk of tumor formation, especially of the head ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:increased risk of tumor formation, especially of the head | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:laryngeal carcinoma ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:laryngeal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant kidney neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant kidney neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant neoplasm after immunosuppressive therapy ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm after immunosuppressive therapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant neoplasm of respiratory system ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of respiratory system | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant neoplasm of thoracic vertebral column ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of thoracic vertebral column | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant neoplasms of ill-defined, secondary and unspecified sites ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant neoplasms of ill-defined, secondary and unspecified sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:malignant vaginal neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:malignant vaginal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:moderately differentiated malignant neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:moderately differentiated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:mucoepidermoid tumor ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:mucoepidermoid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:multiple schwannomas ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:multiple schwannomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:neoplasm/cancer site ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:neoplasm/cancer site | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:neoplasms, connective tissue ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:neoplasms, connective tissue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:nervous system neoplasms malignant and unspecified nec ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:nervous system neoplasms malignant and unspecified nec | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:oral cavity neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:oral cavity neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:primary adrenocortical nodular hyperplasia ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:primary adrenocortical nodular hyperplasia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:radiation-related malignant neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:radiation-related malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:skin appendage tumors may show malignant transformation ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:skin appendage tumors may show malignant transformation | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:therapy-related malignant neoplasm ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:therapy-related malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- en:« osteogenic » sarcoma ---
r_associated #0: 29 -->
en:mesothelial neoplasm
n1=en:« osteogenic » sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=29
- cancer du poumon ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=cancer du poumon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- dépistage du cancer du col de l'utérus ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=dépistage du cancer du col de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:anal carcinoma ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:anal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:aspects of mortality statistics ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:aspects of mortality statistics | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:b-cell non-hodgkin lymphoma ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:b-cell non-hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:bone neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:bone neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:cancerous tumour ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:cancerous tumour | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:cervical cancer (rare) ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:cervical cancer (rare) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:childhood malignant neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:childhood malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:colloid tumor ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:colloid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:colorectal cancer ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:colorectal cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:environment related neoplasm/cancer ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:environment related neoplasm/cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:epithelial neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:epithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:giant cell lesion of small bones ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:giant cell lesion of small bones | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:increased risk of testicular cancer ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:increased risk of testicular cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:increased susceptibility to cancer ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:increased susceptibility to cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant digestive system neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant digestive system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant neoplasm of connective tissue ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of connective tissue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant neoplasm of pelvis ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of pelvis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant neoplasm, primary site unknown, so stated ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm, primary site unknown, so stated | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant thoracic neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant thoracic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:malignant tumor involving vasa deferentia by direct extension from prostate ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving vasa deferentia by direct extension from prostate | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:mammary ductal fibroadenoma ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:mammary ductal fibroadenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:metastatic qualifier ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:metastatic qualifier | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:multiple giant cell granulomas (bones, joints, soft tissues) ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:multiple giant cell granulomas (bones, joints, soft tissues) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:myomatous neoplasm ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:myomatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:neoplasms, post-traumatic ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:neoplasms, post-traumatic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:papillary renal cell carcinoma ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:papillary renal cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:paragangliomas, head and neck (79%) ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:paragangliomas, head and neck (79%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:susceptibility to myeloid leukemia ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:susceptibility to myeloid leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- en:thyroid gland papillary carcinoma ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=en:thyroid gland papillary carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- leucémie aiguë lymphoïde ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=leucémie aiguë lymphoïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- métastase
(médecine) ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=métastase (médecine) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- radiographique ---
r_associated #0: 28 -->
en:mesothelial neoplasm
n1=radiographique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=28
- biopsie ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=biopsie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:benign endocrine neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:benign endocrine neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:biliary tract neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:biliary tract neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:biopsy ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:biopsy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:blood supply aspects ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:blood supply aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:cancer of nose ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:cancer of nose | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:cancerous tumor ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:cancerous tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:cervical neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:cervical neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:chronic lymphocytic leukemia ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:chronic lymphocytic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:epulis ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:epulis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:ganglioneuroma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:ganglioneuroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:gelatinous tumor ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:gelatinous tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:giant cell astrocytoma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:giant cell astrocytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:gonadoblastoma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:gonadoblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:hepatobiliary neoplasms malignant and unspecified ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:hepatobiliary neoplasms malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:hereditary malignant neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:hereditary malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:increased hepatocellular carcinoma risk ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:increased hepatocellular carcinoma risk | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:increased malignancy risk, especially lymphoma and skin neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:increased malignancy risk, especially lymphoma and skin neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:islet cell tumor ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:islet cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:kaposi sarcoma (1 patient) ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:kaposi sarcoma (1 patient) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:lymphatic vessel neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:lymphatic vessel neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant fibrous histiocytoma (in about 35% of patients) ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant fibrous histiocytoma (in about 35% of patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant neoplasm of liver ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of liver | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant neoplasm of lower limb ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of lower limb | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant neoplasm of other and ill-defined sites: other ill-defined sites ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of other and ill-defined sites: other ill-defined sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant neoplasm of other specified sites ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of other specified sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant nervous system neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant nervous system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant soft tissue neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant soft tissue neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:malignant tumor, clear cell type ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:malignant tumor, clear cell type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:mast cell neoplasm ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:mast cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:neuroblastoma (less common) ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:neuroblastoma (less common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:parotid gland adenoma and adenocarcinoma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:parotid gland adenoma and adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:parotid oncocytomas ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:parotid oncocytomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:pheochromocytomas, extraadrenal (48%) ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:pheochromocytomas, extraadrenal (48%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:sinonasal undifferentiated carcinoma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:sinonasal undifferentiated carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:skin basal cell carcinoma ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:skin basal cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:starry sky pattern ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:starry sky pattern | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:testicular sertoli cell tumor, calcified ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:testicular sertoli cell tumor, calcified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:tunica serosa ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:tunica serosa | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- en:vulvar cancer ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=en:vulvar cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- leucémie lymphoïde chronique ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=leucémie lymphoïde chronique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- maladie résiduelle imperceptible ---
r_associated #0: 27 -->
en:mesothelial neoplasm
n1=maladie résiduelle imperceptible | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=27
- Lipome ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=Lipome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- cancer des testicules ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=cancer des testicules | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- cancer embryonnaire ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=cancer embryonnaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- chordome ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=chordome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:acute lymphoblastic leukemia ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:acute lymphoblastic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:aids-related malignant neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:aids-related malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:benign epithelial neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:benign epithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:breast cancer (rare) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:breast cancer (rare) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:embryonal carcinoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:embryonal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:endolymphatic sac tumor ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:endolymphatic sac tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:gastric carcinoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:gastric carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:genital cancer ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:genital cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:increased risk for multiple myeloma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:increased risk for multiple myeloma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:increased risk of malignancy (classic feature) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:increased risk of malignancy (classic feature) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:laryngeal neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:laryngeal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:male breast carcinoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:male breast carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant cell ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant cell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant neoplasm of abdomen ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of abdomen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant peripheral nerve sheath tumor ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant peripheral nerve sheath tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant peripheral nerve sheath tumors (21%) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant peripheral nerve sheath tumors (21%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant tumor involving an organ by direct extension from endometrium ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from endometrium | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:malignant tumor involving an organ by direct extension from vagina ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from vagina | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:mesothelioma, malignant, after asbestos exposure ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:mesothelioma, malignant, after asbestos exposure | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:mucosal neuromas ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:mucosal neuromas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:multicystic mesothelioma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:multicystic mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:neoplasm related morbidities ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:neoplasm related morbidities | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:optic nerve glioma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:optic nerve glioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:paraganglioma, catecholamine-secreting ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:paraganglioma, catecholamine-secreting | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:paragangliomas, head and neck (31%) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:paragangliomas, head and neck (31%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:parathyroid gland carcinoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:parathyroid gland carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:pheochromocytomas, adrenal (28%) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:pheochromocytomas, adrenal (28%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:plasmacytoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:plasmacytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:primary malignant neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:primary malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:prostate neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:prostate neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:radiation-related neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:radiation-related neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:renal cortical adenoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:renal cortical adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:sarcomatoid mesothelioma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:sarcomatoid mesothelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:signet ring cell carcinoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:signet ring cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:soft tissue tumor and/or sarcoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:soft tissue tumor and/or sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:therapeutic aspects ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:therapeutic aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:thyroid follicular cell tumor ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:thyroid follicular cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:thyroid gland oncocytic neoplasm ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:thyroid gland oncocytic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:tumors at multiple other sites including cns ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:tumors at multiple other sites including cns | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:unilateral vestibular schwannoma ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:unilateral vestibular schwannoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- en:vestibular schwannoma (over 90% of patients) ---
r_associated #0: 26 -->
en:mesothelial neoplasm
n1=en:vestibular schwannoma (over 90% of patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=26
- LaM ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=LaM | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- angiome ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=angiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- cancer sébacé ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=cancer sébacé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- en:acoustic neuroma ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=en:acoustic neuroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- en:adenoid tumor ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=en:adenoid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- en:malignant neoplasm of duodenum ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of duodenum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- en:malignant neurinoma ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=en:malignant neurinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- en:neurilemoma ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=en:neurilemoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- néoplasme mésothélial ---
r_associated #0: 25 -->
en:mesothelial neoplasm
n1=néoplasme mésothélial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=25
- carcinome sébacé ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=carcinome sébacé | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- cholangiocarcinome ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=cholangiocarcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- en:angioneoplasm ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=en:angioneoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- en:desmocytoma ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=en:desmocytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- en:glandular carcinoma ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=en:glandular carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- en:secondary carcinoma ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=en:secondary carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- leucémie lymphoïde aiguë ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=leucémie lymphoïde aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- maladie de Recklinghausen ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=maladie de Recklinghausen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- neurofibromatose de type 1 ---
r_associated #0: 24 -->
en:mesothelial neoplasm
n1=neurofibromatose de type 1 | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=24
- carcinogenèse ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=carcinogenèse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- carcinome rénal à cellules claires ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=carcinome rénal à cellules claires | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- en:adenomata ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=en:adenomata | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- en:cancerous growth ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=en:cancerous growth | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- en:spindle cell sarcoma ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=en:spindle cell sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- maladie de von Recklinghausen ---
r_associated #0: 23 -->
en:mesothelial neoplasm
n1=maladie de von Recklinghausen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=23
- Méningiomes ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=Méningiomes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- Recklinghausen (maladie de von) ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=Recklinghausen (maladie de von) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- cancer du sein ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=cancer du sein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- carcinome du poumon ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=carcinome du poumon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- en:Hodgkin lymphoma ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=en:Hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- en:Kaposi sarcoma ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=en:Kaposi sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- en:mucous tumor ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=en:mucous tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- en:myxoblastoma ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=en:myxoblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- en:peripheral glioma ---
r_associated #0: 22 -->
en:mesothelial neoplasm
n1=en:peripheral glioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
- adénocarcinome gastrique ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=adénocarcinome gastrique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- en:mastadenoma ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=en:mastadenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- en:primary malignant germ cell neoplasm ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=en:primary malignant germ cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- leucémie aiguë lymphoblastique ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=leucémie aiguë lymphoblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- mesothéliome ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=mesothéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- traitement aux rayons ---
r_associated #0: 21 -->
en:mesothelial neoplasm
n1=traitement aux rayons | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=21
- Biopsie ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Biopsie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Cancer de l'endomètre ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Cancer de l'endomètre | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Cancer duodénal ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Cancer duodénal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Leucémie myéloïde aiguë ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Leucémie myéloïde aiguë | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Mélanome ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Mélanome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Rétinoblastome ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Rétinoblastome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Séreuse ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Séreuse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Séreux ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Séreux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- Tumeur de l'utérus ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=Tumeur de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:accelerated neoplasm growth ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:accelerated neoplasm growth | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:acoustic schwannoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:acoustic schwannoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:acute leukemia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:acute leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:adenocarcinoma (some) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:adenocarcinoma (some) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:adenoid cystic carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:adenoid cystic carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:adenoma and/or adenocarcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:adenoma and/or adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:adipocytic tumors (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:adipocytic tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:adrenal glands are most common site ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:adrenal glands are most common site | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:advanced malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:advanced malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:aggravated malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:aggravated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:angiolipoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:angiolipoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:aplastic anemia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:aplastic anemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:approximately 10% of cases are paraneoplastic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:approximately 10% of cases are paraneoplastic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:associated with other malignancies ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:associated with other malignancies | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:astrocytoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:astrocytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:b-cell lymphomas ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:b-cell lymphomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:bence jones proteins increased ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:bence jones proteins increased | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:benign genitourinary tract neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:benign genitourinary tract neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:benign nervous system neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:benign nervous system neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:benign skin neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:benign skin neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:benign teratoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:benign teratoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:biological polymorphism ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:biological polymorphism | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:bladder carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:bladder carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:bladder neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:bladder neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:body constitution ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:body constitution | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:body system/site cancer ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:body system/site cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:brain morphology ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:brain morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:breast cancer, lobular ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:breast cancer, lobular | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:breast neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:breast neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:breast neoplasms malignant and unspecified (incl nipple) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:breast neoplasms malignant and unspecified (incl nipple) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:carcinoid tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:carcinoid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:carcinoma in situ ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:carcinoma in situ | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:carcinosarcoma of skin ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:carcinosarcoma of skin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cardiovascular neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cardiovascular neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:carotid body tumors (most common) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:carotid body tumors (most common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cartilage-forming neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cartilage-forming neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cellular morphology ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cellular morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cellular secretion ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cellular secretion | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:central nervous system embryonal neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:central nervous system embryonal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chemical aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chemical aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chemotherapy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chemotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chondrogenic neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chondrogenic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:choroid plexus carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:choroid plexus carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chromaffin cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chromaffin cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chronic leukemia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chronic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chronic lymphocytic leukemia, b-cell, susceptibility to ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chronic lymphocytic leukemia, b-cell, susceptibility to | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chronic monocytic leukemia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chronic monocytic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:chronic myelogenous leukemia, bcr-abl1 positive ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:chronic myelogenous leukemia, bcr-abl1 positive | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:clear cell acanthoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:clear cell acanthoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:colon polyp ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:colon polyp | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:complex epithelial neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:complex epithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:complex mixed and stromal neoplasms ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:complex mixed and stromal neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:complex mixed and/or stromal neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:complex mixed and/or stromal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:compound eye ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:compound eye | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:congenital mesh qualifier ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:congenital mesh qualifier | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:craniopharyngioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:craniopharyngioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cutaneous melanoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cutaneous melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:cystadenoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:cystadenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:desmoid-type fibromatosis ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:desmoid-type fibromatosis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:desmoplastic small cell tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:desmoplastic small cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:development of tumors in adulthood ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:development of tumors in adulthood | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:diagnosis aspect ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:diagnosis aspect | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:disseminated malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:disseminated malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ductal and lobular neoplasms ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ductal and lobular neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ductal breast carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ductal breast carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ductal, lobular and/or medullary neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ductal, lobular and/or medullary neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:duodenal carcinoid ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:duodenal carcinoid | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:dysplasia with neoplasia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:dysplasia with neoplasia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:early-onset hepatocellular carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:early-onset hepatocellular carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ebv-induced b-cell lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ebv-induced b-cell lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:embryologic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:embryologic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:embryonal neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:embryonal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:endometrial adenocarcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:endometrial adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:environment-related malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:environment-related malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ependymoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ependymoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ewing sarcoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ewing sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:exposure as collected domain ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:exposure as collected domain | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:extra-adrenal paraganglioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:extra-adrenal paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:fibroblastic/myofibroblastic tumors (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:fibroblastic/myofibroblastic tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:fibroepithelial neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:fibroepithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:fibromatous neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:fibromatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:fibrous connective tissue neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:fibrous connective tissue neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:follicular neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:follicular neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ganglioneuroblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ganglioneuroblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:genetic aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:genetic aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:genitourinary neoplasms ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:genitourinary neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:germ cell and gonadal stromal cell neoplasms (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:germ cell and gonadal stromal cell neoplasms (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:germ cell tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:germ cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:gestational trophoblastic tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:gestational trophoblastic tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:giant cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:giant cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:glioblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:glioblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:glioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:glioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:glomus tympanicum paraganglioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:glomus tympanicum paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:granular cell tumors and alveolar soft part sarcomas ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:granular cell tumors and alveolar soft part sarcomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hamartoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hamartoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:heart dimension/size ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:heart dimension/size | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hemophagocytic lymphohistiocytosis ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hemophagocytic lymphohistiocytosis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hemophagocytic lymphohistiocytosis (in some patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hemophagocytic lymphohistiocytosis (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hepatic and biliary neoplasms benign ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hepatic and biliary neoplasms benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hepatoblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hepatoblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hepatocellular carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hepatocellular carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:historical aspects qualifier ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:historical aspects qualifier | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hormone related neoplasm/cancer ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hormone related neoplasm/cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:hypersensitivity to chemotherapy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:hypersensitivity to chemotherapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:imaginal discs ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:imaginal discs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:immunology aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:immunology aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:in blood ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:in blood | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:in cerebrospinal fluid ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:in cerebrospinal fluid | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:in urine ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:in urine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk for embryonal tumors ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk for embryonal tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk for lymphoma hodgkin disease ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk for lymphoma hodgkin disease | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk for monoclonal gammopathy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk for monoclonal gammopathy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk for wilms tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk for wilms tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk of malignant lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk of malignant lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk of medulloblastoma (rare) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk of medulloblastoma (rare) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased risk of myelodysplastic syndrome or leukemia (in some patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to b-cell lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased susceptibility to b-cell lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:increased susceptibility to large granular lymphocytic t-cell leukemia ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:increased susceptibility to large granular lymphocytic t-cell leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:index tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:index tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:intra-abdominal cancer advanced ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:intra-abdominal cancer advanced | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:invertebrate cuticle ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:invertebrate cuticle | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:leukemia (both all and aml) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:leukemia (both all and aml) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lip and oral cavity carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lip and oral cavity carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:liver carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:liver carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lund ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lund | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lymphoma (in some patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lymphoma (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lymphomas nec ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lymphomas nec | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lymphoproliferative disorder (in some patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lymphoproliferative disorder (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:lymphosarcoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:lymphosarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignancy (34%) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignancy (34%) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant bladder neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant bladder neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant endocrine neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant endocrine neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant giant cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant giant cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant intestinal neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant intestinal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant lipomatous neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant lipomatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm (morphology) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm (morphology) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm associated with aids ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm associated with aids | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm by grade ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm by grade | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of digestive organs and peritoneum ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of digestive organs and peritoneum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of gartner's duct ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of gartner's duct | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of genitourinary organ ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of genitourinary organ | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of lip, oral cavity and pharynx ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of lip, oral cavity and pharynx | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of multiple primary sites ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of multiple primary sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of other and unspecified sites ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of other and unspecified sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of skeletal system ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm of skeletal system | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm, uncertain whether primary or metastatic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasm, uncertain whether primary or metastatic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplasms of respiratory and intrathoracic organs ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplasms of respiratory and intrathoracic organs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant neoplastic disease in pregnancy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant neoplastic disease in pregnancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant ovarian neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant ovarian neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant skin appendage neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant skin appendage neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant solid tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant solid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant spindle cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant spindle cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant thymus neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant thymus neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant tumor involving an organ by direct extension from bladder ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from bladder | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant tumor involving an organ by direct extension from ovary ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from ovary | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant tumor involving an organ by direct extension from uterine cervix ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant tumor involving an organ by direct extension from uterine cervix | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant tumor of lymphoid hemopoietic and related tissue ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant tumor of lymphoid hemopoietic and related tissue | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:malignant tumor, small cell type ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:malignant tumor, small cell type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mature b-cell neoplasms (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mature b-cell neoplasms (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mature t- and nk-cell neoplasms (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mature t- and nk-cell neoplasms (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:medulloblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:medulloblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:meningothelial cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:meningothelial cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mesenchymal cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mesenchymal cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mesothelial cell ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mesothelial cell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mesothelium ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mesothelium | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:metabolic aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:metabolic aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:metachronous malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:metachronous malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:metastatic neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:metastatic neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:miscellaneous and site unspecified neoplasms benign ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:miscellaneous and site unspecified neoplasms benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:miscellaneous bone tumors ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:miscellaneous bone tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:miscellaneous soft tissue tumors (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:miscellaneous soft tissue tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:miscellaneous tumors ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:miscellaneous tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:mixed neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:mixed neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:morphology ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:multicystic mesothelioma, benign ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:multicystic mesothelioma, benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:multiple tumors in 74% of patients ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:multiple tumors in 74% of patients | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:myelodysplastic syndrome ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:myelodysplastic syndrome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:myxomatous neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:myxomatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm by site ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm by site | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm by special category ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm by special category | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of uncertain behavior, site unspecified ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain behavior, site unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of uncertain histogenesis ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain histogenesis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of uncertain malignant potential ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of uncertain malignant potential | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of unspecified nature of other genitourinary organs ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of unspecified nature of other genitourinary organs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm of unspecified nature of other specified sites ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm of unspecified nature of other specified sites | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasm/cancer type ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasm/cancer type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms of histiocytes and accessory lymphoid cells ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms of histiocytes and accessory lymphoid cells | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms of uncertain or unknown behaviour ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms of uncertain or unknown behaviour | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms, adnexal and skin appendage ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms, adnexal and skin appendage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms, experimental ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms, experimental | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms, hormone-dependent ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms, hormone-dependent | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplasms, second primary ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplasms, second primary | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplastic mesothelial cell ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplastic mesothelial cell | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neoplastic processes ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neoplastic processes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neuroblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neuroblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neuroendocrine neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neuroendocrine neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:neurofibroma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:neurofibroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nevi and melanomas ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nevi and melanomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nevus and/or melanoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nevus and/or melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:no progression to cancer ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:no progression to cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:non-hematologic malignancy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:non-hematologic malignancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:non-hodgkin lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:non-hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nonmelanoma skin cancer (in some patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nonmelanoma skin cancer (in some patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nonneoplastic disorders/lesions (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nonneoplastic disorders/lesions (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nursing therapy ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nursing therapy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:nutritional management ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:nutritional management | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:oral cavity carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:oral cavity carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:oropharyngeal carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:oropharyngeal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:osseous and chondromatous neoplasms ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:osseous and chondromatous neoplasms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:osseous and/or chondromatous neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:osseous and/or chondromatous neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:osteogenic/miscellaneous bone tumors (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:osteogenic/miscellaneous bone tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:osteosarcoma and meningioma especially ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:osteosarcoma and meningioma especially | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pancreatic adenocarcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pancreatic adenocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:papillary thyroid carcinoma (rare) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:papillary thyroid carcinoma (rare) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:paraganglioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:paraneoplastic sps is associated with breast cancer and other malignancies ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:paraneoplastic sps is associated with breast cancer and other malignancies | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:paraneoplastic syndrome ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:paraneoplastic syndrome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:parathyroid disease rare ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:parathyroid disease rare | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pathological aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pathological aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:physiopathological ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:physiopathological | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pigmentation ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pigmentation | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pilocytic astrocytoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pilocytic astrocytoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pituitary gland adenoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pituitary gland adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pituitary gland neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pituitary gland neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:plant morphology ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:plant morphology | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:plasma cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:plasma cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:plasma cell neoplasms (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:plasma cell neoplasms (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:possible increased risk of germ-cell tumors ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:possible increased risk of germ-cell tumors | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:possibly increased risk for other cancers ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:possibly increased risk for other cancers | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:possibly increased risk of cancer ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:possibly increased risk of cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:predisposition to uv-induced malignancies ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:predisposition to uv-induced malignancies | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:pregnancy complications, neoplastic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:pregnancy complications, neoplastic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:primary malignant liver neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:primary malignant liver neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:prolactin-producing pituitary gland adenoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:prolactin-producing pituitary gland adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:protozoal cyst ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:protozoal cyst | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:psammomatous melanotic schwannomas ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:psammomatous melanotic schwannomas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:psychological aspect of cancer ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:psychological aspect of cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:radiotherapeutic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:radiotherapeutic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:recurrent malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:recurrent malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:rehabilitation aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:rehabilitation aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:renal and urinary tract neoplasms benign ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:renal and urinary tract neoplasms benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:renal cell carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:renal cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:renal cell carcinoma (less common) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:renal cell carcinoma (less common) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:renal cell carcinoma, usually clear cell type ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:renal cell carcinoma, usually clear cell type | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:reproductive and genitourinary neoplasms gender unspecified nec ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:reproductive and genitourinary neoplasms gender unspecified nec | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:reproductive neoplasms female malignant and unspecified ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:reproductive neoplasms female malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:reproductive neoplasms male malignant and unspecified ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:reproductive neoplasms male malignant and unspecified | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:retinal cell neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:retinal cell neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:rhabdoid tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:rhabdoid tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous adenoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:sebaceous adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sebaceous epithelioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:sebaceous epithelioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:seminoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:seminoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sensitivity to genotoxic agents ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:sensitivity to genotoxic agents | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sertoli cell tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:sertoli cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:sertoli-leydig cell ovarian tumors may occur ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:sertoli-leydig cell ovarian tumors may occur | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:skin cancer susceptibility ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:skin cancer susceptibility | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:skin squamous cell carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:skin squamous cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:small intestinal carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:small intestinal carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:soft tissue sarcoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:soft tissue sarcoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:solid neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:solid neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:squamous cell carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:squamous cell carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:squamous cell carcinoma (skin and tongue) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:squamous cell carcinoma (skin and tongue) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:squamous cell carcinoma (skin or mucosa) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:squamous cell carcinoma (skin or mucosa) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:squamous epitheliomas, multiple ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:squamous epitheliomas, multiple | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:surgical aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:surgical aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:synovial neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:synovial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:synovial-like neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:synovial-like neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:t-cell non-hodgkin lymphoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:t-cell non-hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:taxonomic ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:taxonomic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:testicular sertoli cell tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:testicular sertoli cell tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:thymoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:thymoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:thymus epithelial neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:thymus epithelial neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:thyroid gland carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:thyroid gland carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:thyroid gland medullary carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:thyroid gland medullary carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:thyroid gland oncocytic adenoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:thyroid gland oncocytic adenoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:transitional cell papilloma and/or carcinoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:transitional cell papilloma and/or carcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:trichoblastoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:trichoblastoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:trophoblastic tumor ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:trophoblastic tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:tumor cells, benign ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:tumor cells, benign | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:tumor in vein ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:tumor in vein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:ultrastructure ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:ultrastructure | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:unresectable malignant neoplasm ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:unresectable malignant neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:use of ultrasonography ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:use of ultrasonography | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:uveal melanoma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:uveal melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:vagus nerve paraganglioma ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:vagus nerve paraganglioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:vascular and perivascular tumors (all subtypes) ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:vascular and perivascular tumors (all subtypes) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:veterinary aspects ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:veterinary aspects | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- en:viruses ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=en:viruses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- gliome astrocytaire ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=gliome astrocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- néoplasme ---
r_associated #0: 20 -->
en:mesothelial neoplasm
n1=néoplasme | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=20
- second cancer ---
r_associated #0: 16 -->
en:mesothelial neoplasm
n1=second cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=16
- Adénome ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Adénome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer de l'oesophage ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer de l'oesophage | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer de l'utérus ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer de la gorge ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer de la gorge | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer des testicules ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer des testicules | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer du col de l'utérus ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer du col de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer du sang ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer du sang | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer du sein ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer du sein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Cancer du testicule ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Cancer du testicule | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Carcinome colorectal ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Carcinome colorectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Chordome ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Chordome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Enzymologie ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Enzymologie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Hémangiome ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Hémangiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- LLC
(médecine) ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=LLC (médecine) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Leucémie aiguë lymphoblastique ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Leucémie aiguë lymphoblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Leucémie aigüe myéloïde ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Leucémie aigüe myéloïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Leucémie lymphoïde chronique ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Leucémie lymphoïde chronique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Microbiologique ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Microbiologique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Ostéosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Parasitologie ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Parasitologie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Tumeurs du pancréas ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=Tumeurs du pancréas | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- adénine-phosphoribosyltransférase (APRTase) (déficit en) ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=adénine-phosphoribosyltransférase (APRTase) (déficit en) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- anémie médullaire ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=anémie médullaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- anémie par aplasie médullaire ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=anémie par aplasie médullaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- cancer épidermoïde ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=cancer épidermoïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- carcinome malpighien ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=carcinome malpighien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- carcinome médullaire de la thyroïde ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=carcinome médullaire de la thyroïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- carcinome spino-cellulaire ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=carcinome spino-cellulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- chronique leucémie lymphoïde ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=chronique leucémie lymphoïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- en:vascular tumor ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=en:vascular tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- fibromyalgie (critères de l' American College of Rheumatology ) ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=fibromyalgie (critères de l' American College of Rheumatology ) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- gliome (classifications de l'OMS) ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=gliome (classifications de l'OMS) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- lymphome malin diffus ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=lymphome malin diffus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- lymphome à cellules b ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=lymphome à cellules b | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- maladie clinique de recklinghausen ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=maladie clinique de recklinghausen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- métastase ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=métastase | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- non précisée, anémie aplasique ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=non précisée, anémie aplasique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- tumeur bénigne de la peau ---
r_associated #0: 15 -->
en:mesothelial neoplasm
n1=tumeur bénigne de la peau | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- LLC ---
r_associated #0: 11 -->
en:mesothelial neoplasm
n1=LLC | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=11
- chorio-épithéliome ---
r_associated #0: 11 -->
en:mesothelial neoplasm
n1=chorio-épithéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=11
- chorioépithéliome ---
r_associated #0: 11 -->
en:mesothelial neoplasm
n1=chorioépithéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=11
- leucose ---
r_associated #0: 11 -->
en:mesothelial neoplasm
n1=leucose | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=11
- Cancer colorectal ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Cancer colorectal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Cancer des os ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Cancer des os | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Cancer du côlon ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Cancer du côlon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Cancers ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Cancers | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Carcinogenèse ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Carcinogenèse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Cholangiocarcinome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Cholangiocarcinome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Chopart (désarticulation de) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Chopart (désarticulation de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- LANL ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=LANL | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Leucémie ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Leucémie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Leucémie aiguë myéloblastique ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Leucémie aiguë myéloblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Lung ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Lung | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Melanoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Melanoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Méningiome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Méningiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Mésothéliome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Mésothéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Nesbit (opération de) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Nesbit (opération de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Neurofibromatose ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Neurofibromatose | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Paraquat ® (intoxication par le) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Paraquat ® (intoxication par le) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Radiothérapie ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Radiothérapie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Sarcome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Sarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- Schwann (gaine de) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=Schwann (gaine de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- anémie aplasique ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=anémie aplasique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- anémie aplasique non précisée ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=anémie aplasique non précisée | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- aplasie médullaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=aplasie médullaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- aplasie érythrocytaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=aplasie érythrocytaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- cachexie maligne ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=cachexie maligne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- cancer de l'ovaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=cancer de l'ovaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- carcinome spinocellulaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=carcinome spinocellulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- carcinome squameux ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=carcinome squameux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- carcinome trophoblastique ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=carcinome trophoblastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- crabes ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=crabes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- cyst ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=cyst | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- dépendance environnementale (syndrome de) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=dépendance environnementale (syndrome de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- dépistage des lésions du col de l?utérus ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=dépistage des lésions du col de l?utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:Recklinghausen's disease ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:Recklinghausen's disease | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:acoustic neurinoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:acoustic neurinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:acute lymphocytic leukemia ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:acute lymphocytic leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:adipose wen ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:adipose wen | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:and endocrine overactivity ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:and endocrine overactivity | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:angioma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:angioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:breast tumor ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:breast tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:breastcancer ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:breastcancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:cancer of the breast ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:cancer of the breast | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:cancer of the colon ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:cancer of the colon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:cancer of the oesophagus ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:cancer of the oesophagus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:carcinoma of colon ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:carcinoma of colon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:carcinoma of the breast ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:carcinoma of the breast | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:cholangiocarcinoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:cholangiocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:chronic lymphocytic leukaemia ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:chronic lymphocytic leukaemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:chronic lymphoid leukemia ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:chronic lymphoid leukemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:colon malignancy ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:colon malignancy | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:ethnological ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:ethnological | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:fatty tumor ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:fatty tumor | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:fatty tumour ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:fatty tumour | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:in situ cancer ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:in situ cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:lymphocytic leukaemia ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:lymphocytic leukaemia | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:malignant duodenal neoplasm ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:malignant duodenal neoplasm | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:mastocarcinoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:mastocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:metrocarcinoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:metrocarcinoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:oesophageal cancer ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:oesophageal cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:radiographic ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:radiographic | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:spotty pigmentation ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:spotty pigmentation | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:type I ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:type I | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:type VI ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:type VI | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- en:von recklinghausen's disease ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=en:von recklinghausen's disease | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- gliome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=gliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- hamartoma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=hamartoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- interaction hôte-tumeur ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=interaction hôte-tumeur | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- lymphome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=lymphome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- lymphome malin non hodgkinien ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=lymphome malin non hodgkinien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- lymphome malin à cellules à noyaux non encochés ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=lymphome malin à cellules à noyaux non encochés | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- lymphome non hodgkinien ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=lymphome non hodgkinien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- lymphomes non hodgkiniens ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=lymphomes non hodgkiniens | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- malignité ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=malignité | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- morphologie des tumeurs du système nerveux ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=morphologie des tumeurs du système nerveux | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- myxoïde (dégénérescence) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=myxoïde (dégénérescence) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- myélome (manifestations rénales du) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=myélome (manifestations rénales du) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- mélanisation (unité épidermique de) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=mélanisation (unité épidermique de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- méningé (syndrome) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=méningé (syndrome) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- neurinome bilatéral du nerf cochléaire (VIII) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=neurinome bilatéral du nerf cochléaire (VIII) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- oeil à facettes ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=oeil à facettes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- ostéoporose-pseudogliome (syndrome) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=ostéoporose-pseudogliome (syndrome) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- processus néoplasiques ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=processus néoplasiques | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- propension au développement tumoral ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=propension au développement tumoral | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- radiothérapie (et insuffisance rénale) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=radiothérapie (et insuffisance rénale) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- radiothérapie superficielle ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=radiothérapie superficielle | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- reclassement professionnel ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=reclassement professionnel | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- risque accru de tumeur de Wilms ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=risque accru de tumeur de Wilms | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- risque accru de tumeurs embryonnaires ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=risque accru de tumeurs embryonnaires | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- risque possiblement accru de tumeurs germinales ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=risque possiblement accru de tumeurs germinales | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- sarcome des tissus mous ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=sarcome des tissus mous | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- sarcoïde de Spiegler-Fendt (sarcoïde de ) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=sarcoïde de Spiegler-Fendt (sarcoïde de ) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- siège primitif inconnu ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=siège primitif inconnu | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- taxinomique ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=taxinomique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- thymome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=thymome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tricho-épithéliome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tricho-épithéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- trichoépithéliome ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=trichoépithéliome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur de Wilms du rein ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur de Wilms du rein | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur des cellules des îlots ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur des cellules des îlots | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur des cordons sexuels et du stroma ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur des cordons sexuels et du stroma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur des cordons sexuels et du stroma ovarien ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur des cordons sexuels et du stroma ovarien | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur fibreuse solitaire pleurale ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur fibreuse solitaire pleurale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur gliale ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur gliale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur index ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur index | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur juvénile des cellules de la granulosa ovarienne ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur juvénile des cellules de la granulosa ovarienne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne d'origine de la gaine nerveuse ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne d'origine de la gaine nerveuse | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne d'origine inconnue ou de siège mal défini ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne d'origine inconnue ou de siège mal défini | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne d'un ovaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne d'un ovaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne de l'oropharynx ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'oropharynx | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne des tissus lymphoïde, hématopoïétique et apparentés ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne des tissus lymphoïde, hématopoïétique et apparentés | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne des voies génito-urinaires ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne des voies génito-urinaires | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne du stroma des cordons sexuels ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne du stroma des cordons sexuels | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant les canaux déférents par extension directe de la prostate ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant les canaux déférents par extension directe de la prostate | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de l'endomètre ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de l'endomètre | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de l'ovaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de l'ovaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de l'utérus ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de la prostate ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de la prostate | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de la trompe de Fallope ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de la trompe de Fallope | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe de la vessie ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe de la vessie | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe du col de l'utérus ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe du col de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne impliquant un organe par extension directe du vagin ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne impliquant un organe par extension directe du vagin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur maligne ovarienne ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur maligne ovarienne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur neuroendocrine produisant de la somatostatine ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur neuroendocrine produisant de la somatostatine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur testiculaire à cellules de Sertoli ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur testiculaire à cellules de Sertoli | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur à cellules de Sertoli ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur à cellules de Sertoli | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeur à cellules folliculaires thyroïdiennes ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeur à cellules folliculaires thyroïdiennes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs multiples ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs multiples | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs multiples chez 28% des patients ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs multiples chez 28% des patients | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs multiples chez 74% des patients ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs multiples chez 74% des patients | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs osseuses diverses ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs osseuses diverses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs sous-cutanées myxoïdes ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs sous-cutanées myxoïdes | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- tumeurs à cellules granuleuses et sarcomes alvéolaires des parties molles ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=tumeurs à cellules granuleuses et sarcomes alvéolaires des parties molles | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- épithélioma spinocellulaire ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=épithélioma spinocellulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- étalement(d&apos,uneirradiation) ---
r_associated #0: 10 -->
en:mesothelial neoplasm
n1=étalement(d&apos,uneirradiation) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=10
- gliome du nerf optique ---
r_associated #0: 6 -->
en:mesothelial neoplasm
n1=gliome du nerf optique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=6
- Angiome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=Angiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- Cancer du poumon ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=Cancer du poumon | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- Letterer-Siwe (maladie de) ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=Letterer-Siwe (maladie de) | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- Vibrisses ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=Vibrisses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- adéno-acanthome du col utérin ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=adéno-acanthome du col utérin | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- adénoacanthome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=adénoacanthome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- adénoaméloblastome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=adénoaméloblastome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- adénocarcinome endométrial ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=adénocarcinome endométrial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- anémie aplastique ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=anémie aplastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- anémie par atteinte isolée de la lignée rouge ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=anémie par atteinte isolée de la lignée rouge | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- aplasie de globules rouges purs ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=aplasie de globules rouges purs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- aplasie des globules rouges purs ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=aplasie des globules rouges purs | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- aplasie isolée de la lignée rouge ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=aplasie isolée de la lignée rouge | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- aplasie primitive de la lignée rouge ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=aplasie primitive de la lignée rouge | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- astrocytome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=astrocytome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- cancer médullaire de la thyroïde ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=cancer médullaire de la thyroïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- carcinome intra-épithélial ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=carcinome intra-épithélial | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- carcinome épidermoïde ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=carcinome épidermoïde | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- craniopharyngiome classique ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=craniopharyngiome classique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- craniopharyngiome de l'adulte ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=craniopharyngiome de l'adulte | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- craniopharyngiome papillaire ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=craniopharyngiome papillaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- déficit en adénine-phosphoribosyltransférase ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=déficit en adénine-phosphoribosyltransférase | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- en:angiome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=en:angiome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- en:colon cancer ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=en:colon cancer | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- fibroplastique ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=fibroplastique | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome de haut grade ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome de haut grade | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome de l'utérus ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome de l'utérus | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome des voies optiques ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome des voies optiques | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome du chiasma ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome du chiasma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome malin du nerf optique et du chiasma ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome malin du nerf optique et du chiasma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome nasal ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome nasal | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- gliome papillaire ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=gliome papillaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- hamartome ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=hamartome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- leucémie aigüe myéloblastique (LAM) : stratification de risques ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=leucémie aigüe myéloblastique (LAM) : stratification de risques | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas aberrant ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas aberrant | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas accessoire ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas accessoire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas annulaire ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas annulaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas artificiel ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas artificiel | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas de Willis ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas de Willis | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas de Winslow ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas de Winslow | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréas divisum ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréas divisum | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- pancréastatine ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=pancréastatine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- tumeur dans la veine ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=tumeur dans la veine | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- tumeur maligne de l'ovaire ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=tumeur maligne de l'ovaire | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- tumeur maligne endocrinienne ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=tumeur maligne endocrinienne | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- tumeurs diverses ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=tumeurs diverses | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- tumeurs à plusieurs autres sites, y compris le système nerveux central ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=tumeurs à plusieurs autres sites, y compris le système nerveux central | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- Événement indésirable du syndrome de lyse tumorale ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=Événement indésirable du syndrome de lyse tumorale | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
- épithélioma ---
r_associated #0: 5 -->
en:mesothelial neoplasm
n1=épithélioma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=5
|